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ABSTRACT 
 
Addiction to activity and to psychoactive substances share psychologically and 
physiological characteristics. A transcriptome study compared a mouse line selected for 
high voluntary activity to a control line in environments restricting or enabling a 
rewarding activity. Results offered insights into genetic factors behind activity 
dependence and provided a model for understanding addiction and other reward-
dependent behaviors.   
Most genes differentially expressed between activity genotypes were only 
moderately differentially expressed between activity environments, suggesting that 
environmental effects were not confounded with activity genotype effects. Adora2a had a 
significant genotype-by-environment interaction effect evidenced by over-expression in 
the activity genotype relative to control in high activity environment and under-
expression in the low activity environment.  Our findings of differentially expressed 
genes related to dopaminergic transmission between activity genotypes support the 
association between these genes and activity. A central theme from the functional 
analysis of activity genotype-environment was neuron morphogenesis. Gene network 
analysis identified connected genes that exhibited similar (e.g. Lhx9) and opposite (e.g. 
Nrgn) expression patterns between activity genotypes across reward availability 
environment. 
Our findings suggest that some transcriptomic changes in mice selected for high 
voluntary activity are shared with other reward-dependent behaviors. Results from this 
study support that high voluntary activity selection lines in mice are a helpful model to 
understand molecular mechanisms behind addition. Also, identification of genes and 
biological processes associated with both high voluntary activity and the pleasurable 
neurological response to physical activity may allow for the development of drugs which 
make it more pleasurable for people to exercise or less pleasurable to be sedentary as a 
treatment approach for overweight/obesity as well as a way to improve health overall in 
the general population. 
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
 
Exploring gene expression is necessary for understanding the functioning of an 
organism at system level. In the past years, advances in next-generation sequencing (NGS) 
technologies such as RNA-sequencing (RNA-seq) have provided crucial tools to study 
changes in transcriptome abundance. My research will illustrate how these advances help 
understand behavior, gene-environment and genotype-phenotype interactions in model 
animal systems. The present chapter presents an overview of the main topics of my thesis. 
 In chapter II, I used data from an RNA-seq experiment to uncover interaction and 
main effects of Myostatin genotype and exercise on muscle transcriptome. Levels of 
myostatin expression and physical activity have both been associated with transcriptome 
dysregulation and skeletal muscle hypertrophy. The transcriptome of triceps brachii 
muscles from male mice (strain C57/BL6) corresponding to two genotypes (wild-type 
and myostatin-reduced) under two conditions (high and low physical activity) was 
characterized using RNA-seq. In chapter III, I explored differential gene and transcript 
abundance to characterize the cerebellum of mice demonstrating a high desire for 
physical activity relative to control that are restricted from or allowed to exercise. I am 
using a mouse model of dependency to study the transcriptome of reward-dependent 
behaviors.  
 
Literature Review 
 
The environment influences the expression of genes and molds how the molecular 
machinery of an organism and corresponding holobiont (host and symbiogenic 
microbiota) reacts to external and internal cues. Simple abiotic external stimuli such as 
temperature, light and chemicals, or biotic factors such as bacteria, archaea, fungi, and 
viruses that cause disease or are beneficial for the well-being of interacting organism, are 
among many factors that readily change patterns of gene expression as the organism 
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adapts to environmental change. The environment also triggers more durable changes that 
are hardwired into the organismal make up. These changes provide internal cues that are, 
for example, responsible for metabolic effects on disease (Hunter, 2005), hormonal 
control of sex and development (Pieau & Dorizzi, 2004), obesity-causing misregulation 
(Duhl et al., 1994), or regulatory control of social behavior (Zayed & Robinson, 2012). 
The advent of comparative genomics revealed that the number of genes of an organism is 
surprisingly invariant along vast organismal transects and that the differences in 
organismal complexity arise from elaborate mechanisms of regulation that impact the 
expression of their genes more than their genetic makeup (Levine & Tijan, 2003). 
Genome-wide studies have also shown that seemingly small changes in gene regulation 
result in large changes of morphology and physiology and that gene-environment 
regulation can cause extensive transcriptional rewiring and major modulation of 
transcript abundance (Tuch et al., 2008). Consequently, changes in gene expression 
patterns are primarily regulatory, express mostly at transcript abundance level, and 
respond appropriately to the generally highly dynamic interaction that exists between 
organisms and their environments. These changes affect for the most part the vast 
networks of protein-protein interactions that are responsible for the phenotype, which in 
humans are in the millions (Stumpf et al., 2008). Exploring gene expression is therefore 
necessary for understanding the functioning of an organism at system level. In the past 
years, advances in next-generation sequencing (NGS) technologies such as RNA-
sequencing (RNA-seq) (Mortazavi et al., 2008) provided crucial tools to study changes in 
transcriptome abundance that are triggered by the many external and internal cues. This 
has changed the landscape of biological investigation, prompting a focus on 
bioinformatics, statistical genomics and system biology. The present research will 
illustrate how these advances help understand gene-environment interactions in model 
animal systems. 
Gene Expression Microarray platforms 
 
 Microarrays have long been the most popular option for profiling global gene 
expression.  Oligonucleotide ‘probes’ matching gene complements are synthesized and 
attached to specific positions of a microarray plate. Since each physical address of the 
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plate holds a specific oligonucleotide, addresses that “light up” indicate sets of genes 
present in DNA complementary to mRNA matching specific probes. While the use of 
microarrays is quick, cheap, and user-friendly, there is a substantial number of drawbacks 
to using this approach. These limitations have made finding an alternative method 
crucial. Firstly, hybridization methods such as those used in microarray profiling are 
limited by their reliance on existing genomic information. Microarrays must be built with 
in advance using known sequence information, meaning that the microarray resource 
becomes out-of-date as new genomic data is discovered and released. Additionally, this 
does not allow for discovery of new genes, since exploration is limited by the probes of 
the microarray plate. Hybridization-methods have high background levels and a limited 
dynamic range of detection, which results in low accuracy.  
Gene Expression RNA-seq platforms 
 
RNA-seq matches samples that you have, so your sample produces the actual 
outcome instead of using an external device limiting genomic features to be discovered. 
RNA-seq data can be reanalyzed an unlimited number of times as new information 
becomes available and updated tools and packages are released (Wang et al., 2009). The 
main benefit of RNA-seq approaches is that they allow for approximation of the 
abundance value of transcript (exactly how many copies of that transcript are present in 
the sample or biological endpoint). Sensitivity of microarrays is very low compared to 
RNA-Seq, so while you can measure increases or decreases in hydridization signal, it is 
impossible to numerically quantify changes in abundance relative to the entire 
transcriptomic profile. Microarray methods do not provide quantitative assessment of 
mRNA abundance nor dissect isoforms (Wang et al., 2009). 
 
Tuxedo Suite and Galaxy 
 
There are multiple methods available for RNA-seq; selection of a specific method 
for a study depends on various considerations, including factors such as transcript type, 
complexity or transcript boundaries. Transcriptome data appropriately processed can be 
analyzed using bioinformatics tools and software such as the TUXEDO suite, a collection 
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of applications to analyze differential gene expression (Langmead et al., 2009; Langmead 
& Salzberg, 2012; Trapnell et al., 2010; Trapnell et al., 2009). These applications are 
available free through Galaxy, a web-based gene expression analysis server (Goecks et 
al., 2010), which we make extensive use in the studies we here report.  Use of this suite 
follows a Bowtie/Tophat -> Cufflinks  ->  Cuffmerge  -> Cuffdiff workflow. Read 
alignment is performed by using either the Bowtie or Tophat applications depending on 
type of experiment and species studied. Bowtie, which is typically used to align shorter 
DNA reads to the human genome, is fast and memory efficient but not ideal for large 
genomes (Trapnell et al., 2012). Tophat, a fast splice junction mapper for RNA-seq reads, 
uses Bowtie to align reads to mammalian-sized genomes between 1 and 10 Gb (billions 
of base pairs per haploid genome) and identifies splice junctions between exons. 
Transcripts are assembled with the Cufflinks package, which also estimates abundances 
and tests for differential expression and regulation in RNA-seq samples. Cufflinks 
assembles aligned RNA-seq reads into transcripts and calculates estimates for the relative 
abundances of individual transcripts, using the number of reads supporting each transcript 
and controlling for library preparation protocol bias. After merging transcripts using 
Cuffmerge, Cuffdiff is used to compare the relative abundances of transcripts in various 
experimental conditions (Trapnell et al., 2012). 
 
RNA-seq data analysis process 
 
RNA-seq experiments follow a six-step pipeline (Van Verk et al., 2013), which is 
summarized here: 
 
Step 1: RNA-seq library preparation  
Before beginning data analysis, it is important to assess the quality of RNA, as 
poor quality can undermine the success of an experiment. Techniques such as Agilent 
Lab-on-Chip assay produce an RNA integrity number (RIN) between 1 and 10. A score 
of higher than 8 is typically considered favorable (Van Verk et al., 2013). 
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Step 2: Generating RNA-seq reads using Illumina-based sequencing  
To perform RNA-sequencing, mRNA is first converted into cDNA; these millions 
of DNA fragments (reads) become the RNA-library, which is subsequently sequenced to 
obtain the measure of relative abundance of each individual transcript. (Van Verk et al., 
2013) Currently, the most commonly used platform for RNA-seq analysis is the Illumina 
HiSeq platform. Total RNA is first quantified using a Nanodrop spectrophotometer and 
quality-assessed with an assay kit. NGS sequencing libraries are generated from around 
one microgram of total RNA using an RNA Sample Prep Kit (Illumina). Briefly, RNA is 
purified using oligo-T attached magnetic beads. After purification, the total poly A+ 
RNA is fragmented into small pieces. In the first strand of cDNA with random primers, 
the segmented mRNA fragments are reverse transcribed. These fragments are purified 
with a PCR extraction kit, resolved with elution buffer, and linked to sequencing 
adapters. The resulting libraries were then paired-end sequenced with the Illumina 
HiSeq™ 2000 system. Finally, complete paired end sequences are obtained as individual 
fastq files (forward and reverse) from output images with the CASAVA V 1.8.2 base 
calling software with ASCII Q-score offset 33 (Wang et al., 2009). 
 
 
Step 3: Assess read quality, Alignment of RNA-seq reads  
After these steps are performed, data is sent to the bioinformatics lab for 
downstream analysis in FastQ format, which includes both genomic and quality 
information. Quality is given in the format of a “PHRED” score (Q), calculated as p=10 (-
Q/10) where p is the probability that the corresponding base call is incorrect (An Extensive 
Evaluation of Read Trimming Effects on Illumina NGS Data Analysis). Adaptor 
sequences and low quality bases with PHERD scores (Q) ≤ 20 are typically removed 
(Wang et al., 2009). Read quality should be assessed using a tool like FastQC (Patel & 
Jain, 2012). FastQC allows data to be imported in various formats to check for unusual 
qualities that might indicate low sequence quality. Information is provided about the 
distribution of sequence length, overrepresented sequences, per sequence quality scores, 
and per base sequence quality. Summary graphs and tables are provided and quality can 
be assessed by visual inspection. (Patel & Jain, 2012) 
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At this point, if low quality portions of the NGS reads are present, read trimming 
can be performed to increase the quality and reliability of analysis. This is typically done 
by simply “surgically removing” the low quality bases (sequences?) and leaving the 
longest possible string of high quality sequence. Other common read preprocessing 
methods include duplicate removal, filtering contaminant sequences, or removal of 
adapter sequences. (Del Fabbro et al., 2013). 
Reads are then aligned to either a reference genome, transcriptome, or de novo 
assembly. In cases where a reference genome is not available, for example if a non-model 
organism is being studied with no genomic information available, a de novo assembly can 
be created- this method blindly reconstructs the genome/transcripome using software 
such as Trinity (Haas et al., 2013). Mapping to a reference genome allows for precise 
measurements of transcript abundance and the identification of splicing isoforms. (Del 
Fabbro et al., 2013). For alignment to the transcriptome, Bowtie and BWA are most 
commonly used (Van Verk et al., 2013). Alignment to the transcriptome takes longer than 
alignment to the genome since it is more computationally intensive. These two aligners 
are not “splice aware”, meaning that they cannot map reads over exon/intron junction. 
For alignment to a reference genome, splice aligner TopHat can be used (Van Verk et al., 
2013). 
Step 4: Assembly and quantification of gene expression  
Cufflinks, part of the Tuxedo suite, assembles the mapped reads (Trapnell et al., 
2010). Under Tophat, Bowtie previously flagged where reads match a location. Using the 
reference genome as a map, Cufflinks can assemble the reads where there is enough 
information to confirm the location.  Next, the number of reads that map to each gene or 
transcript isoform are counted in order to quantitatively interpret our RNA-seq results. 
This count is referred to as “abundance”. The more fragments of a transcript are 
sequenced, the more abundant that transcript is. Cuffmerge can merge multiple Cufflinks 
transcripts into a single transcriptome annotation file, which is useful for comparing 
results of different experimental conditions. 
Step 5: Normalization of RNA-seq count data  
Since most studies compare gene expression between different experimental 
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conditions and across samples, count data between different samples needs to be 
normalized in order to perform an accurate comparison. Differences in sequence depth 
and transcript length cause between-sample bias and within-sample bias, respectively. 
The most common normalization method is RPKM/FPKM (reads or paired-end 
fragments per kilobase of exon model per million mapped reads). This method both 
normalizes total gene length and the within-sample number of reads mapped, and is done 
in Cufflinks. 
Step 6: Differential gene expression 
Cuffdiff helps identify differences in transcript expression by calculating 
expression levels in more than one condition. They are then tested for significant 
differences. The FPKM (normalized) values from two conditions are divided from 
eachother and the log is taken. Next, the mean divided by the variance of this distribution 
provides a test statistic, which is used to calculate a P-Value and Q-Value (FDR adjusted 
p-value). A list of differentially expressed genes can be outputted and sorted by total 
expression levels in order to identify the most significant differentially expressed genes 
between conditions. 
 
Gene ontology analysis using D.A.V.I.D. 
Gene expression analyses give a large amount of extremely valuable data for 
downstream analysis. One crucial next step after gene expression profiling is to convert 
the large tables of gene lists into information that is adequately processed to biologically 
interpret results. The enrichment of functional categories and pathways among 
differentially expressed genes is one approach that can be explored using the web service 
Database for Analysis, Validation, and Integrated Discovery (DAVID; 
http://david.abcc.ncifcrf.gov). DAVID makes use of functional annotations derived from 
several genomic resources, including the Gene Ontology (GO) project and the Kyoto 
Encyclopedia of Genes and Genomes (KEGG). The GO project (Ashburner et al., 2000) 
is a community effort to define ontological terms associated with gene functions and 
annotate relevant biological information in a hierarchy, under three main GO functional 
categories, biological process (BP), molecular function (MF), and cellular components 
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(CC). These high level terms are root nodes with no common parent nodes, meaning that 
terms of the annotation hierarchy will originate from each of these three root terms and 
will produce directed acyclic graphs (DAG), in which child terms can be associated to 
multiple parents to establish functional relationships and associations. Figure 1.1 shows 
the hierarchical structure of GO terms. BP represents the biological objective to which 
the gene or its product contributes, MF refers to the biochemical activity of a gene 
product, and CC refers to the location in a cell where the gene product is active 
(Ashburner et al., 2000). Pathways were those defined by the Kyoto Encyclopedia of 
Genes and Genomes (KEGG, Kanehisa et al., 2008). Minimization of redundancy within 
BP, MF and KEGG terms was attained by using GO Functional Annotation Tool (FAT) 
categories, which comprise more general BP and MF terms while filtering broad and less 
informative terms (Dennis et al., 2003).  Statistical significance of the individual FAT or 
KEGG categories was based on the EASE Scores (modified Fisher Exact) available in 
DAVID. Further minimization of redundancy between FAT and KEGG categories was 
achieved through the use of clusters of categories that share genes. The statistical 
significance of these clusters was assessed using the enrichment score that corresponds to 
the geometric mean of the EASE Scores of the functional categories in the cluster (Huang 
da et al., 2007).  Evaluation of clusters of categories enabled the discovery of molecular 
processes that respond to variation in physical activity and myostatin genotype levels.   
 
Technical considerations in RNA-seq analysis 
 
Most reads will map to a single location in the genome or transcriptome. 
However, in some cases, reads may align with more than one location. These are known 
as “multi-reads”. This can be attributed to duplicated or overlapping genes, or repetitive 
regions (Van Verk et al., 2013). Read aligners handle multireads by either randomly 
assigning them to one of the mapped locations, or equally distributing fractions of a read 
to each matched location. This causes gene regions with multireads assigned to them to 
have a different per base coverage than others, which subsequently causes under or over-
estimation of the gene’s expression. These multireads are typically flagged in output and 
can be discarded, however, this leads to loss of information and accuracy when 
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estimating gene expression. Recent strategies have been developed that minimize 
information and power loss by assigning multireads to matched genes probabilistically. 
However, more research is needed to develop more effective ways to handle multireads 
in RNA-seq experiments (Van Verk et al., 2013). 
 
De novo transcriptome assembly 
 
Unfortunately, in some cases, no official reference genome for the species being 
studied exists. In this situation, there are effectively two representative approaches of 
profiling of gene expression using RNA-seq. One approach is for reads to be mapped to a 
related species. For example, in the case of quail, the closest reference genome would be 
that of the chicken. This approach can only measure expression of conserved regions in 
both species and is therefore unsuitable for precisely profiling the transcriptome. The 
second approach is making consensus by assembly reads to each other. There is a variety 
of assembly software available which can map the reads into assembled consensus sets 
without a reference genome for measurement of transcriptome levels.  
 
Rationale for the use of mouse as a model system 
 
The mouse (Mus musculus) has been selected as a useful model system for 
genomic, genetic and developmental research on mammalian species. While other 
organisms, such as yeast (Saccharomyces cerevisiae), worm (Caenorhabditis elegans) 
and fly (Drosophila melanogaster), represent excellent model systems for many 
biological and biomedical studies, especially for the study of development, the biology of 
the mouse has close genetic and physiological similarities to that of humans. Mammals 
arose 50-65 million years ago and rapidly diversified (Springer et al. 2004). They share a 
number of important biological features that unify many mammalian orders. For that 
reason, the mouse genome can be easily manipulated and analyzed using advanced 
techniques of genomic research for the study of the skeletal, nervous, immune, 
cardiovascular and endocrine systems of mammals. This helps the exploration of the 
molecular and physiological basis of numerous diseases that affect human and many 
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other mammalian organisms of economic and biological importance, including cancer, 
cardiovascular (e.g. heart and arterial diseases), metabolic (e.g. diabetes, obesity), 
neuromuscular (e.g. Parkinson’s, multiple sclerosis), and skeletal  (e.g. osteoporosis) 
disorders. Important diseases such as Alzheimer's, cystic fibrosis, and other 
neurodegenerative diseases, while not impacting the mouse, can be induced in the mouse 
and studied using the mouse model. Mice also represent excellent models for 
neurobiology and the study of behavior, including research on anxiety, aggressive 
behavior, drug and alcohol addiction. 
 A number of important resources support a vast scientific community exploring 
mouse biology, including integrated genetic, genomic and biology resource repositories 
(e.g. Mouse Genome Database; Eppig et al. 2014), gene expression (e.g. GXD; Smith et 
al. 2014), and developmental and functional databases (e.g. Mouse Atlas Project; 
Hayamizu et al. 2014) databases. The Mouse Genome Informatics initiative (MGI; 
http://www.informatics.jax.org) and the The Jackson Laboratory (public research center 
established in 1929) preserves and distributes mutant, transgenic and other variant mice, 
other resources, and important information for the mouse community. Genetically 
engineered mice (knockout mice) are available that have one or more genes made 
inoperable through gene knockout techniques. The Jackson Laboratory provides also 
genomic DNA and maintains a Bacterial Artificial Chromosome (BAC) library for 
distribution. MGI together with the International Mouse Strain Resource 
(http://www.findmice.org//index.jsp) provides information related to mutant genetic 
makeup, cryopreserved gametes, embryos or embryonic stem cells. Alleles of genes in 
gene trap libraries are available for example from the International Genetrap Consortium 
(IGTC; http://www.genetrap.org). 
 Adult mice weight 30-40 grams, multiply quickly (they reproduce as often as 
every 9 weeks) and have a relatively low cost of maintenance. Mouse are selected and 
bred to produce offspring with desirable traits utilizing the classical tools of genetics. 
Mice have been also exposed to DNA damage (irradiation and chemical mutagenesis) to 
produce variants that can be used as models of genetic disease. More recently, scientists 
have utilized numerous genetic technologies to produce ‘mouse models’ for the study of 
targeted genes and a wide array of specific diseases. Specifically, the creation of 
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transgenic mice, in which a new gene is inserted into the germline of the mouse, and the 
use of homologous recombination that permit to "knock out" and “knock in” genes 
(replacement of existing genes with altered versions in vitro or in situ), have generated 
invaluable information for our understanding the genome. There are over 450 inbred 
strains of mice providing information about their genotype and phenotype, and thousands 
of spontaneous, irradiation and chemically-induced mutants and transgenic lines. The 
Jackson Laboratory alone distributes 2,700 different strains and stocks as breeding mice, 
frozen embryos or DNA samples.  
The mouse has 20 chromosomes in its haploid genome (i.e. 40 total 
chromosomes), with most chromosomes being acrocentric (not metacentric like in 
humans) (Figure 1.2). The mouse genome has a genome size of ~2,800 millions of base 
pairs (Mb) and a GC content of 42%. The genome holds 48,807 genes organized in 279 
scaffolds encoding 78,107 proteins (updated 2/9/2015; NCBI; 
http://www.ncbi.nlm.nih.gov/genome/). There are 4.16 million records of curated gene 
expression profiles related to the mouse that have been deposited in the Gene Expression 
Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geoprofiles/) and ~272,000 gene 
expression datasets deposited in the GEO datasets repository  
(http://www.ncbi.nlm.nih.gov/gds/) of the NCBI. This wealth of information benefits the 
analysis of mouse gene expression patterns for the study of the transcriptome and the 
molecular biology of the cell. 
 
Project Summary 
 
My research will utilize NGS technologies to achieve the following three goals, 
each salient to the fields of animal sciences and bioinformatics:  
 
(1) Use massive parallel next-generation RNA-seq methods to characterize the complete 
transcriptome of triceps brachii muscles from myostatin-reduced and wild-
type/myostatin-typical mice at different physical activity levels. This work has been 
completed and published in PLoS ONE (Caetano-Anolles et al., 2015) 
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Myostatin is a hormonal protein responsible for inhibition of muscle growth and 
proliferation. Animals with Myostatin deficiencies show extremely large muscles and 
exhibit increased numbers and size of muscle fibers (McPherron & Lee, 1997). This is 
often referred to as ‘double muscling.’ While a substantial amount of research has been 
invested on the impact of Myostatin on muscle development during embryogenesis, very 
few studies have explored its effect when Myostatin is depleted post-development. This 
understanding is crucial, as researchers race for prevention and treatment of muscle 
diseases. In particular, genetic treatments to reduce Myostatin or exon skipping have 
potential to increase muscle mass in adults with disorders that affect muscle tone.  
Understanding the genetic factors behind the function of Myostatin is essential in 
this regard. Our study utilized a 2 x 2 factorial approach, with two treatment groups 
(encouraged to or restricted from exercising) and two mouse strains (Myostatin-knockout 
and wild-type mice). RNA-seq data was gathered from the triceps brachii muscles, 
processed in Galaxy, and gene expression profiles subjected to downstream analyses with 
DAVID and collection of relevant gene ontology (GO) information. We found 
differential expression of genes not previously linked with Myostatin, related genes such 
as Follistatin, or genes associated with skeletal muscle function. While these genes are 
generally connected to muscle contraction and regulation, their expression reveals that 
they may play an important role in how Myostatin affects muscle development. For 
example, the highly abundant CYP26B1 is a gene responsible for lipid metabolism and 
synthesis. The gene has been shown to signal aortic smooth muscle cells through all-
trans-retinoic acid regulation during cardiovascular development (Elmabsout et al., 2012; 
Ocaya et al., 2010; Nelson, 1999). There is no demonstration that CYP26B1 regulates 
aspects of muscle function and development other than those of a cardiovascular nature. 
Another highly expressed gene, TPM3, is essential for regulation of striated and smooth 
muscle contraction (Morris et al., 1991). Again, TPM3 has not been established to 
regulate any kind of muscle growth. These results reveal that genes once thought to 
exclusively control the contraction and function of fully developed muscles may have 
important roles in muscle development during myogenesis. 
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(2) Explore genomic variants at the RNA-level, transcription variants, and differential 
abundance of RNA-seq data obtained from the cerebellum of mice demonstrating a high 
desire for physical activity, similar to that of individuals with exercise dependence, and 
then either restricted from or allowed to exercise. (In progress) 
 The similarities between the biological reaction of the body to exercise and 
addiction-forming substances has been well established, laying the foundation for the use 
of exercise as a model for reward-dependent behaviors (Arias-Carrión et al., 2010; 
Hausenblas & Downs, 2002). The dopaminergic mesocorticolimbic system of the brain 
has a primary role in many aspects of reward-motivated response, such as associative 
learning or reinforcement and incentive salience (Berridge & Robinson, 1998; Chiara et 
al., 1999; Koob, 1992). The dopaminergic system has been shown to activate in studies 
where animals are provided with food or sexual stimuli, addictive substances, or 
electrical and self-stimulation, even reacting to secondary reinforcing stimuli (Ivlieva, 
2011). Exercise causes a synthesis and release of dopamine in the basal ganglia (Meussen 
et al., 1997), indicating that it activates the dopaminergic mesocorticolimbic brain system 
and the neural processes of physical activity overlaps with those of other rewards 
substances. Given that exercise dependence and addiction to psychoactive substances 
share these similar characteristics psychologically and biologically, research on mice 
with a desire for physical activity similar to that of individuals with exercise dependence 
can not only give us insight into genetic factors behind the characteristic but can provide 
a model for understanding drug addiction.   
 
3) In chapter IV, with the goal of using a mouse model of dependency to study the 
transcriptome of reward-dependent behaviors, I plan to explore differential gene and 
transcript abundance to characterize the cerebellum of mice demonstrating a high desire 
for physical activity relative to control that are restricted from or allowed to exercise. I 
plan to perform network analysis on the results of Chapter 3 to visualize the interactions 
between genes and associated addiction-related pathways to provide insight into 
similarities between addiction to drugs of abuse and addiction to exercise, as well as 
provide a foundation for better understanding gene interactions behind the unique 
phenotype and behavioral traits that selected mice in this experiment display.  
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FIGURES 
 
Figure 1.1 The hierarchical structure of Gene Ontology terms. 
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Figure 1.2 The 20 haploid set of the mouse genome (from NCBI Genome database). 
The X and Y chromosomes of the 20th set are shown.  
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CHAPTER 2: SYNERGISTIC AND ANTAGONISTIC INTERPLAY BETWEEN 
MYOSTATIN GENE EXPRESSION AND PHYSICAL ACTIVITY LEVELS ON 
GENE EXPRESSION PATTERNS IN TRICEPS BRACHII MUSCLES OF C57/BL6 
MICE 
 
Caetano-Anollés K, Mishra S, Rodriguez-Zas SL (2015) Synergistic and Antagonistic 
Interplay between Myostatin Gene Expression and Physical Activity Levels on Gene 
Expression Patterns in Triceps Brachii Muscles of C57/BL6 Mice. PLoS ONE 10(2): 
e0116828. doi:10.1371/journal.pone.0116828 
 
Published manuscript available at: 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0116828 
Abstract 
Levels of myostatin expression and physical activity have both been associated with 
transcriptome dysregulation and skeletal muscle hypertrophy. The transcriptome of 
triceps brachii muscles from male mice (strain C57/BL6) corresponding to two genotypes 
(wild-type and myostatin-reduced) under two conditions (high and low physical activity) 
was characterized using RNA-seq. Synergistic and antagonistic interaction and ortholog 
modes of action of myostatin genotype and activity level on genes and gene pathways in 
this skeletal muscle were uncovered. The number of genes exhibiting significant (FDR-
adjusted P-value < 0.005) activity-by-genotype interaction, genotype and activity effects 
were 1836, 238, and 399 genes respectively. The most common profiles were differential 
expression in (i) inactive myostatin-reduced relative to active and inactive wild-type, (ii) 
inactive myostatin-reduced and active wild-type, and (iii) inactive myostatin-reduced and 
inactive wild-type.  Several remarkable genes and gene pathways were identified. The 
expression profile of nascent polypeptide-associated complex alpha subunit (Naca) 
supports a synergistic interaction between activity level and myostatin genotype, while 
Gremlin 2 (Grem2) displayed an antagonistic interaction pattern. Comparison between 
activity levels revealed expression changes in genes coding for structural proteins that are 
important for muscle function (including troponin, tropomyosin and myoglobin) and 
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genes important for fatty acid metabolism (some linked to diabetes and obesity, DNA-
repair, stem cell renewal, and various forms of cancer). Conversely, comparison between 
genotype groups revealed changes in genes associated with G1-to-S-phase transition of 
the cell cycle of myoblasts and the expression of Grem2 proteins that modulate the 
cleavage of the myostatin propeptide.  A number of myostatin-feedback regulated gene 
products that are primarily regulatory were uncovered, including microRNA impacting 
central functions and Piezo proteins that make cationic current-controlling 
mechanosensitive ion channels. These important findings extend hypotheses of myostatin 
and physical activity master regulation of genes and gene pathways, impacting medical 
practices and therapies associated with muscle atrophy in humans and companion animal 
species and genome-enabled selection practices applied to food-production animal 
species.  
Introduction 
 
Genetic and non-genetic conditions impact the molecular pathways and 
physiology of the skeletal muscle. The myostatin (Mstn) gene encodes a growth and 
differentiating factor and hormonal protein responsible for inhibition of muscle growth 
and proliferation in vertebrates. myostatin negatively regulates muscle fiber number 
during skeletal muscle development (McPherron & Lee, 1997; McPherron et al., 1997) 
and inhibits myogenic differentiation by reducing mRNA levels of the muscle regulatory 
factors (Rios et al., 2002; Matsakas et al., 2012). Conversely, myostatin deficiency 
caused by alterations at the DNA or RNA level is linked to increased numbers and size of 
muscle fibers, a phenomenon often referred to as ‘double muscling (Grobet et al., 1997). 
Likewise, myostatin-deficient Cre/loxP mice show hyperplasia (increased number of 
muscle fibers) and hypertrophy in the skeletal muscle (Heineke et al., 2010). 
Physical activity influences muscle fiber in manners akin to the effect of 
myostatin deficiency (Bernardo et al., 2010). Contractile activity in muscle promotes 
changes in the synthesis and degradation of contractile and metabolic proteins that allow 
muscles to optimize, adapt, and endure activity (Kadi, 2000; Salmons & Vrbova, 1968; 
Cummins & Salmons, 1999). Activity causes an immediate sarcolemmal disruption that 
damages the cytoskeletal network. Muscle inflammation caused by physical activity is 
	 18	
accompanied by an increase of nitric oxide (NO) production, and skeletal muscle derived 
NO regulates contraction and metabolism as well as modulates muscle glucose uptake 
during activity (Kingwell, 2000).  
While targeted genetic and non-genetic studies have associated skeletal muscle 
hypertrophy to dysregulation of the IGF1-Akt-mTOR and myostatin-Smad2/3 signaling 
pathways, muscle atrophy has been associated to dysregulation of the autophagic-
lysosomal and proteasomal pathways (Schiaffino et al., 2013). Studies of the effect of 
myostatin deficiency using transgenic null myostatin (-/-) mice and quantitative real time 
PCR (qRT-PCR) identified over-expression of genes involved in myogenesis, protein 
degradation, extracellular matrix components and mitochondrial ATP synthesis (Zhao et 
al., 2009). Likewise, studies of the impact of physical activity on gene expression in the 
skeletal muscle using qRT-PCR demonstrated over-expression of myostatin and 
follistatin and under-expression of the myostatin receptor Activin IIB (ActRIIB) in 
murine limb muscles after acute physical activity (MacKenzie et al., 2013).  
Few studies have evaluated the simultaneous effects of physical activity and 
myostatin genotype on the transcripts in the skeletal muscle of mice (Matsakas et al., 
2012; Mosler et al., 2014). Results from one study demonstrated that the area of 
hypertrophic myofibres (extensor digitorum longus, gastrocnemius and rectus femoris 
muscles) in myostatin-depleted mice decreased towards wild-type levels meanwhile 
BCL2/Adenovirus E1B 19kDa Interacting Protein 3 (Bnip3), a key autophagy-related 
gene, was over-expressed in response to endurance exercise (Matsakas et al., 2012). Also, 
qRT-PCR profiling confirmed that activity increased the expression of the Uncoupling 
Protein 3 Mitochondrial, Proton Carrier (Ucp3), Carnitine Palmitoyltransferase 1A 
(Cpt1a), Pyruvate Dehydrogenase Kinase Isozyme 4 (Pdk4), and estrogen-related 
receptor-γ (Errγ) genes (Matsakas et al., 2012). Investigations focusing on the expression 
of a myostatin target gene, Mighty, using qRT-PCR suggested that acute resistance 
exercise decreased myostatin signaling in the skeletal muscle (soleus, plantaris and 
tibialis anterior muscles) of rats through the activation of the TGFβ inhibitor Notch. The 
activation of this inhibitor resulted in lower myostatin transcriptional activity that 
correlated with muscle hypertrophy (MacKenzie et al., 2013). A report of the effect of 
myostatin knockdown and exercise (swimming) in gastrocnemius muscle demonstrated 
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the over-expression of Pax-7 on knockdown mice without exercise relative to all other 
groups and over-expression of Myo-D on all knockdown mice irrespective of exercise 
level (Mosler et al., 2014). These previous studies have offered insights into the 
relationship between myostatin, physical activity and gene expression. However, studies 
that simultaneously consider genetic and non-genetic factors associated with the 
biological processes and molecular pathways in the skeletal muscle using high-
throughput sequencing-based techniques could allow for a more comprehensive 
understanding of molecular networks of the skeletal muscle.  
This study characterizes the complete transcriptome of triceps brachii muscles 
from C57/BL6 mice representing one of two genotype transcript levels (wild-type or 
myostatin typical and myostatin-reduced) and one of two physical activity levels (high 
and low) using massive parallel next-generation RNA sequencing. Synergistic, 
antagonistic and ortholog modes of action of the factors myostatin genotype and activity 
on genes and gene pathway profiles were investigated. This study is supported by: (a) 
mapping RNA sequencing reads to the mouse genome, identification of differentially 
expressed genes, and testing for differential expression among activity-genotype 
combination groups; (b) identification and interpretation of gene profiles revealing 
significant interaction between genotype and activity; (c) identification and interpretation 
of gene profiles revealing significant genotype (or activity) effect irrespective of activity 
(or genotype); and (d) functional analysis in support of the identification and 
interpretation of biological processes and pathways associated with genotype and activity 
levels. Our findings provide a basis to understand multifactorial gene regulation and 
dysregulation in triceps brachii and other skeletal muscles of mice. 
 
Materials and Methods 
Sample Collection 
 
Profiling information stems from an experiment comparing the transcriptome of a 
skeletal muscles, triceps brachii muscle of adult (6 months of age) male C57/BL6 mice 
(Personal communication with Welle S., 2014). Difference in gene expression associated 
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with two factors were studied. The factor termed genotype encompasses two levels: wild-
type mice exhibiting baseline expression of the myostatin gene and myostatin-reduced 
mice exhibiting lower expression of the myostatin gene.  The factor termed activity 
encompasses two levels: inactive and active. Four physical activity-by-genotype 
combination groups of mice were compared (n=3/group): (1) active and myostatin-
reduced, (2) inactive and wild-type (control genotype); (3) inactive and myostatin-
reduced; and (4) active and wild-type. Prior to the trial, mice were housed in standard 
cages in groups of 2 or 3, given ad libitum access to food and water and kept in a 12-hour 
dark cycle. Myostatin-reduced mice were developed from C57/BL6 mice with floxed 
myostatin that was activated using Cre recombinase. At 4 months of age, all mice were 
fed chow with 0.025% tamoxifen content for 6 weeks to activate the Cre Recombinase 
enzyme and deplete myostatin only in mice with floxed myostatin genes. Tamoxifen is 
used to induce the Cre recombinase; it binds to the mouse estrogen receptor and disrupts 
its interactions with “chaperone proteins”. Disruption of these interactions allows Cre-ER 
fusion proteins to enter the nucleus and perform recombination on the specific gene 
which has been floxed (Hayashi and McMahon, 2002). Myostatin was under-expressed 
(approximately 85%) in the myostatin-reduced mice. One week after the end of the 
tamoxifen feeding (approximately 6 months of age), mice in the active group were moved 
to be housed individually and given free access to running wheels during the last 12 
weeks of the study. Physical activity was monitored and the sum over 1-hour periods was 
recorded. At the end of the wheel-running period, all mice were euthanized and samples 
taken from their triceps brachii muscles were frozen in melting isopentane and stored at 
−70°C. Muscles were sampled from myostatin-reduced and control mice that were 
matched for running behavior; this was done to ensure that the amount of physical 
activity performed was not a contributor to differences in gene expression between 
control and myostatin-reduced mice. Polyadenylated RNA was extracted as directed by 
Invitrogen using a Trizol reagent, converted to cDNA, and amplified with an Illumina 
TruSeq RNA library preparation kit following manufacturer instructions. 
Triceps brachii muscle transcriptome was studied using Illumina Genome 
Analyzer IIx (Illumina, Inc. San Diego, CA) producing 65-base long single-end reads. 
Data processing was performed using CASAVA software. The 65-base sequence reads 
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were mapped to the mouse genome (mm9) using default settings and reads mapping to 
exons in the Refseq database (http://http://www.ncbi.nlm.nih.gov/refseq/) of transcripts 
were counted. Exon-level data was consolidated to gene-level read counts and 
summarized. Data normalization was performed so trimmed column means (excluding 
the highest and lowest 5th percentiles) were equal for all samples. In total, 13 protein-
coding mtDNA transcripts were mapped to NC_005089.1, counted separately, and 
normalized to the trimmed mean of the non-mitochondrial transcripts. The transcriptome 
data, additional experimental details and preliminary analysis are available in the 
National Center for Biotechnology Information, Gene Expression Omnibus database, 
accession number GSE31839 (Edgar et al., 2002). Results from these preliminary 
analysis uncovered a main effect of activity on genes associated with oxidative energy 
metabolism and no interaction between activity and myostatin levels. Results from 
advanced modeling and functional analysis of the experiment are presented.  
 
RNA-seq using Galaxy 
 
The RNA-seq workflow generally involves five sequential steps: (i) Establishing an 
experimental design that surveys a number of biological endpoints used for hypothesis 
testing; (ii) Isolation and purification of RNA (generally mRNA, but sometime small 
RNA), (iii) Conversion of RNA into cDNA and addition of sequencing adapters; (iv) 
cDNA sequencing using one of the many NGS platforms; and (v) Assembly of the short-
read sequences into transcription profiles and analysis. Here we focus on the assembly, 
statistical and downstream analysis of gene expression patterns (Figure 2.1). 
There are multiple methods available for RNA-seq; selection of a specific method 
for a study depends on various considerations, including factors such as transcript type, 
complexity or transcript boundaries. Transcriptome data appropriately processed can be 
analyzed using bioinformatics tools and software such as the TUXEDO suite, a collection 
of applications to analyze differential gene expression (Langmead et al., 2009; Langmead 
& Salzberg, 2012; Trapnell et al., 2010; Trapnell et al., 2009). These applications are 
available free through Galaxy, a web-based gene expression analysis server (Goecks et 
al., 2010), which we make extensive use in the studies we here report.  Use of this suite 
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follows a Bowtie/Tophat -> Cufflinks  ->  Cuffmerge  -> Cuffdiff workflow. Read 
alignment is performed by using either the Bowtie or Tophat applications, depending on 
type of experiment and species studied. Bowtie, which is typically used to align shorter 
DNA reads to the human genome, is fast and memory efficient but not ideal for large 
genomes (Trapnell et al., 2012). Tophat, a fast splice junction mapper for RNA-seq reads, 
uses Bowtie to align reads to mammalian-sized genomes between 1 and 10 Gb (billions 
of base pairs per haploid genome) and identifies splice junctions between exons. 
Transcripts are assembled with the Cufflinks package, which also estimates abundances 
and tests for differential expression and regulation in RNA-seq samples. Cufflinks 
assembles aligned RNA-seq reads into transcripts and calculates estimates for the relative 
abundances of individual transcripts, using the number of reads supporting each transcript 
and controlling for library preparation protocol bias. After merging transcripts using 
Cuffmerge, Cuffdiff is used to compare the relative abundances of transcripts in various 
experimental conditions (Trapnell et al., 2012). 
 
Data Analysis 
 
The 65-base, single-end sequence reads from FastQ files were mapped to the 
mouse mm10 genome assembly accessed from the UCSC Genome Browser database 
(http://genome.ucsc.edu). Prior to mapping, FastqGroomer was used to convert file 
format to FastqSanger (Blankenberg et al., 2010) and FastQC was used for quality 
control of the reads (Patel & Jain, 2012). Using Fastq Quality Trimmer, 3’ end positions 
that exhibited Phred quality values < 20 were removed. Data was normalized so trimmed 
transcript count means, excluding values in the upper and lower 5 percentiles, were the 
same for all samples. The 13 protein-coding mtDNA transcripts were mapped to 
`NC_005089.1 (Mus musculus mitochondrion, complete genome), counted separately, 
and normalized to the trimmed mean of non-mitochondrial transcript counts. Sequence 
reads were mapped using Tophat (v1.4.0), transcript isoforms were identified, quantified 
in number of fragments per kilobase of exon per million mapped reads (FPKM; Vivier et 
al., 2008), and differential transcript abundance was tested using Cufflinks routines 
including Cuffmerge, and Cuffdiff (v2.1.1) with default settings (Trapnell et al., 2012).  
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Differential expression was tested between activity-genotype groups, between activity 
groups and between genotype groups to determine the statistical significance of 
interaction and main effects on individual transcript isoforms (Le Bechec et al., 2011; 
Allison et al., 2002). False discovery rate (FDR) adjusted P-values were used to account 
for multiple test adjustment across transcripts (Benjamini & Hochberg, 1995; Storey, 
2002; Storey et al., 2004). The vast majority of the differentially expressed genes were 
represented by one transcript and thus, results are discussed on a gene basis. The routine 
workflow was implemented in Galaxy (Goecks et al., 2010; Blankenberg et al., 2011; 
Giardine et al., 2005). Comparisons of lists of differentially expressed genes among 
contrasts between pairs of activity-genotype combinations were visualized with Venn 
diagrams, created using VENNY, an online interactive tool for comparing lists (Oliveros, 
2007). 
 
Gene ontology analysis using D.A.V.I.D. 
 
Enrichment of functional categories and pathways among the differentially 
expressed genes was explored using the web service Database for Analysis, Validation, 
and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov). The Gene Ontology 
(GO) functional categories investigated included biological process (BP) and molecular 
function (MF), the biological objective to which the gene or its product contributes or the 
biochemical activity of a gene product, respectively (Ashburner et al., 2000), and 
pathways were those defined by the Kyoto Encyclopedia of Genes and Genomes (KEGG, 
Kanehisa et al., 2008). Minimization of redundancy within BP, MF and KEGG terms was 
attained by using GO Functional Annotation Tool (FAT) categories, which comprise 
more general BP and MF terms while filtering broad and less informative terms (Dennis 
et al., 2003).  Statistical significance of the individual FAT or KEGG categories was 
based on the EASE Scores (modified Fisher Exact) available in DAVID. Further 
minimization of redundancy between FAT and KEGG categories was achieved through 
the use of clusters of categories that share genes. The statistical significance of these 
clusters was assessed using the enrichment score that corresponds to the geometric mean 
of the EASE Scores of the functional categories in the cluster (Huang da et al., 2007).  
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Evaluation of clusters of categories enabled the discovery of molecular processes that 
respond to variation in physical activity and myostatin genotype levels.   
 
Identification of Synergistic and Antagonistic Gene Expression Patterns 
 
Beyond the identification of differentially expressed genes exhibiting significant 
physical activity-by-genotype interaction, this study aimed at uncovering the synergistic 
or antagonistic interplay between these factors. Six pairwise contrasts were used to 
profile the expression patterns: active wild-type vs inactive myostatin-reduced [AW-IM], 
active myostatin-reduced vs active wild-type [AM-AW], active myostatin-reduced vs 
inactive myostatin-reduced [AM-IM], inactive wild-type vs active wild-type [IW-AW], 
inactive wild-type vs active myostatin-reduced [IW-AM], and inactive wild-type vs 
inactive myostatin-reduced [IW-IM]. Among the genes that exhibited significant (FDR-
adjusted P-value < 0.001) activity-by-genotype interaction, alternative profiles of over- 
and under-expression or non-significant (raw P-value < 0.00005 or FDR-adjusted P-value 
< 0.05) differential expression in each of the six contrasts between pairs of activity-
genotype combinations were identified. The concept of synergism and antagonism has 
been used previously in studies on expression and regulation (Lutter et al., 2010). While 
positively correlated gene expression patterns indicate synergism, anti-correlated or 
uncorrelated expression patterns indicate antagonism between genes. In this study, a 
synergistic interaction was detected when the effect of a particular combination of 
genotype and activity levels on gene expression was more than the sum of the effects of 
genotype and activity levels considered independently.  In other words, synergistic 
effects were identified when the expression of a gene under a combination of genotype 
and activity levels was more extreme than the average expression under each level 
separately. Likewise, an antagonistic interaction was detected when the effect of a 
particular combination of genotype and activity levels on gene expression was less than 
the sum of the effects of genotype and activity levels considered independently. In other 
words, antagonistic effects were detected when the expression of a gene under a 
combination of genotype and activity levels was less extreme than the average expression 
under each level separately. Distinct profiles including a minimum of 50 genes were 
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further evaluated and functional categories enriched within cluster were investigated in 
DAVID.  
 
Presentation of findings  
 
Findings are presented and discussed in a sequence starting with genes exhibiting 
significant activity-by-genotype interaction, followed by genes exhibiting significant 
main effects of activity or genotype. Genes corresponding to transcripts exhibiting 
significant (FDR-adjusted P-value < 0.005; log2(fold change) > |1.3|) differential 
expression were identified in the Results section and their profile is discussed in the 
Discussion sections. Broader lists of genes reaching a lower significance threshold are 
presented in the supplementary materials (in File S1). Discussion focuses on gene 
expression patterns previously unreported in the context of the conditions studied and on 
patterns previously reported in similar or comparable studies. 
 
Results  
 
RNA-seq analysis and organization of findings 
 
Considering that myostatin inhibition and physical activity are being explored as 
treatment options for muscle degeneration and other disorders, it is important to 
understand the impact of these factors at the gene co-regulation level. The RNA-seq 
profile analyses revealed changes in the transcriptome of a skeletal muscle, the triceps 
brachii muscle, between C57/BL6 wild-type and myostatin-reduced mice under two 
physical activity conditions. First, the quality and quantity of the sequence reads was 
evaluated across samples. The average size of the RNA-seq FastQ file was 1.3 G 
bases/sample. The average quality score Phred of the reads along the 65 positions across 
all samples was 30. The number of reads and quality scores along the reads were 
comparable across samples from all four activity-by-genotype groups. Likewise, the 
percentage of reads mapped to the mouse genome was similar across samples and was on 
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average 84.6% (17,486,782 of 20,675,801 total reads mapped). Of these, 5,013,631 
(28.7%) had multiple alignments (12,183 had >20 alignments).   
 
Activity-by-genotype interaction effect on gene expression in triceps brachii muscles   
 
Overall, 1,836 genes exhibited significant (FDR-adjusted P-value < 0.005; 
maximum log2(fold change) > |1.3|) activity-by-genotype interaction. Table 2.1 lists 
genes exhibiting significant (FDR-adjusted P-value < 2XE-12) activity-by-genotype 
interaction effects due to space limitations. An extended list of differentially expressed 
genes with FDR-adjusted P-value < .01 is presented in Table S2.1 (supplementary table 
within published manuscript); in total, 84 genes were differentially expressed at this 
cutoff. The most extreme average fold change among genes exhibiting significant 
interaction was observed for the contrasts IM-AW, followed by IW-IM and AM-IM. This 
result indicates that the expression of genes in the inactive myostatin-reduced mice 
tended to be most different than the other three activity-genotype groups and this profile 
is a driving factor on the identification of genes expression exhibiting significant 
interaction. Conversely, on average the less extreme fold change among genes exhibiting 
significant interaction was observed in the contrast IW-AM. This finding reveals that 
these two conditions do not exhibit a synergistic effect among the genes presenting 
significant interaction.  
 
Patterns of differential gene expression across activity-genotype contrasts 
 
 The number of differentially expressed genes (P-value < 0.05) for AW-IM, AM-
AW, AM-IM, IW-AW, IW-AM, and IW-IM was 1,051, 86, 711, 119, 238 and 390, 
respectively. Several interpretations can be made from the progression of number of 
differentially expressed genes starting with the highest number in AM-IM followed by 
AM-IM, followed by IW-IM followed by AM-AW. Firstly, activity level was associated 
with more differentially expressed genes in myostatin-reduced mice than in the wild-type 
mice. Also, genotype was associated with more differentially expressed genes in active 
relative to inactive mice. Among all activity-genotype combination groups, inactive 
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myostatin-reduced mice exhibited the most number of differentially expressed genes 
relative to other activity-genotype combinations, including the highest number of over-
expressed genes at FDR-adjusted P-value < 0.01. On the other hand, active wild-type 
mice exhibited the fewest number of differentially expressed genes relative to all other 
activity-genotype combinations, and these genes were overexpressed at FDR-adjusted P-
value < 0.01.  
 Among active mice, the genotype difference was associated with the fewest 
number of differentially expressed genes among all pairwise contrasts. Likewise, among 
wild-type mice, activity level was associated with the second lowest number of 
differentially expressed genes among all pairwise contrasts. In contrast, changes in 
activity level elicited more differentially expressed genes in myostatin-reduced mice than 
in wild-type mice.  
Figure 2.2 presents a Venn diagram illustrating shared differentially expressed 
genes between one set of three orthogonal contrasts including the IW baseline group. Of 
these genes, 33 genes were shared between all three contrasts including the IW baseline 
group (Table 2.2). These genes are highlighted because their expression in IW (inactive 
wild type) was significant different from all other three groups. These genes are of 
interest because either one or both conditions (genotype and activity) resulted in a 
departure from baseline conditions. The majority of the genes differentially expressed 
between IW-AM were shared with the contrasts IW-AW and IW-IM (130 out of 238). 
This same pattern was evident in the contrast of IW-AW to IW-AM and IW-IM (90 out 
of 119). In contrast, the majority of the genes differentially expressed in the contrast IW-
IM were unique to this contrast (263).    
 
Functional enrichment analysis of activity-genotype contrasts 
 
Functional enrichment analysis was performed on genes exhibiting differential 
expression between pairs of activity-genotype combination groups (FDR-adjusted P-
value < 0.01) for each of the six contrasts individually. Clusters of categories exhibiting 
enrichment scores > 3.0 (corresponding to average across categories within a cluster P-
value < 0.01) were considered for discussion. These functional enrichment results can be 
	 28	
found in Tables S2.2 to S2.6 (supplementary tables within published manuscript). The 
contrasts AM-IM (Table S2.2) and IW-AW (Table S2.3) shared the cardiac muscle 
contraction (mmu04260) KEGG pathway, indicating that changes in activity level are 
associated with differential expression of genes linked to the muscle contraction network, 
regardless of genotype. The differentially expressed genes in these contrasts also exhibit 
enrichment of the tricarboxylic acid cycle TCA cycle (mmu00020) KEGG pathway and a 
number of GO MF terms linked to metabolism of cofactors and vitamins that are also 
linked to these metabolic pathways.  
 Notably, some functional categories enriched among the genes differentially 
expressed in the IW-IM contrast (Table S2.4) were also enriched among genes 
differentially expressed in the AM-AW (Table S2.5). Amid these, the BP categories of 
muscle cell differentiation (GO:0042692), various muscle development terms, and the 
KEGG pathways hypertrophic and dilated cardiomyopathy (mmu05410 and mmu05414, 
respectively). Also, the BP vasculature development (GO:0001944) was enriched among 
the genes differentially expressed in the AM-IM (Table S2.2) and IW-IM (Table S2.4) 
contrasts.  
 
Genes exhibiting significant activity-by-genotype interaction 
 
 Overall, 2,074 genes exhibited a significant activity-by-genotype interaction 
association with expression (FDR-adjusted P-value < 0.01) The genes exhibiting the most 
significant interaction effect including the log2 fold change between pairs of activity-by-
genotype groups and the overall FDR-adjusted P-value are presented in Table 2.1. A 
more extensive list of genes is provided in Table S2.1 (supplementary table within 
published manuscript).  Several genes that exhibited a significant interaction also had one 
or more significant individual pairwise contrasts between activity-genotype 
combinations. Examples of these genes included: methyltransferase like 21E gene 
(Mettl21e); Tropomyosin 3 (Tpm3); Troponin T1 slow skeletal muscle (Tnnt1); nascent 
polypeptide-associated complex alpha polypeptide (Naca); dual specificity phosphatase 
18 (Dusp18) and ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2).  
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 Other genes that exhibited a significant interaction did not reach high significance 
in particular contrasts; however, the integration of consistent borderline significant 
contrasts resulted in a significant overall interaction effect (Table 2.1 and Table S2.1). 
Examples of these genes included: ATPase, Na+/K+ Transporting, Beta 2 Polypeptide 
(Atp1b2), p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1), and Nascent Polypeptide-
Associated Complex Alpha Subunit (Naca). The interaction pattern of PAK1 is 
characterized by highest expression in active myostatin-reduced, followed by inactive-
wild type, followed by inactive myostatin-reduced mice.  
 The interaction pattern of cysteine and glycine-rich protein 3 (CSRP3) and Myozenin 
2 (Myoz2) were characterized by highest expression in inactive myostatin-reduced mice 
relative to all other activity level-genotype groups. The consistent interaction patterns of 
Myosin, light polypeptide 2 (Myl2) and myosin, light polypeptide 3 (Myl3) can be 
summarized by over-expression in inactive myostatin-reduced mice relative to all other 
activity level-genotype groups. The pathways of these Myosin genes could result in this 
consistent profile. Myosin light chains (Myls) modulate muscle contraction and may be 
involved in myogenesis or muscle regeneration (Zhang et al., 2009; Rushforth et al., 
1998; Andruchov  et al., 2006; Timson, 2003). 
 
Clusters of expression profiles among genes exhibiting significant activity-by-genotype 
interaction 
 
 Within the genes that exhibit significant interaction, various profiles of over- and 
under-expression were identified. However, the joint functional analysis of these groups 
may hinder or bias the discovery of enriched categories. Thus, discretizing the pairwise 
contrasts into over-, under- and non-differentially expressed identified clusters of genes 
exhibiting common expression profiles across the six contrasts. Profiles including more 
than 100 genes were subjected to functional enrichment analysis in DAVID. Table 2.3 
lists the most common profiles of over- (denoted with a 1), under- (denoted with a -1) 
and not differentially expressed genes across the 6 pairwise contrasts considered and the 
number of genes in each profile cluster. The three most common profiles were: +100000 
(183 genes), -100000 (146 genes), and -10-1000 (142 genes), where the first column in 
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the series of +1, -1 and 0 denotes the AW-IM contrast and the third column denotes the 
AM-IM contrast. For example, +100000 represents a pattern of significant positive 
differential expression in the AM-IM contrast and non-significant (P-value > 0.0001) 
differential expression in all other contrasts. 
  Tables 2.4, 2.5, and 2.6 list the clusters of functional categories enriched for 
profiles +100000 and -100000 (enrichment score > 3.0), and -10-1000 (enrichment score 
> 2.0). Two of the differential expression profiles across the pairwise contrasts included 
over- or under-expression in the two most extreme activity-genotype contrasts studied 
IW-AM (categories +100000 and -100000). Considering that genes from a process or 
pathway can be impacted in opposite manner by the same activity-genotype combination, 
the genes in the previous two profile clusters were combined and functional analysis of 
this augmented cluster was also undertaken.  
 Gene under-expression in active wild-type and active myostatin-reduced relative 
to inactive myostatin-reduced is a clear example of activity-by-genotype interaction 
because the combination of inactivity and myostatin-reduced genotypes was associated 
with higher gene expression than activity (regardless of genotype). Among genes sharing 
the first profile (under-expression in active wild-type and active myostatin-reduced 
relative to inactive myostatin-reduced) one highly enriched functional cluster (enrichment 
score = 16.28) was identified (Table 2.4). This cluster is comprised of 14 GO BP, MF, 
and KEGG pathway terms including the cardiac muscle pathway and pathways for 
inflammation-associated neurodegenerative conditions including Parkinson’s disease, 
Alzheimer’s disease, and Huntington’s disease.  
Among the profile cluster characterized by genes under- or over-expressed in the 
AW-IM contrast and not differentially expressed in all other contrasts (Table 2.5), five 
functional clusters presented enrichment scores > 2.0. Functional categories in the two 
clusters with highest scores are discussed (Table 2.5). The first functional cluster 
(enrichment score = 5.06) contained 9 BP terms.  Oxidation reduction and oxidative 
phosphorylation were again found significant in this list along with multiple electron 
transport terms including electron transport chain, respiratory electron transport chain, 
ATP synthesis coupled electron transport, and mitochondrial ATP synthesis coupled 
electron transport. Additionally, this list includes generation of precursor metabolites and 
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energy, cellular respiration, and energy derivation by oxidation of organic compounds 
terms. The second functional cluster (enrichment score = 4.18) contained 15 GO BP, MF, 
and KEGG pathway terms. This cluster contained many of the same terms found 
significant in the previous contrast discussed, including oxidative phosphorylation, 
cardiac muscle contraction, and neurodegenerative diseases. A large number of electron 
transport chain, energy generation, and mitochondrial ATP synthesis terms appeared on 
this list as well, highlighting again the crucial electron-transfer role of mitochondrial-
driven processes.  
 Among the profile characterized by genes under- or over-expressed in the AM-IM 
contrast and not differentially expressed in all other contrasts (Table 2.6), the functional 
cluster presenting an enrichment score > 2.0 is discussed. The first functional cluster 
(enrichment score = 2.43) contained 5 BP terms. These significant terms included: 
angiogenesis, blood vessel development, vasculature development, blood vessel 
morphogenesis, and tube development. These categories are consistent with the vascular 
development category previously identified.  
 
Main effect of myostatin genotype on gene expression in triceps brachii muscles  
  
Table 2.7 lists the genes differentially expressed (FDR-adjusted P-value < 0.005; 
log2(fold change) > |1.3|) between genotype groups excluding transcripts exhibiting 
significant interaction effects. An extended list of differentially expressed genes (FDR-
adjusted P-value < 0.01) is presented in Table S2.7 (supplementary table within 
published manuscript). In total, 230 genes were differentially expressed between 
genotypes at FDR-adjusted P-value < 0.005. The most significant differentially expressed 
genes (Table 2.7) had positive log2(fold change) estimates indicating over-expression of 
those genes in the myostatin-reduced relative to wild-type mice. 
Clusters of functional categories enriched (enrichment score > 3.0) among the 
genes differentially expressed between genotypes (raw P-value < 0.00005 comparable to 
FDR-adjusted P-value < 0.005) are listed in Table 2.8.  An extended list of clusters 
(enrichment score > 1.5) including gene membership is presented in Table S2.8 
(supplementary table). 
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Main effect of physical activity on gene expression in triceps brachii muscles   
 
Table 2.9 lists the genes differentially expressed (FDR-adjusted P-value < 0.005; 
log2(fold change) > |1.3|) between triceps brachii muscle from active and inactive mice 
excluding genes exhibiting significant interaction effects. An extended list of 
differentially expressed genes between activity levels (FDR-adjusted P-value < 0.01) is 
presented in Table S2.9 (supplementary table). In total, 384 genes were differentially 
expressed at FDR-adjusted P-value < 0.005. The most significant differentially expressed 
genes (Table 2.9) had positive log2 (fold change) estimates indicating over-expression of 
those genes in active relative to inactive mice. 
Clusters of functional categories enriched (enrichment score > 3.0) among the 
genes differentially expressed between activity levels (raw P-value < 0.00005 or FDR-
adjusted P-value < 0.005) are listed in Table 2.10. An extended list of clusters enriched 
among genes exhibiting significant activity effect (including gene membership) is 
presented in Table S2.10 (enrichment score > 2.0). 
Both genotype and activity level were associated with significant changes in gene 
expression, irrespective of the remainder factor indicating main effects. The more 
extreme fold change estimates observed in the genotype relative to the activity contrasts 
(based on the top differentially expressed genes) indicate that the genotypes considered in 
this study have a higher impact on gene expression than the physical activity levels 
evaluated (Tables 2.7 and 2.9).  
 
DISCUSSION 
 
Understanding activity-by-genotype interaction effect on gene expression in triceps 
brachii muscles  
 
Common expression profiles. The patterns of differential gene expression across 
activity-genotype contrasts provided insight into activity-by-genotype interaction effect 
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on gene expression in triceps brachii muscles. The identification of 33 genes shared 
between one set of the three orthogonal contrast groups including the baseline group set, 
inactive wild-type mice (IW-AM, IW-AW, and IW-IM) suggests a specific role of these 
genes in inactive wild-type mice that are sensitive to changes in the activity-genotype 
condition (Table 2.2). Meanwhile, the large percentage of non-overlapping genes in the 
contrast of inactive wild-type relative to both active and inactive myostatin-reduced 
offers a glimpse to the distinct impact of activity level on gene expression within 
myostatin-reduced mice. 
Consideration of the number of differentially expressed genes across pairwise 
contrasts alone uncovered insightful interaction patterns that are cornerstone for more 
complex patterns across contrasts. Among all pairwise contrasts, myostatin-related 
genotype differences within the active group (contrast AM-AW) were associated with the 
fewest number of differentially expressed genes (86 genes), suggesting that activity may 
be picking up and modulating or compensating some expression regulated by myostatin. 
The second lowest number of differentially expressed genes (119 genes) was related to 
differences in activity level within wild-type mice (contrast IW-AW), indicating that 
activity alone was associated with more limited changes in gene expression than those 
observed in the combination of activity and myostatin reduction. Finally, considering the 
fact that activity level elicited more differentially expressed genes in myostatin-reduced 
than in wild-type mice along with the finding that the greatest number of differentially 
expressed genes is in the AW-IM contrast confirms the hypothesized synergistic impact 
of physical activity and the silencing of myostatin on gene expression. 
Functional enrichment within profiles. Functional enrichment analysis of the 
activity-genotype contrasts offered insights into the impact of the activity-genotype 
combinations on GO MF and BP categories and KEGG pathways. Differentially 
expressed genes in the AM-IM and the IW-AW contrasts exhibited enrichment of the 
tricarboxylic acid cycle TCA cycle (mmu00020) KEGG pathway and a number of GO 
MF terms linked to metabolism of cofactors and vitamins that are also linked to these 
metabolic pathways. These enriched categories are consistent with the higher metabolism 
of active muscles; elevated amino acid and energy metabolism are seen in muscles of 
	 34	
physically active mice, and presumably this elevated amino acid metabolism maintains 
the TCA cycle intermediates needed for fatty acid metabolism (Wone et al., 2011).  
Muscle cell differentiation (GO:0042692) and muscle organ development 
(GO:0007517) were two BP terms enriched among the genes differentially expressed in 
the IW-IM and AM-AW contrasts. These categories are consistent with the known role of 
myostatin on cell differentiation and proliferation in triceps. Multiple studies have 
confirmed the direct impact of myostatin on these muscles. Specifically, myostatin-
deficient mice have significantly larger tricep muscles than wild-type mice (Personius  et 
al., 2010; Savage & McPherron, 2010; Hamrick et al., 2002). Myostatin depletion 
increased muscle mass by an average of 28%-44% in sedentary mice (Personius et al., 
2010).  
Enrichment of hypertrophic and dilated cardiomyopathy KEGG pathways 
(mmu05410 and mmu05414, respectively) was observed among genes differentially 
expressed in the IW-IM and AM-AW contrasts. Although hypertrophic cardiomyopathy 
is characterized by an hypertrophied heart muscle while tricep samples were used in this 
study, our results suggest that the expression of genes in similar biological processes are 
altered by myostatin genotype regardless of activity level. Our result is consistent with a 
previous report that a hypertrophic cardiomyopathy mutation is expressed in the 
messenger RNA of skeletal as well as cardiac muscle (Yu et al., 1993).  
Finally, enrichment of the vasculature development BP (GO:0001944) among the 
genes differentially expressed in the AM-IM and IW-IM contrasts suggests that activity 
level within myostatin-reduced mice and myostatin genotype within inactive mice have 
comparable impact on the expression of genes in the vascular development pathway. 
While inactivity may have counteracted the effect of myostatin reduction in the former 
contrast, myostatin reduction may have counteracted the effect of inactivity in the latter 
contrast. Our results offer support at the gene expression level to claims that the 
processes that regulate blood vessel development can also enable the adult to adapt to 
changes in tissues that can be elicited by activity or pathologies (Udan et al., 2013).  
Notable genes. Consideration of individual genes exhibiting significant activity-
by-genotype interaction further augmented the understanding of the interplay between 
activity and myostatin genotype on the triceps brachii muscle transcriptome in C57/BL6 
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mice. PAK1 displayed consistent borderline significant differential expression across 
multiple contrasts, resulting in a significant overall interaction effect.. A study of target 
genes of myostatin loss-of-function in muscles of bovine fetuses identified PAK1 
(Cassar-Malek et al., 2007).  The complex interplay between PAK proteins in regulation 
of signaling cascades controlling cell motility, proliferation, and morphology and 
reorganization of the cytoskeleton (Schneeberger & Raabe, 2003) may lead to 
compensatory mechanisms resulting in wild-type mice exhibiting higher levels of PAK1 
than myostatin-reduced mixed within the inactive group. Supporting this hypothesis, 
signaling of PAK1 has been linked to the G1 to S phase transition of the cell cycle via 
regulation of cyclin D1 machinery (Heng & Koh, 2010). This function is consistent with 
our findings of high levels of expression of MIR1945- G1 to S phase transition 1 (Gspt1) 
in our genotype contrast of myostatin-reduced vs. wild-type mice. Both genes are known 
to be associated with SMAD3 that in turn is associated with TGFB1.  Similarly, 
myostatin negatively regulates the activation of satellite cells by controlling the G1 to S 
phase transition through down-regulation of Cdk2 and up-regulation of P21, the protein 
encoded by PAK1 (McCroskery et al., 2003). The expression of PAK1 was highest in 
active myostatin-reduced mice, followed by inactive wild-type mice and then inactive 
myostatin-reduced mice. The detection of this gene further confirms the importance of 
G1 to S phase transition 1 in muscular physiology and the role of myostatin in inhibition. 
PAK1 appears to be activated during the process of vascular remodeling (Hinokie et al., 
2010) and this is in agreement with the identification of enrichment of vascular 
development pathway in the IM-AW and IW-IM contrasts. 
CSRP3 and Myoz2 shared the same interaction pattern of highest expression in 
inactive myostatin-reduced relative to all other activity level genotype groups. The 
parallel expression profiles of these two genes detected in the present study is in 
agreement with previous reports. The expression of CSRP3 and Myoz2 is high in skeletal 
muscles (Arber et al., 1994; Takada et al., 2001), positively regulating myogenesis 
through promotion of myogenic differentiation (Kong et al., 1997). CSRP3 encodes the 
muscle LIM protein (MLP), a muscle specific protein expressed and located at the z-line 
(Knoll et al., 2002) which has been described as essential for myogenesis given its 
potential for induction of myogenic differentiation (Arber et al., 1994). Mice with a 
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deficiency of this gene exhibit dilated cardiomyopathy (Arber et al., 1997). Only a few 
proteins have been shown to interact directly with MLP: actin (Arber & Caroni, 1996), 
alpha-actinin (Harper et al., 2000), beta-spectrin (Flick & Konieczny, 2000), and N-RAP 
(Ehler et al., 2001); A definitive link between myostatin and MLP has not been 
established. Other studies have found a relationship between expression of MLP and 
contractility (Ecarnot-Laubriet et al., 2000; Schneider  et al., 1999). In addition to playing 
structural and functional roles in skeletal muscle, MLP has been suggested to be a 
mediator of mechanical stress in cardiac tissue (Barash et al., 2005). Muscle growth 
resulting from myostatin inactivation presumably creates an imbalance between the 
metabolic requirements of tissue cells and the previous perfusion capabilities of blood 
vessels, and CSRP3-encoded MLP may work to mediate this stress and reduce likelihood 
of cardiomyopathy.  
Clusters of expression profiles among genes exhibiting significant activity-by-
genotype interaction were identified as well. Among genes sharing the first profile 
(under-expression in active wild-type and active myostatin-reduced relative to inactive 
myostatin-reduced and similar expression levels across all other activity-genotype 
groups), KEGG pathways for several inflammation-associated neurodegenerative 
conditions including Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease 
were enriched. Our results are in agreement with reports that myostatin causes sporadic 
inclusion body myositis (sIBM), a muscle-wasting disease that has pathogenesis similar 
to that of Alzheimer’s and Parkinson’s diseases (Starck & Sutherland-Smith, 2010). Also, 
activin A protects from neural degeneration in individuals with Huntington’s disease, 
(Hughes et al., 1999) and the relationship between myostatin and activin has been well 
established. Myostatin signals muscle mass control through activin receptors (Lee, 2004), 
meanwhile activin type IIB receptor acts as a myostatin inhibitor, causing a dramatic 
muscle mass increase (Lee et al., 2005). In addition to the previous pathways, oxidation-
reduction, oxidoreductase activity, and oxidase activity categories were also enriched 
among genes in the first profile. This enrichment is consistent with studies demonstrating 
that oxidative stress is often induced by physical activity due to the generation of reactive 
oxygen species (ROS) that occurs as skeletal muscles contract (Powers & Jackson, 2008). 
Also, myostatin acts as a pro-oxidant, inducing oxidative stress in skeletal muscle by 
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inducing ROS (Sriram et al., 2014). In turn, this induces anti-oxidant enzymes in skeletal 
muscle through TNF-α and NADPH oxidase in a feed-forward manner (Sriram et al., 
2011). Additional GO terms associated with the electron transport chain, such as 
generation of precursor metabolites and energy, monovalent inorganic transmembrane 
transporter activity, and inorganic cation transmembrane transporter activity, enriched in 
the first profile highlight the expected link between muscle function and mitochondria-
dependent reformation of ATP through nutrient oxidation.  
Additionally, oxidative phosphorylation, electron transport chain, energy 
generation, and mitochondrial ATP synthesis GO terms were enriched among the profile 
characterized by genes under- or over-expressed in the AW-IM contrast and not 
differentially expressed in all other contrasts. These findings are consistent with the 
electron transport chain, or the flow of electrons resulting from NADH and FADH2 
oxidation, that establishes an electrochemical gradient vital in powering ATP synthesis in 
oxidative phosphorylation, the final stage of aerobic cell respiration. Myostatin reduction, 
although not affecting phosphorylated compound concentrations and intracellular pH at 
rest, causes up to a 206% increase in ATP cost of contraction as well as limiting the shift 
toward oxidative metabolism during muscle activity (Giannesini et al., 2013). Muscle 
buildup caused by myostatin is sustained through a combination of reduced ATP 
synthesis and decreased protein degradation activity (Uyttenhove et al., 2003)  
Antagonistic and synergistic expression patterns. Finally, using genes exhibiting 
significant (FDR-adjusted P-value < 2XE-12) genotype-by-activity interaction effects, 
antagonistic and synergistic expression patterns were identified. Synergistic effects occur 
when the expression of a gene under a combination of genotype and activity levels is 
more extreme than the average expression under each level separately. Antagonistic 
effects occur when the expression of a gene under a combination of genotype and activity 
levels is less extreme than the average expression under each level separately. An 
example of synergistic pattern would be when a gene that has high over-expression (e.g. 
4 fold) in myostatin inactive relative to the average of all other groups meanwhile the 
expression in myostatin relative to wild type and the expression in inactive relative to 
active are less or non-significant (e.g. less than 2 fold). An example of antagonistic 
pattern would be a gene that is not or less differentially expressed (e.g. 1 fold) in 
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myostatin inactive mice relative to the average of all other groups meanwhile the 
expression in myostatin relative to wild type and the expression in inactive relative to 
active are more significant  or extreme (e.g. more than 3 fold). 
 Examples of synergistic or antagonistic mode of action of genotype and activity 
factors on gene expression are listed in Table 2.1.  Mettl21e; Cytochrome P450, Family 1, 
Subfamily A, Polypeptide 1 (Cyp1a1); and Myelin protein zero (Mpz) were identified as 
antagonistic genes, where gene expression increases in one contrast and concurrently 
decreases in another contrast. Cyp1a1 and Mpz shared the same interaction pattern, 
characterized by lower expression in active wild-type mice relative to the inactive wild-
type mice, and by higher expression in active myostatin-reduced relative to inactive 
myostatin-reduced mice. A striking example of antagonistic interaction among these 
significant genes is Mettl21e, which follows the opposite interaction pattern. The 
expression of Mettl21e in active wild-type mice is higher than that in inactive wild-type 
mice, and the expression in active myostatin-reduced mice is lower than in inactive 
myostatin-reduced mice. Similarly, Sarcolipin (Sln), Actin Alpha 2 (Acta2), nuclear 
receptor corepressor 2 (Ncor2), guanine nucleotide binding protein beta polypeptide 2-
like 1 (Gnb2l1), and Gremlin 2 of the Cysteine Knot Superfamily (Grem2) displayed 
antagonistic interactions (Table 2.1 and Table S2.1).  
The identification of significant interactions enabled the detection of synergistic 
effects between genotype and activity. For genes Naca, Dusp23, and Dhcr24, the 
difference in expression between myostatin genotype groups was more extreme than 
between activity groups (Table S2.1). The changes in gene expression between genotypes 
appeared to be magnified by activity. This suggests that the observed changes in 
transcript abundances identified in the activity-level contrast may be due to the sole effect 
of physical activity, while changes identified in the genotype contrast may be due to the 
effect of both physical activity and myostatin depletion. The similar expression levels 
between genotypes among inactive mice and striking differential expression between 
genotypes among the active mice indicates strong synergistic interplay. Other genes also 
exhibiting synergistic interaction between genotype and activity, included 
Dimethylarginine Dimethylaminohydrolase 1 (Ddah1), FBJ Murine Osteosarcoma Viral 
Oncogene Homolog (Fos), WNK Lysine Deficient Protein Kinase 2 (Wnk2), 
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Transmembrane Protein 100 (Tmem100), Prostate Transmembrane Protein Androgen 
Induced 1 (Pmepa1), Receptor G Protein-Coupled Activity Modifying Protein 1 
(Ramp1), LanC Lantibiotic Synthetase Component C-Like 1 (Lancl1), P21 Protein 
Cdc42/Rac-Activated Kinase 1 (Pak1), and Attractin-Like 1 (Atrnl1).  
 
Understanding the main effect of myostatin on gene expression in triceps brachii muscles   
 
Among the genes differentially expressed (FDR-adjusted P-Value < 0.005 and 
log2(fold change) > |1.3|) between myostatin-reduced and wild-type mice (Table 2.7 and 
Table S2.7), the functions of three genes are associated to muscle physiology. The 
detection of Actin, alpha, cardiac muscle 1 (Actc1) in this study is consistent with reports 
that cardiac α-actin can functionally substitute at least in part for skeletal muscle α-actin 
in skeletal muscle (Ravenscroft et al., 2008) Similarly, the detection of Sln differential 
expression between myostatin genotype groups is consistent with reports postulating that 
high Sln expression in human skeletal muscle is important to the physiology of the tissue 
(Fajardo et al., 2013). Interestingly, Sln has recently been shown to mediate muscle-based 
thermogenesis (Bal et al., 2012). Finally, differential expression of Grem2 has been 
detected in the quadricepts of a mouse model of non-dystrophic skeletal muscle 
congenital disease (Gineste et al., 2013). Also, Grem2 acts as an antagonist of bone 
morphogenetic proteins (BMPs) that influence the effectiveness of myostatin. Myostatin 
is synthesized as a precursor protein, which then becomes biologically active through 
BMP-driven proteolytic processing events (Lee, 2010; Wolfman et al., 2003). The profile 
observed in this study can be explained by myostatin gene expression depletion requiring 
lower BMP convertase, which is achieved through the inhibitory action of Grem2.   
Among the rest of the genes differentially expressed between genotype groups, 
four provided remarkable insight into myostatin’s effects on the gene networks of muscle 
development. The protein coded by the Piezo-type mechanosensitive ion channel 
component 1 (Piezo1) allows cells to react to physical stimuli. Mechanosensitive ion 
channels play a key role in the physiology of smooth muscle (Fajardo et al., 2013; Kirber  
et al., 1988; Davis et al., 1992). Consistent with the differential expression of XPD (also 
known as Excision repair cross-complementing rodent repair deficiency complementation 
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group 2 or Ercc2) between genotype groups, a mutation on XP genes has been associated 
with a reduction in skeletal muscle in mice (de Boer et al., 2002). Similarly to the present 
study, Microprocessor complex subunit DGCR8 (Dgcr8) or DiGeorge syndrome critical 
region gene 8 has been linked to myoblast differentiation (Kozakowska et al., 2012).  
Finally, our results revealed the expression of gene G1 to S Phase Transition 1 (Gspt1), 
responsible for the G1 to S phase transition of the cell cycle (Bartek & Lukas 2001). 
Given the differential expression pattern of the present study, we propose that that 
myostatin could inhibit the process of myoblasts moving from the G1 to S phase of the 
cell cycle through up-regulation of p21 and subsequent inhibition of Cdk2 activity. An 
extended list (FDR-adjusted P-value < 0.01) of differentially expressed genes between 
myostatin-reduced and wild-type mice in triceps brachii muscles can be found in Table 
S2.7. 
 
Understanding the main effect of physical activity on gene expression in triceps brachii 
muscles   
 
Many of the differentially expressed genes between active and inactive mice, 
unsurprisingly, are associated with the biological processes of contractile response of 
muscles to activity. A notable finding is that Ercc2 was differentially expressed between 
genotype groups and between activity groups as well, yet this gene did not exhibit a 
significant activity-by-genotype interaction effect. A similar molecular mechanism is 
speculated for both comparisons. Among other genes differentially expressed between 
activity groups, Tnnt1 (Samson et al., 1992) plays an essential role in skeletal muscle 
contraction by regulating calcium sensitivity (Nadal-Ginard & Mahdavi, 1989). The 
myoglobin protein, encoded by Mb, is present only in myocytes and oxidative skeletal 
muscle fibers. This gene is essential for oxygen storage in muscle (Ordway & Garry, 
2004), and facilitates oxygen diffusion by desaturating rapidly as muscle activity 
increases (Wittenberg, 1970). Cyp26b1 encodes protein Cytochrome P450 26B1, known 
to be present in adult mice skeletal muscle (Choudhary et al., 2005). Cyp26b1 signals 
aortic smooth muscle cells through regulation of the metabolism of all-trans-retinoic acid, 
(Ocaya et al., 2010) which is crucial for regulation of gene expression, cell growth and 
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differentiation (Ateia Elmabsout et al., 2012). Finally, the protein encoded by 
Tropomyosin alpha-3 (TPM3) is also essential for regulation of skeletal muscle 
contraction (Morris et al., 1991). 
Novel associations between differentially expressed genes and activity level were 
also identified in this study. Many of these genes have indirect links to muscle function 
and activity, but the actual mechanism uncovered is unique and unexpected. The 
differentially expressed gene 3-hydroxybutyrate dehydrogenase (Bdh1) encodes an 
enzyme involved in the interconversion of acetoacetate and (R)-3-hydroxybutyrate, 
essential for fatty acid catabolism. Also, Bdh1 mRNA is found in all forms of muscle 
(Marks et al., 1992). The role in catabolism could be associated with the need for energy 
that characterizes the skeletal muscle under activity.  Regarding the enrichment of the 
ATP metabolic process, physical activity causes an increase in ATP cost of contraction 
(Giannesini et al., 2013). At the same time, active mice have significant reduction in 
accumulation of body fat as compared to wild-type IQ motif Sec7 domain 2 (Iqsec2 or 
Brag2) has been associated with myoblast cell-cell fusion (Pajcini et al., 2008).  In 
addition, estrogen-related receptor beta (ERRbetta) is a nuclear receptor protein encoded 
by the Esrrβ gene that was differentially expressed among activity groups. This result is 
consistent with work demonstrating that ERRbeta/gamma agonist modulates GRalpha 
expression, and glucocorticoid responsive gene expression in skeletal muscle cells (Wang 
et al., 2010). Finally, AK4 was differential expressed between activity groups and this 
gene is responsible for encoding adenylate kinase 4, an energy-mediating enzyme. This 
finding is in agreement with reports that AK4 is highly expressed in human skeletal 
muscle (Noma et al., 2001). 
 The enrichment of GO biological process terms related to vasculature 
development (angiogenesis, blood vessel development, vasculature development, blood 
vessel morphogenesis, and tube development) among the genes differentially expressed 
in the AM-IM and IW-IM contrasts suggests that the combination of activity and 
myostatin-reduced genotype has comparable impact to the combination of inactivity and 
wild-type typical myostatin genotype on the expression of genes in the vascular 
development pathway. A link between vascular development and muscle development is 
expected based on the logical physiological association of the two organ systems. 
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Vasculature is modified in order to meet the metabolic requirements of tissue cells in 
response to changes in metabolic rate; oxygen is a major control element of this 
adaptation, as hypoxia initiates various signals which in turn lead to an increase in vessel 
growth (Adair et al., 1990). Given this information, vascular growth and activation of 
vascular development pathways would be expected upon myostatin inactivation, as the 
resulting muscle growth presumably creates an imbalance between the metabolic 
requirements of tissue cells and the previous perfusion capabilities of blood vessels. In 
addition, genes activated during vascular processes, such as PAK1, were found through 
our analyses to exhibit significant activity-by-genotype interaction. The association 
between myostatin level and PAK1 was confirmed in a previous study of genes targeted 
by myostatin loss-of-function in bovine muscles (Cassar-Malek et al., 2007).    
 
CONCLUSION 
 
The study of the impact of physical activity and myostatin level on gene 
expression in the triceps brachii muscles of C57/BL6 mice uncovered novel and 
confirmed known associations at the gene and gene network levels.  Novel and 
significant interaction effects were observed for some genes (e.g. Naca, Grem2) including 
synergistic effects (e.g. Naca, Dhcr24) and antagonistic effects (e.g. Mettl21e, Cyp1a1, 
Mpz).   Functional analysis of genes presenting significant interaction effects uncovered 
novel (e.g. angiogenesis) and expected (e.g. oxidative phosphorilation, electron transport 
chain) enriched pathways and biological processes. 
Among the genes exhibiting significant main genotype effect, known (e.g. Sln, 
Grem2) and novel (e.g. Piezo1, Ercc2, Gspt1) associations were detected. Functional 
analysis of genes presenting significant genotype effect uncovered novel (e.g. dilated and 
hypertrophic cardiomyopathy) and expected (e.g. muscle cell differentiation, muscle 
organ development) enriched pathways and biological processes. Likewise, among the 
genes exhibiting significant main activity effect, known (e.g. MB, Tpm3) and novel (e.g. 
Bdh1, Esrrβ) associations were detected. Functional analysis of genes presenting 
significant activity effect uncovered novel (e.g. Alzheimer's, Parkinson’s and 
Huntington’s disease) and expected (e.g. oxidative phosphorylation, cardiac muscle 
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contraction) enriched pathways and biological processes. While several genes and 
functional categories enriched among the differentially expressed genes uncovered in this 
study were consistent with previous reports, the identity and profile of the genes 
exhibiting the most extreme interaction and main genotype and activity effects opened 
new avenues of inquiry on the role of specific genes in skeletal muscle development and 
the effects of myostatin and physical activity on muscle function. The present study 
centered on the comparison of four genotype-activity groups based on transcriptome 
information from a specific skeletal muscle type, mouse strain, gender, and age. 
Consideration of additional muscle types, genotypes, activities, ages, and genders would 
help identify additional synergistic and antagonistic relationships between these factors.  
The findings from the present study could have medical implications on preventive 
practices and therapies associated with muscle atrophy in humans and companion animal 
species and genome-enabled selection practices applied to food-production animal 
species.  The study of changes in gene expression in response to myostatin gene 
expression level in skeletal muscle tissue involved genes that code for a number of 
proteins that are feedback regulated by the myostatin molecule. The functions of the 
genes exhibiting differential expression between genotype groups are primarily 
regulatory. This functional category includes microRNA and Piezo proteins that make the 
list of the top 10 differentially expressed genes, side-by-side with Grem2 proteins that 
modulate the metalloprotein BMP-mediated cleavage of the myostatin propeptide. The 
role of genes regulated by microRNAs was unanticipated, especially because these genes 
seem to impact central functions such as the G1 to S phase transition of the cell cycle of 
myoblasts. The role of genes coding for Piezo proteins that make mechanosensitive ion 
channels, which in turn regulate cationic currents in the cells, was also remarkable and 
unanticipated, especially because of the consistent profile of the genes in this family. The 
study of changes in gene expression patterns in response to activity level revealed 
enrichment of genes that code structural proteins important for muscle function, including 
troponin, tropomyosin and myoglobin proteins. Activity was also associated with 
differential expression of genes important for fatty acid metabolism, some linked to type 
II diabetes and obesity and others to DNA-repair capacity, stem cell renewal, and various 
forms of cancer.  
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Our results provide evidence supporting the role of myostatin as a master 
regulator and the hypothesis that physical activity affect the expression of genes 
associated with homeostatic balance between storage of fat and muscle growth. Down-
regulation of myostatin expression enables muscle growth at full expense of storage of 
fat, a condition that is hardwired at the regulatory level (e.g. through antagonists of 
metalloenzymes responsible for the myostatin activation). During activity, the changes in 
gene expression associated with balance between storage of fat and growth appears more 
instantaneous and subtle. This balance involves the regulation of metabolic pathways of 
fatty acid synthesis and does not impinge on oxidative phosphorylation pathways. The 
master regulatory functions of myostatin identified in this study should now be explored 
at the biochemical level to identify details of the regulatory networks, especially because 
of their potential to assist in the development of muscular disorders. 
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TABLES AND FIGURES 
 
Table 2.1 Differentially expressed genes (FDR-adjusted P-value < 2XE-12) across 
activity-genotype contrasts 
 
Gene 
Name* 
  
Log2Fol
d1     
FDR-
adjusted 
P-Value 
AM-
AW3 
AM-
IM4 
AW-
IM2 IW-IM7 IW-AW5 
IW-
AM6 
Mettl21
e 2.72 0.57 3.29 4.48 -1.19 -3.91 1.55E-13 
Dusp18 -0.78 -0.73 -1.51 -0.64 -0.87 -0.09 1.55E-13 
Per1 1.22 0.40 1.62 0.82 0.79 -0.42 1.55E-13 
Atp1b2 0.62 0.34 0.96 0.31 0.65 0.023 1.55E-13 
Tnnc1 -0.89 -4.14 -5.03 -3.67 -1.36 -0.47 1.55E-13 
Zmynd
17 -1.25 0.47 -0.78 -1.63 0.85 2.09 1.55E-13 
Myh7 -0.72 -4.87 -5.58 -4.37 -1.20 -0.49 1.55E-13 
Tpm3 -0.75 -2.22 -2.96 -1.76 -1.20 -0.46 1.55E-13 
Ddah1 -1.64 0.08 -1.57 -2.15 0.59 2.23 1.55E-13 
Myl2 -1.15 -3.74 -4.89 -3.49 -1.39 -0.25 1.55E-13 
Atp2a2 -0.89 -2.15 -3.05 -2.31 -0.74 0.16 1.55E-13 
Pak1 0.56 -0.09 0.46 1.07 -0.60 -1.16 1.55E-13 
Tnnt1 -0.92 -4.07 -4.99 -3.66 -1.33 -0.41 1.55E-13 
Csrp3 -0.91 -1.92 -2.83 -2.01 -0.82 0.09 1.55E-13 
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Table 2.1 (cont.) 
 
Fxyd6 -0.76 -2.05 -2.81 -1.96 -0.85 -0.08 1.55E-13 
Myoz2 -0.59 -2.43 -3.03 -2.12 -0.91 -0.31 6.84E-13 
Myl3 -0.62 -3.15 -3.77 -2.76 -1.01 -0.39 6.84E-13 
Naca 0.87 0.03 0.91 0.43 0.48 -0.39 1.89E-12 
Ak3 0.55 -1.53 -0.99 0.41 -1.40 -1.95 1.89E-12 
Cyp1a1 2.0428 -0.8460 1.19676 0.26727 0.929775 -1.1131 3.16E-12 
Grem2 
1.4498
6 
0.21314
7 1.66277 2.52511 -0.86228 
-
2.31217 3.16E-12 
Fos 
-
0.7807
3 
0.03979
4 
-
0.74082 
-
1.52664 0.786004 1.56659 8.48E-12 
Gnb2l1 
0.7397
97 
-
0.36408 
0.37536
4 
-
0.32355 0.699348 
-
0.04009 8.56E-12 
Wnk2 
1.1055
2 
0.05671
8 1.16275 
0.76078
6 0.402344 
-
0.70346 2.45E-11 
Tmem1
00 
-
0.7657
8 
0.05025
9 
-
0.71569 
-
1.11695 0.401146 1.16691 3.02E-11 
Ncor2 
0.5565
91 
-
0.14625 0.41082 
-
0.02854 0.439626 
-
0.11714 6.96E-11 
Acta2 
0.9726
04 
-
0.62395 
0.34859
4 
-
0.39031 0.738874 
-
0.23374 2.01E-10 
Pmepa1 
-
0.6760
3 -0.0258 
-
0.70168 
-
1.02573 0.324245 1.00005 2.01E-10 
Sln 1.5134 
0.15666
3 1.67004 2.36704 -0.69664 
-
2.21015 2.90E-10 
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Table 2.1 (cont.)  
 
Dhcr24 
0.77144
1 -0.05624 
0.71540
1 -0.12054 0.83638 
0.06472
8 3.20E-10 
Dusp23 
0.46843
7 
0.02480
8 
0.49351
9 
0.02637
1 0.467286 -0.00141 1.01E-09 
Ramp1 
-
0.66605 -0.05061 -0.71666 -0.92948 0.213069 0.87899 1.07E-09 
Atrnl1 
-
0.67904 -0.04955 -0.72883 -0.49233 -0.2365 
0.44258
5 1.32E-09 
Lancl1 
-
1.22412 0.08892 -1.13543 -1.33056 0.195232 1.41926 1.43E-09 
* Genes exhibiting significant synergistic and antagonist activity-by-genotype interaction effects are 
displayed in italics. Ddha1, Lancl1, Fos, Tmem1, and Pmepa1 follow a synergistic pattern; Sln, Grem2, 
Mettl2, and Pak1 follow an antagonistic pattern. 
1. When considering two values, A and B, Log2Fold Change = Log2 (B/A). For example, Log2Fold of the 
contrast AW-IM = log2(IM/AW). 
2. AW-IM refers to the active wild-type vs. inactive myostatin-reduced contrast group 
3. AM-AW refers to the active myostatin-reduced vs. active wild-type contrast group 
4. AM-IM refers to the active myostatin-reduced vs. inactive myostatin-reduced contrast group 
5. IW-AW refers to the inactive wild-type vs. active wild-type contrast group 
6. IW-AM refers to the inactive wild-type vs. active myostatin-reduced contrast group 
7. IW-IM refers to the jnactive wild-type vs. inactive myostatin-reduced contrast group 
*Expanded gene names, listed in alphabetical order: Acta2= actin, alpha 2, smooth muscle, aorta; Ak3= 
adenylate kinase 3; Atp1b2= ATPase, Na+/K+ transporting, beta 2 polypeptide; Atp2a2= ATPase, Ca++ 
transporting, cardiac muscle, slow twitch 2; Atrnl1= Attractin-Like 1; Csrp3= cysteine and glycine-rich 
protein 3; Cyp1a1= Cytochrome P450, Family 1, Subfamily A, Polypeptide 1; Ddah1= dimethylarginine 
dimethylaminohydrolase 1; Dhcr24= 24-Dehydrocholesterol Reductase; Dusp18= dual specificity 
phosphatase 18; Dusp23= Dual Specificity Phosphatase 23; Fos= FBJ Murine Osteosarcoma Viral 
Oncogene Homolog; Fxyd6= FXYD domain-containing ion transport regulator 6; Gnb2l1= Guanine 
Nucleotide Binding Protein (G Protein), Beta Polypeptide 2-Like; Grem2= Gremlin 2, DAN Family BMP 
Antagonist; Lancl1= LanC Lantibiotic Synthetase Component C-Like 1; Mettl21e= methyltransferase like 
21E; Myh7= myosin, heavy chain 7, cardiac muscle, beta; Myl2= myosin, light polypeptide 2, regulatory, 
cardiac, slow; Myl3= myosin, light polypeptide 3; Myoz2= myozenin 2; Naca= nascent polypeptide- 
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Table 2.1 (cont.)  
 
associated complex alpha polypeptide; Ncor2= Nuclear Receptor Corepressor 2; Pak1= p21 protein 
(Cdc42/Rac)-activated kinase 1 
Per1= period circadian clock 1; Pmepa1= Prostate Transmembrane Protein, Androgen Induced 1; Ramp1= 
Receptor (G Protein-Coupled) Activity Modifying Protein 1; Sln= Sarcolipin; Tmem100= Transmembrane 
Protein 100; Tnnc1= troponin C, cardiac/slow skeletal; Tnnt1= troponin T1, skeletal, slow; Tpm3= 
tropomyosin 3, gamma; Wnk2= WNK Lysine Deficient Protein Kinase 2; Zmynd17= zinc finger, MYND-
type containing 17 
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Table 2.2 Shared differentially expressed genes (FDR-adjusted P-value < .01) between 
three orthogonal contrasts including the Inactive-Wild Type (IW) baseline group 
Gene Name* 
Log2(Fold)1  
IW-AW2 IW-AM3 IW-IM4 
M6prbp1 -0.55 -0.92 0.47 
Pak1 -0.60 -1.16 1.07 
Casq2 -0.87 -1.25 -0.75 
Fos 0.79 1.57 -1.53 
Dhrs4 -0.63 -0.64 -0.60 
Gm5514 -1.44 -1.21 -1.52 
Ddah1 0.59 2.23 -2.15 
Fabp3 -0.75 -0.63 -0.93 
Got1 -0.62 -0.55 -0.44 
2310076L09Rik -0.87 -0.72 -1.04 
Mafb -0.78 -1.07 0.58 
EG225594 -1.64 -1.55 2.22 
4832428D23Rik -1.20 -3.91 4.48 
BDH1 -1.83 -1.47 -2.24 
ZMYND11 0.85 2.10 -1.63 
Gck 1.17 1.48 -0.70 
Esrrb -1.26 -1.28 -1.28 
Acaa2 -0.59 -0.53 -0.69 
Ankrd2 -1.18 -0.92 -1.59 
Actn2 -0.62 -0.78 -0.87 
Egr1 1.56 1.65 -1.48 
Myom3 -1.13 -1.08 -1.93 
9830123M21Rik 0.69 2.52 -0.49 	
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Table 2.2 (cont.)  	
Rn45s -0.80 -1.94 1.16 
NNT -0.79 -0.72 -0.70 
Dgat2 -0.83 -0.70 -0.97 
H19 -0.68 -0.89 0.43 
Tbc1d1 0.72 0.98 -0.91 
IL15 -1.05 -1.39 1.06 
Myh2 -1.08 -0.85 -1.78 
COL22A1 0.63 0.74 -0.48 
ORF63 0.85 0.93 -0.75 
IDH2  -0.85 -0.67 -0.92 
M6prbp1 -0.55 -0.92 0.47 
1. When considering two values, A and B, Log2Fold Change = Log2 (B/A). For example, Log2Fold of the 
contrast AW-IM = log2(IM/AW). 
5. IW-AW refers to the inactive wild-type vs. active wild-type contrast group 
6. IW-AM refers to the inactive wild-type vs. active myostatin-reduced contrast group 
7. IW-IM refers to the jnactive wild-type vs. inactive myostatin-reduced contrast group 
*Expanded gene names, listed in alphabetical order: 2310076L09Rik= RIKEN cDNA 2310076L09 gene; 
4832428D23Rik=RIKEN cDNA 4832428D23 gene; 9830123M21Rik= RIKEN cDNA 9830123M21 gene; 
Acaa2= acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase); 
Actn2=actinin alpha 2; Ankrd2=ankyrin repeat domain 2 (stretch responsive muscle); BDH1= 3-
hydroxybutyrate dehydrogenase, type 1; Casq2=calsequestrin 2; COL22A1= collagen, type XXII, alpha 1; 
Ddah1=dimethylarginine dimethylaminohydrolase 1; Dgat2=diacylglycerol O-acyltransferase 2; Dhrs4= 
dehydrogenase/reductase (SDR family) member 4; EG225594=predicted gene 4841; Egr1=early growth 
response 1; Esrrb=estrogen related receptor, beta; Fabp3=fatty acid binding protein 3, muscle and heart; 
similar to mammary-derived growth inhibitor; Fos= FBJ osteosarcoma oncogene; Gck= 
glucokinase;Gm5514= lactate dehydrogenase B; predicted gene 5514; Got1= similar to Aspartate 
aminotransferase, cytoplasmic (Transaminase A) (Glutamate oxaloacetate transaminase 1); glutamate 
oxaloacetate transaminase 1, soluble; H19= H19 fetal liver mRNA; IDH2= Isocitrate Dehydrogenase 2 
(NADP+), Mitochondrial; IL15=interleukin 15; M6prbp1= mannose-6-phosphate receptor binding protein 
1; Mafb=v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) ;Myh2= myosin, 
heavy polypeptide 2, skeletal muscle, adult, myosin, heavy polypeptide 1, skeletal muscle, adult; 
Myom3=myomesin family, member 3; Nnt= nicotinamide nucleotide transhydrogenase; ORF63= open 
reading frame 63; Pak1= p21 protein (Cdc42/Rac)-activated kinase 1; Rn45s= RNA, 45S Pre-Ribosomal 5 
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Table 2.3 Most common profiles of over- (denoted with +1), under- (denoted with -1) 
and not (denoted with 0) differentially expressed (P-value < 0.0001) genes across the 6 
pairwise contrasts 
 
Profile1 Number 
of Genes2 
AM-AW AM-IM AW-IM IW-IM IW-AW IW-AM  
0 0 0 0 0 0 1509 
0 0 +1 0 0 0 183 
0 0 -1 0 0 0 146 
0 -1 -1 0 0 0 142 
0 -1 0 0 0 0 86 
0 +1 0 0 0 0 83 
0 0 +1 +1 0 0 71 
0 +1 +1 0 0 0 68 
0 -1 -1 -1 0 0 67 
0 +1 +1 +1 0 0 54 
1. The six contrast groups are ordered as follows- active wild-type vs. inactive myostatin-reduced, active 
myostatin-reduced vs. active wild-type, active myostatin-reduced vs. jnactive myostatin-reduced, inactive 
wild-type vs. active wild-type, inactive wild-type vs. active myostatin-reduced, and jnactive wild-type vs. 
inactive myostatin-reduced. Each number of the 6 in the Profile “code” refers to each contrast in order (the 
first number in the Profile “code” denotes significance level for the first group, active wild-type vs. inactive 
myostatin-reduced, the second number denotes significance level for the second group, etc.) 
2. Unlisted profiles include < 50 genes 
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Table 2.4 Enriched (enrichment score > 3.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes exhibiting the profile characterized by under-
expressed in active wild-type vs inactive myostatin-reduced and in active myostatin-
reduced vs inactive myostatin-reduced and not differentially expressed in all other 
contrasts. 
 
Category  Term Num
ber 
of 
Gen
es 
P-
Value 
FDR-
adjusted 
P-value 
Score = 16.28     
KEGG 
PATHWAY mmu00190:Oxidative phosphorylation 31 
6.69E-
33 6.84E-30 
KEGG 
PATHWAY mmu05012:Parkinson's disease 30 
6.01E-
31 6.14E-28 
GOTERM BP 
FAT GO:0022900~electron transport chain 24 
1.58E-
27 2.39E-24 
KEGG 
PATHWAY mmu05010:Alzheimer's disease 30 
9.82E-
27 1.00E-23 
KEGG 
PATHWAY mmu05016:Huntington's disease 30 
1.16E-
26 1.19E-23 
GOTERM BP 
FAT 
GO:0006091~generation of precursor 
metabolites and energy 29 
2.84E-
25 4.30E-22 
GOTERM BP 
FAT GO:0055114~oxidation reduction 32 
3.95E-
17 5.99E-14 
	 53	
Table 2.4 (cont.) 		
GOTERM MF 
FAT 
GO:0015078~hydrogen ion 
transmembrane transporter activity 12 
1.27E-
11 1.65E-08 
GOTERM MF 
FAT 
GO:0015077~monovalent inorganic 
cation transmembrane transporter 
activity 12 
2.47E-
11 3.20E-08 
GOTERM MF 
FAT 
GO:0022890~inorganic cation 
transmembrane transporter activity 12 
1.55E-
09 2.01E-06 
KEGG 
PATHWAY mmu04260:Cardiac muscle contraction 10 
2.24E-
07 2.29E-04 
GOTERM MF 
FAT 
GO:0015002~heme-copper terminal 
oxidase activity 6 
5.10E-
07 6.61E-04 
GOTERM MF 
FAT 
GO:0016675~oxidoreductase activity, 
acting on heme group of donors 6 
5.10E-
07 6.61E-04 
GOTERM MF 
FAT 
GO:0016676~oxidoreductase activity, 
acting on heme group of donors, 
oxygen as acceptor 6 
5.10E-
07 6.61E-04 
GOTERM MF 
FAT 
GO:0004129~cytochrome-c oxidase 
activity 6 
5.10E-
07 6.61E-04 
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Table 2.5 Enriched (enrichment score > 3.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes under- or over-expressed in the active wild-type 
vs inactive myostatin-reduced contrast and not differentially expressed in all other 
contrasts. 
 
Category  Term 
Numb
er of 
Genes P-Value 
FDR-
adjusted 
P-value 
Score = 5.07      
GOTERM BP 
FAT 
GO:0006091~generation of 
precursor metabolites and energy 24 1.74E-10 2.86E-07 
GOTERM BP 
FAT 
GO:0022900~electron transport 
chain 15 8.68E-09 1.43E-05 
GOTERM BP 
FAT GO:0055114~oxidation reduction 32 6.91E-07 1.1E-03 
GOTERM BP 
FAT GO:0045333~cellular respiration 9 7.84E-06 0.01 
GOTERM BP 
FAT 
GO:0015980~energy derivation 
by oxidation of organic 
compounds 11 7.88E-06 0.01 
GOTERM BP 
FAT 
GO:0022904~respiratory electron 
transport chain 6 1.10E-04 0.18 
GOTERM BP 
FAT 
GO:0006119~oxidative 
phosphorylation 7 4.14E-04 0.68 
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Table 2.5 (cont.) 	
 
Score = 4.18      
GOTERM BP 
FAT 
GO:0006091~generation of 
precursor metabolites and energy 24 1.74E-10 2.86E-07 
KEGG 
PATHWAY 
mmu00190:Oxidative 
phosphorylation 16 7.12E-09 8.25E-06 
GOTERM BP 
FAT 
GO:0022900~electron transport 
chain 15 8.68E-09 1.43E-05 
KEGG 
PATHWAY mmu05016:Huntington’s disease 18 1.82E-08 2.11E-05 
KEGG 
PATHWAY mmu05012:Parkinson’s disease 15 7.73E-08 8.96E-05 
KEGG 
PATHWAY mmu05010:Alzheimer’s disease 16 6.59E-07 7.63E-04 
GOTERM BP 
FAT 
GO:0006119~oxidative 
phosphorylation 7 4.14E-04 0.68 
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Table 2.6 Enriched (enrichment score > 2.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes under- or over-expressed in the active myostatin-
reduced vs inactive myostatin-reduced contrast and not differentially expressed in all 
other contrasts. 
 
Category Term 
Numb
er of 
Genes P-Value 
FDR-
adjusted P-
value 
Score = 2.43      
GOTERM BP FAT 
GO:0001525~angiogenes
is 8 3.00E-04 0.48 
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Table 2.7 Genes differentially expressed (FDR-adjusted P-Value < 0.005 and log2(fold 
change) > |1.3|) between myostatin-reduced and wild-type mice in the skeletal muscle. 
Gene* 
Log2 (Myostatin-reduced/Wild-
type) FDR-adjusted P-value 
ERCC2 4.19 2.5E-03 
DGCR8 4.09 2.5E-03 
METTL21E 3.48 2.5E-03 
GSPT1 2.38 2.5E-03 
ACTC1 2.29 2.5E-03 
GREM2 1.91 2.5E-03 
SLN 1.89 2.5E-03 
CDH4 1.88 2.5E-03 
F830016B08R
IK 1.87 2.5E-03 
KATNAL2 1.74 2.5E-03 
IL12A 1.47 2.5E-03 
MYBPH 1.34 2.5E-03 
VASH2 1.30 2.5E-03 
*Expanded gene names, listed in alphabetical order: ACTC1=actin, alpha, cardiac muscle 1; 
CDH4=cadherin 4, type 1, R-cadherin; DGCR8=DGCR8 microprocessor complex subunit; 
ERCC2=Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2; 
F830016B08RIK=RIKEN cDNA F830016B08 gene; GREM2=gremlin 2, DAN family BMP antagonist; 
GSPT1=G1 to S phase transition 1; IL12A=interleukin 12A (natural killer cell stimulatory factor 1, 
cytotoxic lymphocyte maturation factor 1, p35); KATNAL2=katanin p60 subunit A-like 2; 
METTL21E=methyltransferase like 21E; MYBPH=myosin binding protein H; SLN=sarcolipin; 
VASH2=vasohibin 2 
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Table 2.8 Enriched (enrichment score > 3.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes differentially expressed between myostatin-
reduced and wild-control mice (FDR-adjusted P-value < 0.05)   
Category  Term 
Num
ber 
of 
Gene
s 
P-
Value 
FDR-
adjusted 
P-value1 
Score = 3.59     
KEGG 
PATHWAY 
mmu05410:Hypertrophic 
cardiomyopathy (HCM) 10 
7.69E-
05 0.09 
KEGG 
PATHWAY mmu04260:Cardiac muscle contraction 9 
2.65E-
04 0.31 
KEGG 
PATHWAY mmu05414:Dilated cardiomyopathy 9 
8.16E-
04 0.96 
Score = 3.43     
GO BP FAT 
GO:0007167~enzyme linked receptor 
protein signaling pathway 20 
7.05E-
06 0.01 
GO BP 
GO:0007179~transforming growth factor 
beta receptor signaling pathway 7 
5.38E-
04 0.89 
1 False Discovery Rate adjusted P-value. Only terms with FDR-adjusted P-value < 0.99 
or with more than 5 genes are listed 
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Table 2.9 Genes differentially expressed (FDR-adjusted P-Value < 0.005 and log2(fold 
change) > |1.3|) between active and inactive mice in the skeletal muscle 
Gene* Log2(Active/Inactive) 
FDR-adjusted 
P-value 
ERCC2 3.95 1.54E-03 
BDH1 2.38 1.54E-03 
GM1078 2.28 1.54E-03 
BC048679 2.28 1.54E-03 
LRRC52 1.92 1.54E-03 
LDHB 1.88 1.54E-03 
TNNC1 1.86 1.54E-03 
EGLN3 1.82 1.54E-03 
MYL2 1.82 1.54E-03 
TNNT1 1.78 1.54E-03 
MYH7 1.78 1.54E-03 
MYOM3 1.76 1.54E-03 
ESRRB 1.74 1.54E-03 
SLC26A10 1.65 1.54E-03 
FHL2 1.65 1.54E-03 
ANKRD2 1.63 1.54E-03 
MYH2 1.61 1.54E-03 
TM6SF1 1.59 1.54E-03 
IQSEC2 1.57 1.54E-03 
VAV2 1.53 1.54E-03 
TPM3 1.51 1.54E-03 
*Expanded gene names, listed in alphabetical order: ANKRD2=ankyrin repeat domain 2 (stretch 
responsive muscle); BC048679=cDNA sequence BC048679; BDH1=3-hydroxybutyrate dehydrogenase, 
type 1; EGLN3=egl-9 family hypoxia-inducible factor 3; ERCC2=excision repair cross-complementing 
rodent repair deficiency, complementation group 2; ESRRB=estrogen-related receptor beta; FHL2=four 
and a half LIM domains 2; GM1078=SH3 domain binding kinase family, member 3; IQSEC2=IQ motif 
and Sec7 domain 2; LDHB=lactate dehydrogenase B; LRRC52=leucine rich repeat containing 52;  
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Table 2.9 (cont.)  	
MYH2=myosin, heavy chain 2, skeletal muscle, adult; MYH7=myosin, heavy chain 7, cardiac muscle, 
beta; MYL2=myosin, light chain 2, regulatory, cardiac, slow; MYOM3=myomesin 3; SLC26A10=solute 
carrier family 26, member 10; TM6SF1=transmembrane 6 superfamily member 1; TNNC1=troponin C 
type 1 (slow); TNNT1=troponin T type 1 (skeletal, slow); TPM3=tropomyosin 3; VAV2=vav 2 guanine 
nucleotide exchange factor 
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Table 2.10 Enriched (enrichment score > 8.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes differentially expressed between active and 
inactive mice (FDR-adjusted P-value < 0.05)   
Category Term 
Num
ber 
of 
Gen
es P-Value 
FDR-
adjusted 
P-value 
Score  = 19.79     
KEGG 
PATHWAY mmu00190:Oxidative phosphorylation 51 
5.29E-
29 6.39E-26 
KEGG 
PATHWAY mmu05012:Parkinson’s disease 50 
2.05E-
27 2.47E-24 
GOTERM BP 
FAT 
GO:0006091~generation of precursor 
metabolites and energy 65 
2.35E-
27 4.12E-24 
KEGG 
PATHWAY mmu05010:Alzheimer’s disease 55 
7.43E-
25 8.98E-22 
KEGG 
PATHWAY mmu05016:Huntington’s disease 53 
5.65E-
23 6.82E-20 
GOTERM BP 
FAT GO:0022900~electron transport chain 39 
4.30E-
22 7.54E-19 
GOTERM MF 
FAT 
GO:0015078~hydrogen ion 
transmembrane transporter activity 23 
4.07E-
11 6.28E-08 
GOTERM MF 
FAT 
GO:0015077~monovalent inorganic 
cation transmembrane transporter 
activity 23 
1.44E-
10 2.22E-07 
GOTERM MF 
FAT 
GO:0022890~inorganic cation 
transmembrane transporter activity 26 
2.46E-
09 3.79E-06 
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Table 2.10 (cont.) 		
Score = 8.42     
KEGG 
PATHWAY mmu04260:Cardiac muscle contraction 28 
1.13E-
14 1.35E-11 
GOTERM MF 
FAT 
GO:0015078~hydrogen ion 
transmembrane transporter activity 23 
4.07E-
11 6.28E-08 
GOTERM MF 
FAT 
GO:0015077~monovalent inorganic 
cation transmembrane transporter 
activity 23 
1.44E-
10 2.22E-07 
GOTERM MF 
FAT 
GO:0022890~inorganic cation 
transmembrane transporter activity 26 
2.46E-
09 3.79E-06 
GOTERM MF 
FAT 
GO:0016675~oxidoreductase activity, 
acting on heme group of donors 10 
7.32E-
07 1.13E-03 
GOTERM MF 
FAT 
GO:0016676~oxidoreductase activity, 
acting on heme group of donors, 
oxygen as acceptor 10 
7.32E-
07 1.13E-03 
GOTERM MF 
FAT 
GO:0015002~heme-copper terminal 
oxidase activity 10 
7.32E-
07 1.13E-03 
GOTERM MF 
FAT 
GO:0004129~cytochrome-c oxidase 
activity 10 
7.32E-
07 1.13E-03 
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Figure 2.1 Basic RNA-sequencing protocol from extraction to analysis. The 
workflow that is boxed is repeated for each biological endpoint being analyzed. 
 
  
	 64	
Figure 2.2 Number of differentially expressed genes that overlap between inactive 
wild-type (IW) and remainder activity-genotype groups: inactive myostatin-reduced 
(IM), active wild-type (AW), and active myostatin-reduced (AM).  
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CHAPTER 3. CEREBELLUM TRANSCRIPTOME OF MICE BRED FOR HIGH 
ACTIVITY OFFERS INSIGHTS INTO REWARD-DEPENDENT BEHAVIOR 
 
Kelsey Caetano-Anollés1, Justin S. Rhodes2,3, Theodore Garland Jr4, Sandra L. 
Rodriguez-Zas1, 5, 6* 
 
Abstract 
 
Addiction to activity and to psychoactive substances share psychologically and 
physiological characteristics. A transcriptome study compared a mouse line selected for 
high voluntary activity to a control line in environments restricting or enabling a 
rewarding activity. Results offered insights into genetic factors behind activity 
dependence and provided a model for understanding addiction and other reward-
dependent behaviors.   
Most genes differentially expressed between activity genotypes were only 
moderately differentially expressed between activity environments, suggesting that 
environmental effects were not confounded with activity genotype effects. Adora2a had 
a significant genotype-by-environment interaction effect evidenced by over-expression 
in the activity genotype relative to control in high activity environment and under-
expression in the low activity environment.  Our findings of differentially expressed 
genes related to dopaminergic transmission between activity genotypes support the 
association between these genes and activity. A central theme from the functional 
analysis of activity genotype-environment was neuron morphogenesis. Gene network 
analysis identified connected genes that exhibited similar (e.g. Lhx9) and opposite (e.g. 
Nrgn) expression patterns between activity genotypes across reward availability 
environment.  
Our findings suggest that some transcriptomic changes in mice selected for high 
voluntary activity are shared with other reward-dependent behaviors. Results from this 
study support that high voluntary activity selection lines in mice are a helpful model to 
understand molecular mechanisms behind addition. Also, identification of genes and 
biological processes associated with both high voluntary activity and the pleasurable 
neurological response to physical activity may allow for the development of drugs which 
make it more pleasurable for people to exercise or less pleasurable to be sedentary as a 
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treatment approach for overweight/obesity as well as a way to improve health overall in 
the general population. 
 
Introduction   
The brain's dopaminergic mesocorticolimbic system has a primary role in 
reward-motivated response including associative learning or reinforcement (R. R. 
Brown et al., 1991; Ivlieva, 2011; Koob, 1992). Neurons in this region synapse and 
release dopamine in response to the introduction of addictive stimuli (Hyman, 2005; 
Kalivas & Volkow, 2005; McKim, 2003; Vivier, Tomasello, Baratin, Walzer, & 
Ugolini, 2008). Psychoactive substances, including opiates, cocaine, amphetamine, 
alcohol, and nicotine impact the neurotransmission of dopamine just as other more 
natural rewards including specific foods or liquids, and exercise (Bowman, Aigner, & 
Richmond, 1996; Carelli, King, Hampson, & Deadwyler, 1993; Chang, Sawyer, Lee, & 
Woodward, 1994; Peoples, Gee, Bibi, & West, 1998; Wise, 1996; Wise, 2002). Other 
forms of pathological behavior including shopping addiction, hypersexuality, and 
compulsive eating have been found to have roots in the dopaminergic system triggering 
chemical reactions in the brain comparable to substances of abuse (Comings et al., 1996; 
Lim, Ha, Choi, Kang, & Shin, 2012). It comes as no surprise, then, than the same would 
be observed with exercise -an activity that can induce a euphoric psychological state 
(Harber & Sutton, 1984). The pleasurable effects, behaviors, hormone levels, and 
potential for addiction experienced by individuals who exercise are similar to those 
elicited by other natural and non-essential rewards (Leuenberger, 2006).  
Physical activity can be a self-rewarding behavior that can exhibit addictive 
properties (Kolb, Kelly, & Garland Jr., 2013) and significant departures from healthy 
activity levels have been associated with behavioral disorders (Majdak et al., 2014). 
While addiction to exercise is not considered an official addictive disorder (American 
Psychiatric Association, 2013), 3% to 5% of the US population experience this condition 
(Sussman, Lisha, & Griffiths, 2011). Exercise dependence involves the brain’s reward 
pathway and is attributed to endorphin hormones which in high levels act in a way 
similar to morphine and have been found to correlate with vigorous exercise (Goldfarb, 
Hatfield, Sforzo, & Flynn, 1987; McKim, 2003; Pierce, Eastman, Tripathi, Olson, & 
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Dewey, 1993). Physical activity causes release of dopamine in the basal ganglia (Pieau 
& Dorizzi, 2004), suggesting that it activates the dopaminergic mesocorticolimbic brain 
system. Also, the neural processes of physical activity overlap with those of rewards 
substances previously discussed. Likewise, withdrawal from physical activity has been 
associated with depression and anxiety behaviors (Kolb et al., 2013).  
The psychological and biological characteristics shared between exercise 
dependence and reward-dependent behaviors have led to an effective model that uses 
mouse lines selected for higher physical activity compared to control unselected lines 
(Garland et al., 2010; Uyttenhove et al., 2003). A number of studies that used this model 
have been performed on the striatum because of its involvement in decision-making, 
goal-directed action (Balleine, Delgado, & Hikosaka, 2007) and association with motor 
behavior and exercise (Alexander, DeLong, & Strick, 1986; Penney & Young, 1983). 
Furthermore, exercise increases the concentration of dopamine in this brain region (De 
Bruin, Schasfoort, Steffens, & Korf, 1990; Kuhr & Korf, 1988a; Kuhr & Korf, 1988b; 
Schasfoort, De Bruin, & Korf, 1988; Teixeira et al., 2009; G. J. Wang et al., 2000). 
However, recent results from studies on mice selectively bred for high levels of 
voluntary wheel running indicate that in these hyperactive mice, physical activity may 
affect the cerebellum in a curious and unique way. While mice from these high-runner 
lines showed statistically larger non-cerebellar brain mass, their cerebellums did not 
differ from those of control mice (Kolb et al., 2013). Given that the cerebellum is linked 
to exercise but was unaltered by this selective breeding, it appears that voluntary 
exercise in highly active may have a distinctive impact on the cerebellum. 
The cerebellum and striatum are closely linked. Studies have demonstrated that 
the output stages of cerebellar processing have a disynaptic connection with the input 
stages of basal ganglia processing, which occur in the striatum. (Hosni et al., 2005) 
However, although these two regions of the brain work together closely, their neurons 
have different targets and functions; additionally, they appear to implement different 
learning algorithms, which would impact physiological responses to reward (Doya, 2000; 
Houk, 2005). Supplementing studies on exercise and reward in the striatum with research 
performed on the cerebellum may be extremely beneficial for better understanding how 
various parts of the brain respond to reward, addiction, and exercise. 
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 The goals of this study are to uncover changes in the cerebellum associated with 
genetic selection for physical activity-dependence and the modulation of these genetic 
changes associated with physical activity environment. We profile the cerebellum 
transcriptome of mice on a 2-by-2 factorial design comparing a line selected for high 
voluntary physical activity versus a parallel control line both under restricted and 
unrestricted running environmental conditions.  The comparison of both genetics lines 
under restricted and unrestricted activity environments permitted to disentangle the 
transcriptome profiles and networks underlying activity dependence from the changes in 
transcriptome in response to coincidental physical activity. Gene networks including 
information on the transcriptome profiles characterized in this study were compared 
across genetic and environmental activity levels. Transcriptomic distinctiveness and 
similarities between genetic lines within environments and between environments within 
genetic lines will advance the understanding of genetic variation in reward dependency 
and addictive behaviors.  
 
Materials and methods 
 
Experimental Design 
An experiment following a randomized 2 x 2 factorial design including the 
factors of activity or exercise genetics and environment was carried out. The design 
included two mouse lines, one line selected for high voluntary physical activity and an 
unselected control line (hereby denoted activity genotype), and two cage environments 
enabling two activity levels blocked from wheel running or allowed to run (hereby 
denoted activity environment). Sample size was n=4/activity genetic-environment 
combination. Mice were weaned at 21 days of age, kept in temperature-controlled rooms 
(21 ± 1°C) on a 12 hour photo-period, and provided food and water ad libitum 
(Swallow, Carter, & Garland, 1998). All procedures that involved animals were 
approved by the University of California, Riverside, Institutional Animal Care and Use 
Committee. 
Activity genotype groups. Two lines, activity genotype levels high and control or 
low (H and L, respectively) were studied. Mice corresponded to a line selectively bred 
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for high voluntary wheel-running (H Line 7) and one non-selected control line (L Line 
1) from an ongoing selective breeding program beginning with a mix of 8 Hsd:ICR 
strains. Details on the successful protocol of selection for high activity have been 
documented previously (Dlugosz et al., 2013; Hannon et al., 2010; Talmadge, Acosta, & 
Garland Jr., 2014; Waters et al., 2013). Briefly, selected lines were bred for higher 
voluntary distance run on a wheel within the habitual cage. The randomly-bred control 
line was raised under the same conditions. Each generation, at approximately 6 to 8 
weeks of age, individual mice are placed in cages with access to a Wahman-type 
running wheel (circumference= 1.12 m) for 6 days. The selection criterion is the average 
count of revolutions run on days 5 and 6 tracked by a computer-automated system. High 
activity line parents of the next generation are the female and male from each litter that 
have the highest revolutions count meanwhile control line parents are two randomly 
chosen males and two females from each litter. Beyond the 6-day period when 
revolution counts are recorded, mice are maintained in randomly assigned, same-sex 
groups of four in standard cages until the environment treatment is evaluated. Male adult 
mice corresponding to approximately the 40th generation of the selection experiment 
were used in this study. By this generation, the 4 high activity lines of mice run nearly 3 
times more distance per day and at higher velocity relative to the four control lines 
(Swallow et al., 1998). The difference between selected and control groups is higher 
than the difference within group. The H and L lines used in this study were selected at 
random among the selected and control lines available. 
High voluntary wheel running has been recognized a recognized self-rewarding 
behavior in mice (Kolb et al., 2013). The higher running of the selected lines has been 
associated with changes in dopamine and endocannabinoid signaling (Keeney, Meek, 
Middleton, Holness, & Garland, 2012; Rhodes, Gammie, & Garland, 2005). 
Furthermore, the high activity lines in these studies also exhibited high home-cage 
activity in the absence of wheel and high behavioral despair after removal of wheel 
following days of access (Kolb et al., 2013). The interpretation of the biological 
significance from the functional enrichment performed on the differentially expressed 
genes between activity genotype-environment combinations, genotypes and 
environments, it is valuable to understand previously identified phenotypic and 
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genotypic characteristics of the mice lines bred for high wheel running. The selectively 
bred mice display increased physical activity compared to control mice (voluntary wheel 
running and climbing) regardless of manipulation of external factors, such as 
maintaining them under constant dark or constant light (Koteja, Swallow, Carter, & 
Garland, 2003). They run faster, bouts of running occur more frequently, and they exit 
the wheel less frequently (Rhodes et al., 2005). Even when the running wheels are 
locked, mice from the selected lines climb more in their cages, and increased wheel 
rotational resistance does not discourage them from wheel-running (Koteja, Garland, 
Sax, Swallow, & Carter, 1999). Interestingly, while both control and selected mice were 
able to be trained to press a lever for a reward of 30 minutes of free running time, only 
control lines could be trained to perform the behavior for only 90 seconds of running 
time (Belke & Garland, 2007). These behaviors suggest a general higher motivation 
towards physical activity, and specifically longer running durations, compared to control 
mice.  Physical features of mice selected for high wheel running include larger hearts, 
thicker femurs and tibiafibulas, larger femoral heads, and more symmetrical hindlimb 
bone lengths (Garland & Freeman, 2005). Mice selected for high wheel running have 
less body mass and length, less body fat even when housed without access to a wheel, 
and eat more for their body mass (Nehrenberg, Hua, Estrada-Smith, Garland, & Pomp, 
2009).After accounting for their reduced body fat, they have lower circulating leptin 
levels and high circulating adiponectin and corticosterone levels, even at rest during the 
day (Majdak et al., 2014). 
Activity environment groups. Two environments, activity unrestricted and 
restricted (activity environment levels H and L, respectively) were studied. These 
environments represent availability and unavailability of the activity reward. These 
environments were evaluated on both genotypes because the comparison of activity 
genotypes alone could lead to confounding between cause and effect (do transcript 
profiles spur or are a result of voluntary activity?). To address this, the comparison 
between activity environments enabled the identification of differential gene expression 
between activity restricted and unrestricted mice due to the ability to exercise rather than 
due to genotypic differences in voluntary activity. The activity restricted and 
unrestricted environments were previously described in detail (Kelly et al., 2014). 
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Briefly, at approximately 11 weeks of age mice were placed in individual cages and 
either allowed (unrestricted) or prevented (restricted) access to a wheel; for mice in the 
restricted environment, the wheel was locked using a wire tie to prevent it from rotating. 
Groups were labeled by genotype followed by environment. Therefore, the mice group 
HL correspond to mice with high activity genotype in a low activity (restricted) 
environment.  
 
RNA profiling 
Mice were euthanized by rapid decapitation 1 day after individual housing in 
running or sedentary environments. Brain was extracted and the whole cerebellum was 
dissected on a chilled aluminum block, flash-frozen in liquid nitrogen and stored at -
80°C. Subsequently, samples were thawed, submerged in RNAlater solution (Qiagen, 
Valencia, CA), and maintained at -20°C until RNA isolation. Individual cerebellum 
samples were homogenized and RNA purified (RNeasy Mini kit, Qiagen, Valencia, CA), 
then quantified and assessed for purity using a NanoDrop ND-1000 Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE) and an Agilent 2100 bioanalyzer (Agilent 
Technologies, Santa Clara CA). RNA integrity was assessed using the Agilent 2100 
Bioanalyzer with RNA Pico chip (Agilent Technologies, Palo Alto, CA). All samples 
had RNA Integrity Numbers (RIN) > 9. Libraries of individual mouse cerebellum 
samples were sequenced (Nixon et al., 2015) and 100nt-long paired-end reads were 
obtained using Illumina HiSeq 2000 (Illumina, San Diego, CA, USA).  
 
Analysis 
Using the FastqGroomer tool, FastQ data files were converted to FastqSanger 
format following proven protocols (Caetano-Anollés, Mishra, & Rodriguez-Zas, 2015; 
Nixon et al., 2015). A quality control check was performed on the reads using FastQC, 
and end positions with low Phred quality values (<20) were removed with Fastq Quality 
Trimmer. Next, the reads were mapped to the mouse mm10 genome assembly (UCSC; 
http://genome.ucsc.edu) using Tophat (v2.0.13) (Trapnell et al., 2012). Tophat settings 
were expected (mean) inner distance = 200nt, anchor length" junctions spanned by reads 
with at least 8bp on each side of the junction with 0 mismatch, independent mapping of 
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read segments of 25nt long, and default intron length specifications. Cufflinks was used 
to assemble transcripts and estimates abundances; transcript isoforms were identified 
and quantified in number of fragments per kilobase of exon per million mapped reads. 
Differential transcript abundance between experimental conditions was tested using 
Cuffdiff (v2.2.0) using a geometric library normalization (Trapnell et al., 2012). 
Beyond standard identification of differentially expressed genes between activity 
genotypes and environments, this study aimed to uncover complex interplay between 
these factors. Differential expression was tested between genotype-environment groups, 
between genotype groups and between environment groups. Evaluation of the 
interaction between genotypes (H or L) and environments (H or L) allowed the 
identification environment-dependent differential profiles between high activity and 
control genotypes (Caetano-Anollés et al., 2015). Differences between genotypes within 
environment offers insights into transcripts associated into behavioral differences 
between genotypes in presence or absence of the reward (wheel activity). These tests 
allowed assessment of the statistical significance of the interaction between genotype 
and environment on the transcriptome. Gene profiles exhibiting significant interaction 
effects were further evaluated for possible synergistic or antagonistic effects. Example 
of synergistic effect would be H genotype and H environment resulting on gene 
expression level more extreme than H genotype and H environment added. Example of 
antagonistic effect would be H genotype and H environment resulting on gene 
expression level less extreme than H genotype and H environment added. Testing for the 
main effects of genotype and environment followed the testing for interaction. False 
discovery rate (FDR) adjusted P-values were used to account for multiple test 
adjustment across transcripts.  
 Six pairwise contrasts were used to profile the expression patterns involving 4 
groups: high activity genotype-high activity environment (HH); high activity genotype-
low activity environment (HL); low activity genotype-high activity environment (LH); 
and low activity genotype-low activity environment (LL). Among the 6 pairwise 
contrasts, 3 orthogonal contrasts were of interest: 1) HH vs. LH, 2) HL vs. LL, and 3) 
HH vs. HL. The first two contrasts allowed the identification of differences between H 
and L genotypes within environment and the third contrasts allowed to identify 
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differences between environments within the H genotype. Commonalities between the 
first two contrasts support the identification of genes associated with high voluntary 
running regardless of environment. Commonalities between the first two groups and the 
third group support the identification of genes that may respond also to the environment. 
Enrichment of functional terms was investigated using the differential gene 
expression from the three orthogonal contrasts of interest: 1) HH vs. LH, 2) HL vs. LL, 
and 3) HH vs. HL. Two complementary functional enrichment analyses of the 
transcriptome profiles were undertaken. First, among genes differentially expressed 
(FDR-adjusted P-value < .05 comparable to P-value < 0.001) enrichment of functional 
categories and pathways was performed using the Database for Analysis, Validation, 
and Integrated Discovery system (DAVID; (Huang da, Sherman, & Lempicki, 2009a; 
Huang da, Sherman, & Lempicki, 2009b)). Gene Ontology (GO) functional categories 
investigated included biological process (BP), molecular function (MF), and pathways 
defined by the Kyoto Encyclopedia of Genes and Genomes (KEGG). GO Functional 
Annotation Tool (FAT) categories, which filter broad and less informative terms, along 
with clustering of categories that share genes were used to minimize redundancy 
between FAT and KEGG categories (Delfino & Rodriguez-Zas, 2013; Serao, Gonzalez-
Pena, Beever, Bollero et al., 2013; Serao, Gonzalez-Pena, Beever, Faulkner et al., 2013). 
Each cluster's statistical significance was assessed using enrichment scores produced in 
DAVID; these values correspond to the geometric mean of the scores of each functional 
category in the cluster. Second, Gene Set Enrichment Analysis (GSEA) was performed 
on the gene expression profiles of all genes studied to uncover enriched categories 
within the up- and down-regulated genes between genotype-environment groups 
(Subramanian et al., 2005). Cuffdiff output files were converted to .gct format using the 
Fpkm_trackingToGct tool within Genepattern software (Subramanian et al., 2005) and 
then submitted to GSEA for analysis. Maximum and minimum cutoffs for gene set size 
were 1000 and 5 respectively, and enrichment significance was assessed using 1000 
permutations. GSEA analyses confirmed results of the gene enrichment analysis 
performed using DAVID, which are interpreted subsequently. 
Gene networks were reconstructed using the differential gene expression from 
the three orthogonal contrasts of interest: 1) HH vs. LH, 2) HL vs. LL, and 3) HH vs. 
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HL. From our list of 430 genes exhibiting significant activity genotype-by-environment 
interaction effect on gene expression at FDR P-value < 0.05, 99 were selected to 
visualize gene networks using the Cytoscape software (Killcoyne, Carter, Smith, & 
Boyle, 2009). In order to select these 99 genes, the 33 genes with the highest FDR 
adjusted P-value from each of the three orthogonal contrasts were selected and the 
relationships between these genes was visualized using the Bisogenet package within 
Cytoscape (Martin et al., 2010). Bisogenet was prompted to search for protein-protein 
interactions; the package utilizes data on interactions stored in publicly available data 
sets including BIOGRID, HPRD, DIP, BIND, INTACT, and MINT among others 
(Martin et al., 2010). All available data sources within BisoGenet were selected in order 
to generate the interactions. 
 
Results and Discussion 
 
Summary of RNA-Seq data 
 The quality and quantity of the RNA sequence reads was evaluated across 
samples. The average quality score Phred of the reads was 30. These scores are 
excellent, considering that a Phred of 30 is the equivalent of P-value < .001 (Z. Wang, 
Gerstein, & Snyder, 2009). The number of reads and quality scores along the reads were 
comparable across samples from all 6 activity genotype-environment groups. Likewise, 
the percentage of reads mapped to the mouse genome was 100% (an average of 
12,9718676.5 total reads were mapped per sample). From these findings, genes 
corresponding to transcripts exhibiting statistical significant (FDR-adjusted P-value < 
0.005) interaction between genotype and environment, or significant main effects of 
genotype or environment (FDR-adjusted P-value < 0.005; log2(fold change) > |1.3|) 
were identified and their profile characterized. 
 
Activity genotype-by-environment interaction effect on gene expression 
Overall, 430 genes exhibited significant interaction effect at FDR < 0.05. The top 
20 genes exhibiting the most significant interaction effect including the log2(fold 
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change) between pairs of genotype-by-environment groups and the overall FDR-
adjusted P-value are presented in Table 3.1.  
Among the gene profiles exhibiting significant genotype-by-environment 
interaction effect, a number of genes have been previously associated with reward-
processing and reward-dependent behaviors. Adenosine A2a receptor (Adora2) was 
over-expressed in the LH-HH contrast and under-expressed in all other contrasts.  A2ar 
has been associated with the physiological response of the body to drug-use and 
hyperactivity (R. M. Brown & Short, 2008). This receptor is involved in goal-focused 
behaviors and motor functions used to carry out those behaviors and when this receptor 
is deleted, mice display reduced exploratory behaviors and even less motivation towards 
sexual activity and eating (Short, Ledent, Drago, & Lawrence, 2006). In rats, subchronic 
doses of morphine increases levels of extracellular adenosine and therefore decreases 
striatal A2a receptor number and function (De Montis, Devoto, Meloni, Saba, & 
Tagliamonte, 1992).  Also, A2ar agonists have been found to significantly decrease 
cocaine induced hyperactivity in mice (Poleszak & Malec, 2002). These receptor is also 
tied to locomotor activity in dopamine D2 receptor (Drd2) deficient mice, locomotor 
impairment was reversed using an A2ar antagonist (Aoyama, Kase, & Borrelli, 2000).   
Consistent with the A2ar finding, our results revealed significant differential 
expression of Drd2. In our study, Drd2 was over-expressed in the LH-HH and HL-HH 
contrasts and under-expressed in all other contrasts. Dopamine plays a major role in 
inducing behavioral and physiological changes.  Exercise increases levels of serum 
calcium, which is transported to the brain and subsequently stimulates dopamine 
synthesis (Sutoo & Akiyama, 2003). In mice lacking D2 receptors, the rewarding 
property of morphine was reduced although the behavioral expression or drug 
withdrawal was unchanged (Maldonado et al., 1997). This indicates that the Drd2 is 
crucial for the motivational component of drug addiction, although it may have a lesser 
effect on the physiological response of the body to addiction. These results suggest that 
both drug abuse and hyperactivity (in the selection line studied) are reward-motivated 
behaviors that involve similar molecular mechanisms in the brain. 
 
Comparison of gene expression across activity genotype-by-environment groups  
	 76	
The number of differentially expressed genes at FDR adjusted P-value < 0.05 
(and corresponding contrast) was: for 117 (LL-HL), 140 (LL-LH), 121 (LL-HH), 261 
(HL-LH), 12 (HL-HH), and 252 (LH-HH). Within these contrasts, the number of over-
expressed genes was: 12, 4, 8, 100, 5, and 130 respectively. Several interpretations can 
be made from the progression of the number of differentially expressed genes starting 
with the highest number in LH-HL followed by LH-HH, followed by LL-LH followed 
by LL-HH. Firstly, the number of differentially expressed genes between genotypes 
regardless of environment (LL-HL and LH-HH) was higher than the number of 
differentially expressed genes between environments regardless of genotype (LL-LH 
and HL-HH). This finding indicates that the impact of genotype is more prevalent than 
that of environment on the transcriptome. Also, genotype differences were associated 
with more than double the number of differentially expressed genes in H environment 
(LH-HH) relative to L environment (LL-HL). This result may suggest that the genotype 
differences in gene expression may benefit from an environment that supports high 
activity. Figure 3.1 presents a Venn diagram illustrating the shared differentially 
expressed genes between on HH vs LH, HL vs LL, and HH vs HL; observing these 
contrasts highlight genetic differences and those which may be related to environment. 
The limited overlap between contrasts depicted in this diagram highlights that the 
differences in gene expression between genotypes are highly dependent on the 
environment. While there were no genes that were differentially expressed in the three 
contrasts, a substantial number of genes were expressed in both HL-LL and HH-LH 
(16), followed by HH-LH and HH-HL (6) and HL-LL and HH-HL (2). Sharing indicates 
trigger of similar molecular mechanisms across environments.  
 Another finding from the comparison of differentially expressed genes across 
contrasts is that environmental differences were associated with significantly more 
differentially expressed genes (almost tenfold) in L genotype (LL-LH, 116 genes) than 
in the H genotype (HL-HH, 11 genes). This result indicates that environment can elicit 
differential gene expression in the L genotype that may already be activated in the H 
genotype and thus the limited differential expression response to the environment.  
 Among all genotype-environment contrasts, HL-LH mice exhibited the highest 
number of differentially expressed genes relative to other genotype-environments 
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contrasts. We conclude that the changes in transcriptome associated with activity 
genotype are not balanced out by changes associated with activity environment. The 
remaining contrast involving different genotypes and environment (LL-HH) exhibited 
half of the number of differentially expressed genes than the contrasts with most 
differentially expressed genes (HL-LH and LH-HH). These findings could imply that 
there may be synergistic effects between opposite levels of genotype and environment 
resulting in the highest number of gene differences and antagonistic effects between 
similar levels of genotype and environment that cancel some of the gene expression 
differences.   
Figure 3.2 illustrates the shared differentially expressed genes between one set 
of orthogonal contrasts including the LL baseline group. Unlike in the previous 
comparison of three contrasts, HH vs LH, HL vs LL, and HH vs HL, where each 
contrast appeared to have a unique set of differential genes with none shared between all 
3, the comparison of all 3 contrasts including the LL baseline group showed a very 
different pattern. Overall, 81 genes were shared between all 3 contrasts, strongly 
suggesting a common molecular mechanisms operating across environments. This 
complementary view confirms that genotypic make-up leading to voluntary high activity 
cause changes in gene expression that environment alone cannot replicate. 
 
Enriched functional categories 
Functional enrichment analysis was performed individually on the 3 orthogonal 
contrasts between genotype-environment combinations of interest. Enriched DAVID 
clusters of Gene Ontology (GO) biological process (BP), molecular function (MF) 
Functional Annotation Tool (FAT) categories, and KEGG pathways among the genes 
differentially expressed (FDR-adjusted P-value < 0.05) between the contrasts are 
provided in Tables 3.2 and 3.3. 
Table 3.2 lists enriched (enrichment score > 3.0) clusters among the genes 
significantly differentially expressed between genotypes within the L environment (HL-
LL). A central theme is neuron morphogenesis and the significant terms included: 
neuron and neuron projection, differentiation, cell and cellular component 
morphogenesis and morphogenesis involved in differentiation, axonogenesis and axon 
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guidance, regionalization. The terms “forebrain and telencephalon development”, 
“forebrain and telencephalon cell migration” together with a whole suite of 
‘developments’ (cortex, hippocampus, diencephalon) are all related to neurogenesis and 
further supported by "cerebral cortex GABAergic interneuron". 
Table 3.3 lists enriched (enrichment score > 3.0) clusters among the genes 
significantly differentially expressed between genotypes within the H environment (HH-
LH). Enriched clusters included terms related to cell development, neurogenesis, nervous 
system development, and homeostatic processes. The former terms related to 
neurogenesis are consistently with enriched terms in the HL-LL contrasts. This finding 
suggests a main effect of high voluntary running genotype independent of reward 
availability (e.g. restricted or enabled wheel running). This is consistent with studies 
reporting association between physical activity and neural development (Kim et al., 2004; 
Noonan, Bulin, Fuller, & Eisch, 2010). However, our finding cannot discriminate 
whether changes in processes associated with neural development lead to changes in 
voluntary physical activity or the selection for voluntary physical activity lead to changes 
in neurological development. The identification of significant terms related to hormone 
metabolism, including cellular hormone metabolic process, regulation of hormone levels, 
and hormone metabolic process is unique to the HL-LL contrast and suggests an 
interaction between activity genotype and environment. This finding suggests that reward 
restriction elicits changes in genes corresponding to hormonal metabolic pathways. 
Hormone activity influences an individual’s behavior as well as the makeup of the brain 
(Arnold & Breedlove, 1985; Arnold, 2009) Testosterone levels are well known to impact 
the extent of novelty-seeking and sensation seeking behaviors (Ehrenkranz, Bliss, & 
Sheard, 1974; Soler, Vinayak, & Quadagno, 2000), and androgens and estrogens also 
elicit a dopamine response in the mesolimbic pathway (de Souza Silva, Mattern, Topic, 
Buddenberg, & Huston, 2009; Lammers et al., 1999; Landry, Levesque, & Di Paolo, 
2002; McEwen, 2002). This enriched group is composed of 4 genes- Aldehyde 
Dehydrogenase 1 Family Member A1 (Alsh1a1), Lecithin Retinol Acyltransferase (Lrat), 
Cytochrome P450 11A1 (Cyp11a1), VGF Nerve Growth Factor Inducible (Vgf). Our 
findings offer valuable leads into hormone metabolism pathways role in reward 
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dependent behavior (e.g. high voluntary activity) on reward-absent environment (e.g. 
restricted activity).  
Only 1 functional cluster among genes significantly (FDR-adjusted P-value < 
0.05) differentially expressed between genotypes within the HH-HL contrast was 
identified and had a low enrichment score of 0.1. This cluster included three terms- 
metal ion binding, cation binding, and ion binding. As ion binding plays an important 
role in muscle function and plasticity (Berchtold, Brinkmeier, & Muntener, 2000), the 
presence of these terms in this exercise contrast is consistent what is currently known of 
the biochemical changes associated with muscle contraction and physical activity (Davis, 
Donovitz, & Hood, 1992; Fajardo et al., 2013; Kirber, Walsh, & Singer, 1988). 
DAVID functional enrichment analysis results for HH-LH, HL-LL, and HH-HL 
were confirmed in GSEA. Unlike DAVID, GSEA can show whether functionally 
enriched clusters are up- or down-regulated. The “Hormone Metabolic Process” term 
was found significantly under-expressed in all three contrasts, and “Neurogenesis” was 
found over-expressed in results of analyses performed on HL-LL and HH-HL groups. 
Interestingly, this term was found significantly under-expressed in HH-LH. 
 
Gene network analysis 
Visualization of networks of genes differentially expressed in the three orthogonal 
contrasts of interest augmented our understanding of the molecular relationships 
impacted by the interaction between activity genotype and environment and by the 
corresponding main effects. Figures 3.3 and 3.4 depict the networks of differentially 
expressed genes (FDR P-value < 0.05) between activity genotypes within activity 
environment (HL-LL and HH-LH, respectively). Figure 3.5 depicts the network of 
differentially expressed genes (FDR P-value < 0.05) between activity environments 
within high voluntary activity (HL-HH). Nodes represent genes and edges represent the 
known associations between genes. The highest under-expressed genes with highest fold 
change were located in sparsely connected peripheral positions of the networks in 
contrasts between activity genotypes within activity environment (Figures 3.3 and 3.4). 
Lower level under expression occurred in hubs of highly connected genes. This is in 
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sharp contrast to the moderate overexpression of those same hubs genes in the contrast 
between activity environments within high voluntary activity (Figure 3.5). 
Four genes exhibit a similar differential pattern in the HL-LL and HH-LH gene 
networks. Laminin, Gamma 2 (Lamc2), Fas Cell Surface Death Receptor (Fas), 
Ribosomal Protein L35a (Rpl35a), and LIM Homeobox 9 (Lhx9) are significantly over-
expressed genes in the high voluntary running line relative to Control in both activity 
environments. The association of these genes with activity dependence, irrespectively of 
reward availability suggest a fundamental disruption that the environment is not able to 
alter. Lxhr9 regulates orexin, a neuropeptide involved in arousal, appetite, wakefulness, 
and reward processes (Liu et al., 2015). The involvement of orexin in the mechanisms of 
reward systems has led to suggestions that this gene could be linked to drug addiction 
(Tsujino & Sakurai, 2009). The other 3 genes also have been associated with addictive 
behaviors. Lamc2 is down-regulated by acute nicotine exposure (J. Wang et al., 2011). 
Fas receptor proteins are modulated during opiate addiction in the rat brain (GarcÃ-a-
Fuster, Ferrer-AlcÃ³n, Miralles, & GarcÃ-a-Sevilla, 2003). 
On the other hand, 6 genes- Neurogranin (Nrgn), dopamine receptor D2 (Drd2), 
Retinoid X Receptor Gamma (Rxrg), Guanine Deaminase (Gda), Adenosine A2a 
Receptor (Adora2a), and Ras-Related Protein Rab-40B (Rab40b)- display strikingly 
dissimilar patterns between the HL-LL and HH-LH gene networks. These genes are over-
expressed in HH-LH and under-expressed in HL-LL. These genes that have different in 
expression patterns across environment exhibit interaction effect, where the effect of 
activity genotype depends on the reward availability environment. Nrgn is a neuropeptide 
associated with alcohol addiction through the role in synaptic plasticity and signal 
transduction (Levran et al., 2015). Drd2 has been associated with addiction to opiods, 
nicotine, and cocaine (Noble, 2003); however our study is first on uncovering the 
dependency of the profile on activity environment. The dramatic expression difference 
indicates that the relationship between Drd2 and addictive behaviors in mice motivated 
for physical activity as the reward has different mechanisms than those of addiction to 
drugs of abuse. 
Finally, genes that were not highly differentially expressed (intermediate colors) 
in the two activity genotype contrasts included histone cluster 2, H4 (Hist2h4), 
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Neurogenin 2 (Neurog2), Ak181631, and minichromosome maintenance complex 
component 6 (Mcm6). These results indicate that high voluntary activity is not clearly 
associated with dysregulation of these genes and consequently these genes do not play a 
strong role in physical activity addiction. However, some of these genes have been 
associated with other types of addiction. Neurog2 is required for midbrain DA neuron 
development in mice (Andersson, Jensen, Parmar, Guillemot, & Bjorklund, 2006; Kele et 
al., 2006) and dysfunction of midbrain DA neurons is linked to drug addiction (Lupica & 
Riegel, 2005; Park et al., 2008).  
Comparison between the networks highlighting genes differentially expressed 
between activity genotypes and the network highlighting genes differentially expressed 
between activity environments within the high activity genotype group offers insights 
into gene dysregulation associated with genotypes that can be mimicked or obliterated by 
the environment. Interestingly, most of the genes over- or under- expressed in the activity 
genotype comparison are only intermediately differentially expressed between activity 
environments. This result suggest that environment is not confounding our previous 
conclusions based on activity genotype comparisons. The only exception is Midline 1 
(Mid1). This gene was significantly over-expressed in the HL-LL contrast yet was 
significantly under-expressed in the HH-LH. In fact, Mid1 was the only significantly 
under-expressed in this network. This finding suggests that reward availability 
environment can counteract the dysregulation in Mid1 expression associated with high 
voluntary activity genotype. 
  
Effect of activity genotype on gene expression in the cerebellum 
   
Table 3.4 summarizes genes significantly differentially expressed (FDR-adjusted 
P-Value < 0.005 and log2(fold change) > |3|) between low and high activity genotypes. 
Results from the functional enrichment analysis of the genes differentially expressed 
between activity genotypes (P-value < 0.001), and enriched (enrichment score > 3.0) 
clusters are highlighted in Table 3.5.  
Dopamine receptor D1 (Drd1a) was overexpressed in H relative to L genotypes. 
Our results are consistent with reports that this receptor is key in mediating the effects of 
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drugs and has a strong role in reward-dependent behaviors (Tobon, Catuzzi, Cote, 
Sonaike, & Kuzhikandathil, 2015). Both D1-like and D2-like dopamine receptors (two 
classes of dopamine receptors; regulated by Drd1a and Drd2, respectively) are involved 
in rats who are taught to perform a behavior in order to receive pleasurable electrical 
stimulation (Franklin & Vaccarino, 1983; Kornetsky & Esposito, 1981). In mice 
addicted to cocaine, D1-like receptors regulated by Drd1a act to reduce the desire for 
further cocaine reinforcement (Self, Barnhart, Lehman, & Nestler, 1996). This result 
indicates that D1-like receptor agonists may be an attractive option for cocaine addiction 
and could be of value in understanding addiction to high voluntary activity. The role of 
the D1 receptor has been explored in studies of drug self-administration. Both D1 and 
D2 receptors are involved in the reward response and addiction to drugs of abuse; 
endogenous DA simulates D1 receptors, which leads to the expression of D2 receptor-
mediated reward-driven behaviors and gene expression changes (Beninger, Hoffman, & 
Mazurski, 1989; Maldonado, Robledo, Chover, Caine, & Koob, 1993; Phillips, Robbins, 
& Everitt, 1994; Self et al., 1996). As this gene was found overexpressed in our study, it 
appears that this gene’s process and function may be similar in mice seeking an exercise 
reward as those seeking drugs of abuse.  
Retinoid X receptor gamma (Rxrg) was over-expressed in H relative to L activity 
genotype. Retinoid receptors directly up-regulate Drd2 (Samad, Krezel, Chambon, & 
Borrelli, 1997). Consistent with our findings, this gene has been found to directly impact 
ambulatory activity and Rxrg knock-out mice show impaired locomotion along with 
reduced dopamine signaling (Krezel et al., 1998). Also, ablation/loss of Rxrg signaling 
in mice leads to depressive behaviors due to the decreased dopamine signaling in the 
striatum, supporting the association of this gene with reward and pleasure (Krzyzosiak et 
al., 2010). Over-expression of Rxrg in humans is associated with sensation seeking 
(Alliey-Rodriguez et al., 2011). This is consistent with our finding of the over-
expression of this gene in this study; just as this gene impacts sensation seeking in 
humans addicted to psychoactive substances, this gene may similarly impact the drive of 
selected mice to perform physical activity with pleasure as the sole incentive.  
Muscarinic Acetylcholine Receptor M1 (Chrm1) was over-expressed in H 
relative to L activity genotype. The differentially expression of yet another gene related 
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to dopamine transmission (Nathanson, 1987; Wess, 1996) further confirms that activity, 
drug and other reward-dependent behaviors share disruption of dopamine pathways. In 
agreement with our findings, Chrm1 deficient mice display elevated dopamine 
transmission in the striatum (Gerber et al., 2001). 
 
Effect of activity environment on gene expression in the cerebellum 
Table 3.6 summarizes genes significantly differentially expressed (FDR-adjusted 
P-Value < 0.005 and log2(fold change) > |3|) between control and L environments. 
Results from the functional enrichment analysis of the genes differentially expressed 
between activity environments (P-value < 0.001) and enriched (enrichment score > 3.0) 
clusters are highlighted in Table 3.7.  
 Functional analysis of the genes differentially expressed between activity 
environments identified the enrichment of voltage gated channel activity and ion binding 
terms. Among the genes affiliated to these terms are those that code for transmembrane 
proteins that move cations and anions through membranes with energy costs. G-protein 
coupled receptors, which are involved in the energetics of these processes, are also 
enriched among the genes differentially expressed between activity environments 
(Kroeze, Sheffler, & Roth, 2003). Enrichment in this contrast group appears to be more 
related instant physiological responses while enrichment of genes differentially 
expressed between genotype and genotype-by-environment groups included the effects 
of selection appear to be related to cellular development and long-term responses 
occurring in the brain. 
 
CONCLUSIONS 
Exercise dependence and addiction to psychoactive substances share 
psychologically and physiological characteristics. A transcriptome study of a mouse line 
selected for high voluntary activity and compared to a control line in environments 
restricting or enabling rewarding activity was undertaken. Results offered insights into 
genetic factors behind activity dependence and provide a model for understanding 
addiction and other reward-dependent behaviors.   
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Gene network analysis identified connected genes that exhibited similar (e.g. 
Lhx9) and opposite (e.g. Nrgn) expression patterns between activity genotypes across 
reward availability environment. Meanwhile the former set of genes represent 
fundamental dysregulation, irrespectively of reward availability, the dysregulation of the 
second set of genes due to activity genotype can be altered by the reward availability.  
Most of the genes over- or under- expressed in the activity genotype comparison were 
only intermediately differentially expressed between activity environments, suggesting 
that environment did not confound our previous conclusions based on activity genotype 
comparisons.  
Adora2a had a significant genotype-by-environment interaction effect evidenced 
by over-expression in the genotype contrast within high activity environment and under-
expressed in other contrasts.  This gene is involved in goal-focused behaviors and motor 
functions used to carry out those behaviors and our finding suggest that for activity 
addiction, the effect is dependent on the availability of the reward. A central theme from 
the functional analysis of activity genotype-environment was neuron morphogenesis. 
The enrichment of this and related biological processes is consistent with previous 
reports of association between exercise and neurological development.  
Our findings of differentially expressed genes related to dopaminergic 
transmission are consistent with previous reports of increased locomotor activity 
correlated with elevated levels of dopamine in rodents. Drd1a was found to be 
overexpressed in the high voluntary activity relative to the control genotype. 
Furthermore, the Drd2, was also found overexpressed in high voluntary activity relative 
to the control genotype and is primarily involved in the motivational component of drug 
addiction [57]. Rxrg was over expressed in the high voluntary activity relative to the 
control genotype and is associated with higher ambulatory activity and sensation seeking 
in humans.   
These results suggest that some of the molecular mechanisms underlying 
transcriptomic changes in mice selected for high voluntary activity are shared with other 
reward-dependent behaviors. Our findings support that high voluntary activity selection 
lines in mice are a helpful model to understand molecular mechanisms behind addition.  
 Also, identification of genes and biological processes associated with both high 
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voluntary activity and the pleasurable neurological response to physical activity may 
allow for the development of drugs and gene therapies which make it more pleasurable 
for people to exercise or less pleasurable to be sedentary as a treatment approach for 
overweight/obesity as well as a way to improve health overall in the general population. 
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TABLES AND FIGURES 
 
Table 3.1 Genes exhibiting significant (FDR-adjusted P-value < 0.005, average 
log2(fold change) > |2|) activity genotype-by-environment interaction 
Gene 
Name
* 
Log2Fold1  FDR-
adjusted P-
Value 
 
P-
Valu
e 
LL
-
HL 
LL
-
LH 
LL-
HH 
HL
-
LH 
HL-
HH 
LH-
HH Avera
ge of 
all 
|Log2
Fold| 
Ddn 
-
5.1
239 
-
7.6
548 
-
6.92
317 
-
2.5
309 
-
1.79
927 
0.73
162
7 2.57307E-14 
1.11
022E
-16 
3.5376
66714 
AK04
9668 
2.3
673
3 
-
3.8
180
8 
2.45
53 
-
6.1
854
2 
0.08
7971
9 
6.27
339 2.57307E-14 
1.11
022E
-16 
3.0270
57553 
Gpr88 
-
4.4
843
9 
-
6.4
263
5 
-
5.93
863 
-
1.9
419
6 
-
1.45
425 
0.48
771
9 2.57307E-14 
1.11
022E
-16 
2.9618
99857 
Gda 
-
4.6
083
5 
-
6.5
446
3 
-
5.29
571 
-
1.9
362
8 
-
0.68
7357 
1.24
892 2.57307E-14 
1.11
022E
-16 
2.9030
35286 
Icam5 
-
4.5
764
7 
-
6.2
187
8 
-
5.70
06 
-
1.6
423
1 
-
1.12
413 
0.51
818
2 2.57307E-14 
1.11
022E
-16 
2.8257
81714 
Kcnj4 
-
4.5
96 
-
6.1
714
4 
-
5.47
734 
-
1.5
754
4 
-
0.88
1339 
0.69
410
3 2.57307E-14 
1.11
022E
-16 
2.7708
08857 
Arhga
p8 
2.0
669
2 
-
3.5
080
8 
2.25
669 
-
5.5
75 
0.18
9776 
5.76
478 2.31366E-11 
1.56
875E
-13 
2.7679
09329 
Scd4 
3.2
811
5 
-
1.6
647
7 
3.17
214 
-
4.9
459
2 
-
0.10
9003 
4.83
692 2.57307E-14 
1.11
022E
-16 
2.5974
29143 	
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Table 3.1 (cont.) 		
Lrrc
10b 
-
4.43
931 
-
5.64
017 
-
5.25
873 
-
1.20
086 
-
0.81941
8 
0.38
144 
2.5730
7E-14 
1.110
22E-
16 
2.5342
75429 
Cpn
e5 
-
4.54
153 
-
5.76
022 
-
4.81
7 
-
1.21
869 
-
0.27547
4 
0.94
3217 
2.5730
7E-14 
1.110
22E-
16 
2.5080
18714 
Nrgn 
-
4.50
147 
-
5.50
741 
-
4.02
525 
-
1.00
594 0.47622 
1.48
216 
2.5730
7E-14 
1.110
22E-
16 
2.4283
5 
Rxrg 
-
3.84
299 
-
5.28
96 
-
4.36
536 
-
1.44
661 
-
0.52237
2 
0.92
4239 
2.5730
7E-14 
1.110
22E-
16 
2.3415
95857 
Cyp
11a1 
1.47
43 
-
3.17
024 
1.57
059 
-
4.64
454 
0.09629
09 
4.74
083 
8.9795
7E-06 
1.503
67E-
07 
2.2503
91514 
Tbr1 
-
3.99
168 
-
4.93
814 
-
4.66
18 
-
0.94
6458 
-
0.67012
2 
0.27
6336 
2.5730
7E-14 
1.110
22E-
16 
2.2120
76572 
Ador
a2a 
-
4.02
261 
-
4.86
96 
-
4.72
083 
-
0.84
6991 
-
0.69822
1 
0.14
877 
2.5730
7E-14 
1.110
22E-
16 
2.1867
17429 
Drd2 
-
4.18
193 
-
4.83
802 
-
4.09
709 
-
0.65
609 
0.08483
17 
0.74
0922 
2.5730
7E-14 
1.110
22E-
16 
2.0855
54815 
Lam
p5 
-
2.95
93 
-
4.53
335 
-
3.87
565 
-
1.57
405 
-
0.91635
3 
0.65
7694 
2.5730
7E-14 
1.110
22E-
16 
2.0737
71001 
Sst 
-
4.16
424 
-
4.60
927 
-
3.54
259 
-
0.44
5032 
0.62164
9 
1.06
668 
2.5730
7E-14 
1.110
22E-
16 
2.0642
08715 
Cpn
e4 
-
3.45
958 
-
4.77
135 
-
3.56
315 
-
1.31
177 
-
0.10357
2 
1.20
82 
2.5730
7E-14 
1.110
22E-
16 
2.0596
60292 
Nts 
-
3.36
256 
-
4.72
986 
-
3.36
298 
-
1.36
731 
-
0.00042
5478 
1.36
688 
5.2147
E-08 
5.571
49E-
10 
2.0271
49268 
 
1. Log2Fold is the log2-transformed fold change between two genotype-environment groups. When 
considering groups A vs B = A - B, Log2Fold Change = Log2 (A/B). Groups are: LL=low activity 
genotype-low activity environment; LH=low activity genotype-high activity environment; HL=High 
activity genotype-low activity environment; HH=High activity genotype-high activity environment 
*Expanded gene names, listed in alphabetical order: 4933409K07Rik= RIKEN cDNA 4933409K07 gene; 
Adi1= acireductone dioxygenase 1; Adora2a= adenosine A2a receptor; AK049668=  ; Cntn4= contactin 4; 
Cox7b= cytochrome c oxidase subunit VIIb; Cpne4= copine IV; Cpne5= copine V; Ctxn1= cortexin 1; 
D430019H16Rik= RIKEN cDNA D430019H16 gene; Ddn= dendrin; Dnah1= dynein, axonemal, heavy 
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chain 1; Drd2= dopamine receptor D2; Gda= guanine deaminase; Gm1976= predicted gene 1976; Gpr88= 
G-protein coupled receptor 88; Gsn= gelsolin; Icam5= intercellular adhesion molecule 5, telencephalin; 
Kcnj4= potassium inwardly-rectifying channel, subfamily J, member 4; Lamp5= lysosomal-associated 
membrane protein family, member 5 
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Table 3.2 Enriched (enrichment score > 2.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes significantly (P-value < 0.001) differentially 
expressed between Low activity Control genotype – Low activity environment vs High 
activity genotype – Low activity environment(LL-HL)  mice. 
  
Category Term Co
unt 
PVal
ue 
FDR 
Score = 4.54 
GOTERM_B
P_FAT 
GO:0030900~forebrain development 11 1.91E
-08 
2.99E
-05 
GOTERM_B
P_FAT 
GO:0031175~neuron projection development 12 2.10E
-08 
3.27E
-05 
GOTERM_B
P_FAT 
GO:0030182~neuron differentiation 15 2.16E
-08 
3.37E
-05 
GOTERM_B
P_FAT 
GO:0048812~neuron projection 
morphogenesis 
11 3.16E
-08 
4.94E
-05 
GOTERM_B
P_FAT 
GO:0048666~neuron development 13 4.42E
-08 
6.91E
-05 
GOTERM_B
P_FAT 
GO:0048858~cell projection morphogenesis 11 1.16E
-07 
1.81E
-04 
GOTERM_B
P_FAT 
GO:0032990~cell part morphogenesis 11 1.82E
-07 
2.85E
-04 
GOTERM_B
P_FAT 
GO:0007409~axonogenesis 10 2.08E
-07 
3.24E
-04 
GOTERM_B
P_FAT 
GO:0006928~cell motion 13 5.25E
-07 
8.20E
-04 
GOTERM_B
P_FAT 
GO:0048667~cell morphogenesis involved in 
neuron differentiation 
10 5.29E
-07 
8.26E
-04 
GOTERM_B
P_FAT 
GO:0007411~axon guidance 8 9.03E
-07 
0.001
41 
GOTERM_B
P_FAT 
GO:0030030~cell projection organization 12 9.77E
-07 
0.001
527 
GOTERM_B
P_FAT 
GO:0000904~cell morphogenesis involved in 
differentiation 
10 1.89E
-06 
0.002
954 
GOTERM_B
P_FAT 
GO:0000902~cell morphogenesis 11 5.59E
-06 
0.008
736 
GOTERM_B
P_FAT 
GO:0032989~cellular component 
morphogenesis 
11 1.70E
-05 
0.026
589 
GOTERM_B
P_FAT 
GO:0021954~central nervous system neuron 
development 
5 2.79E
-05 
0.043
55 
GOTERM_B
P_FAT 
GO:0021953~central nervous system neuron 
differentiation 
5 7.35E
-05 
0.114
815 		
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Table 3.2 (cont.) 		
GOTERM_B
P_FAT 
GO:0007389~pattern specification process 7 0.004
17 
6.320
529 
GOTERM_B
P_FAT 
GO:0003002~regionalization 6 0.005
835 
8.736
59 
GOTERM_
MF_FAT 
GO:0003700~transcription factor activity 11 0.006
469 
7.736
076 
GOTERM_
MF_FAT 
GO:0043565~sequence-specific DNA binding 9 0.007
916 
9.389
923 
GOTERM_
MF_FAT 
GO:0030528~transcription regulator activity 12 0.045
488 
43.87
611 
GOTERM_B
P_FAT 
GO:0006355~regulation of transcription, 
DNA-dependent 
14 0.046
954 
52.82
693 
GOTERM_B
P_FAT 
GO:0051252~regulation of RNA metabolic 
process 
14 0.052
108 
56.65
88 
GOTERM_B
P_FAT 
GO:0045449~regulation of transcription 18 0.079
545 
72.60
868 
GOTERM_
MF_FAT 
GO:0003677~DNA binding 14 0.126
552 
81.33
892 
GOTERM_B
P_FAT 
GO:0006350~transcription 12 0.352
403 
99.88
728 
     
Score = 3.47  
Category Term Co
unt 
PVal
ue 
FDR 
GOTERM_B
P_FAT 
GO:0030900~forebrain development 11 1.91E
-08 
2.99E
-05 
GOTERM_B
P_FAT 
GO:0021537~telencephalon development 7 2.30E
-06 
0.003
598 
GOTERM_B
P_FAT 
GO:0021892~cerebral cortex GABAergic 
interneuron differentiation 
4 5.13E
-06 
0.008
01 
GOTERM_B
P_FAT 
GO:0021954~central nervous system neuron 
development 
5 2.79E
-05 
0.043
55 
GOTERM_B
P_FAT 
GO:0021895~cerebral cortex neuron 
differentiation 
4 3.16E
-05 
0.049
375 
GOTERM_B
P_FAT 
GO:0021953~central nervous system neuron 
differentiation 
5 7.35E
-05 
0.114
815 
GOTERM_B
P_FAT 
GO:0021885~forebrain cell migration 4 1.36E
-04 
0.211
512 
GOTERM_B
P_FAT 
GO:0021830~interneuron migration from the 
subpallium to the cortex 
3 1.70E
-04 
0.264
68 
GOTERM_B
P_FAT 
GO:0021853~cerebral cortex GABAergic 
interneuron migration 
3 1.70E
-04 
0.264
68 
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Table 3.2 (cont.) 		
GOTERM_
BP_FAT 
GO:0021894~cerebral cortex GABAergic 
interneuron development 
3 1.70
E-04 
0.26
468 
GOTERM_
BP_FAT 
GO:0021543~pallium development 5 1.84
E-04 
0.28
7046 
GOTERM_
BP_FAT 
GO:0021826~substrate-independent 
telencephalic tangential migration 
3 2.82
E-04 
0.43
9238 
GOTERM_
BP_FAT 
GO:0021843~substrate-independent 
telencephalic tangential interneuron migration 
3 2.82
E-04 
0.43
9238 
GOTERM_
BP_FAT 
GO:0016477~cell migration 7 0.00
1809 
2.78
9374 
GOTERM_
BP_FAT 
GO:0022029~telencephalon cell migration 3 0.00
412 
6.24
6199 
GOTERM_
BP_FAT 
GO:0048870~cell motility 7 0.00
417 
6.32
0529 
GOTERM_
BP_FAT 
GO:0051674~localization of cell 7 0.00
417 
6.32
0529 
GOTERM_
BP_FAT 
GO:0021766~hippocampus development 3 0.00
7279 
10.7
8636 
GOTERM_
BP_FAT 
GO:0021761~limbic system development 3 0.01
3499 
19.1
3005 
GOTERM_
BP_FAT 
GO:0021987~cerebral cortex development 3 0.01
6794 
23.2
4853 
GOTERM_
BP_FAT 
GO:0021536~diencephalon development 3 0.01
7666 
24.3
0521 
GOTERM_
BP_FAT 
GO:0042493~response to drug 3 0.08
113 
73.3
3619 
     
Score = 3.08 
Category Term Co
unt 
PVal
ue 
FDR 
GOTERM_
BP_FAT 
GO:0030900~forebrain development 11 1.91
E-08 
2.99
E-05 
GOTERM_
BP_FAT 
GO:0060284~regulation of cell development 7 2.08
E-04 
0.32
4851 
GOTERM_
BP_FAT 
GO:0050767~regulation of neurogenesis 6 7.10
E-04 
1.10
3177 
GOTERM_
BP_FAT 
GO:0045665~negative regulation of neuron 
differentiation 
4 7.90
E-04 
1.22
6933 
GOTERM_
BP_FAT 
GO:0051960~regulation of nervous system 
development 
6 0.00
1187 
1.83
8294 
GOTERM_
BP_FAT 
GO:0045596~negative regulation of cell 
differentiation 
6 0.00
2938 
4.49
2073 	
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Table 3.2 (cont.) 		
GOTERM_M
F_FAT 
GO:0043565~sequence-specific DNA 
binding 
9 0.007
916 
9.389
923 
GOTERM_BP
_FAT 
GO:0045664~regulation of neuron 
differentiation 
4 0.017
48 
24.08
129 
GOTERM_BP
_FAT 
GO:0045165~cell fate commitment 3 0.186
894 
96.05
33 
     
Score = 3.02 
Category Term Cou
nt 
PValu
e 
FDR 
GOTERM_BP
_FAT 
GO:0021954~central nervous system 
neuron development 
5 2.79E
-05 
0.043
55 
GOTERM_BP
_FAT 
GO:0021953~central nervous system 
neuron differentiation 
5 7.35E
-05 
0.114
815 
GOTERM_BP
_FAT 
GO:0050767~regulation of neurogenesis 6 7.10E
-04 
1.103
177 
GOTERM_BP
_FAT 
GO:0051960~regulation of nervous system 
development 
6 0.001
187 
1.838
294 
GOTERM_BP
_FAT 
GO:0008284~positive regulation of cell 
proliferation 
3 0.453
056 
99.99
195 
     
Score = 2.63 
Category Term Cou
nt 
PValu
e 
FDR 
GOTERM_M
F_FAT 
GO:0022843~voltage-gated cation channel 
activity 
7 5.18E
-05 
0.064
279 
GOTERM_M
F_FAT 
GO:0005249~voltage-gated potassium 
channel activity 
6 1.60E
-04 
0.198
065 
GOTERM_M
F_FAT 
GO:0022832~voltage-gated channel 
activity 
7 3.26E
-04 
0.403
855 
GOTERM_M
F_FAT 
GO:0005244~voltage-gated ion channel 
activity 
7 3.26E
-04 
0.403
855 
GOTERM_M
F_FAT 
GO:0005267~potassium channel activity 6 5.45E
-04 
0.674
557 
GOTERM_BP
_FAT 
GO:0015672~monovalent inorganic cation 
transport 
8 0.001
184 
1.833
755 
GOTERM_BP
_FAT 
GO:0006813~potassium ion transport 6 0.001
676 
2.587
2 
GOTERM_BP
_FAT 
GO:0006812~cation transport 10 0.001
688 
2.605
178 
GOTERM_M
F_FAT 
GO:0005261~cation channel activity 7 0.001
786 
2.193
625 	
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Table 3.2 (cont.) 		
GOTERM_B
P_FAT 
GO:0030001~metal ion transport 9 0.002
485 
3.812
287 
GOTERM_M
F_FAT 
GO:0030955~potassium ion binding 5 0.003
276 
3.989
465 
GOTERM_M
F_FAT 
GO:0022836~gated channel activity 7 0.003
332 
4.055
913 
GOTERM_M
F_FAT 
GO:0046873~metal ion transmembrane 
transporter activity 
7 0.003
888 
4.718
625 
GOTERM_M
F_FAT 
GO:0031420~alkali metal ion binding 6 0.004
293 
5.197
335 
GOTERM_M
F_FAT 
GO:0005216~ion channel activity 7 0.009
395 
11.05
167 
GOTERM_M
F_FAT 
GO:0022838~substrate specific channel 
activity 
7 0.010
842 
12.65
057 
GOTERM_M
F_FAT 
GO:0022803~passive transmembrane 
transporter activity 
7 0.011
55 
13.42
28 
GOTERM_M
F_FAT 
GO:0015267~channel activity 7 0.011
55 
13.42
28 
GOTERM_B
P_FAT 
GO:0006811~ion transport 10 0.013
677 
19.35
736 
GOTERM_B
P_FAT 
GO:0055085~transmembrane transport 6 0.100
989 
81.04
721 
     
Score = 2.08 
Category Term Co
unt 
PVal
ue 
FDR 
KEGG_PAT
HWAY 
mmu04080:Neuroactive ligand-receptor 
interaction 
8 4.75E
-05 
0.041
743 
GOTERM_B
P_FAT 
GO:0007186~G-protein coupled receptor 
protein signaling pathway 
16 0.071
843 
68.80
041 
GOTERM_B
P_FAT 
GO:0007166~cell surface receptor linked 
signal transduction 
18 0.172
778 
94.83
569 
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Table 3.3 Enriched (enrichment score > 2.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes significantly (P-value < 0.001) differentially 
expressed between high activity genotype-high activity environment and low activity 
Control genotype- high activity environment (HH-LH) mice. 
 
Category Term Co
unt 
PValu
e 
FDR 
Score = 1.20 
GOTERM_B
P_FAT 
GO:0042592~homeostatic process 11 0.016
696 
22.93
35 
GOTERM_B
P_FAT 
GO:0048878~chemical homeostasis 8 0.025
178 
32.60
153 
GOTERM_B
P_FAT 
GO:0030003~cellular cation homeostasis 5 0.032
022 
39.56
209 
GOTERM_B
P_FAT 
GO:0006875~cellular metal ion homeostasis 4 0.044
328 
50.41
698 
GOTERM_B
P_FAT 
GO:0055065~metal ion homeostasis 4 0.051
153 
55.62
173 
GOTERM_B
P_FAT 
GO:0006873~cellular ion homeostasis 6 0.055
255 
58.49
857 
GOTERM_B
P_FAT 
GO:0055080~cation homeostasis 5 0.057
407 
59.93
774 
GOTERM_B
P_FAT 
GO:0055082~cellular chemical homeostasis 6 0.060
531 
61.94
312 
GOTERM_B
P_FAT 
GO:0050801~ion homeostasis 6 0.081
636 
73.22
354 
GOTERM_B
P_FAT 
GO:0030005~cellular di-, tri-valent 
inorganic cation homeostasis 
4 0.089
087 
76.39
42 	
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Table 3.3 (cont.) 		
GOTERM_BP_
FAT 
GO:0055066~di-, tri-valent inorganic 
cation homeostasis 
4 0.1081
1 
82.970
44 
GOTERM_BP_
FAT 
GO:0019725~cellular homeostasis 6 0.1339
66 
89.197
55 
GOTERM_BP_
FAT 
GO:0006874~cellular calcium ion 
homeostasis 
3 0.1608
5 
93.368
31 
GOTERM_BP_
FAT 
GO:0055074~calcium ion homeostasis 3 0.1719
99 
94.608
01 
     
Score = 1.04 
GOTERM_BP_
FAT 
GO:0060284~regulation of cell 
development 
5 0.0368
6 
44.070
99 
GOTERM_BP_
FAT 
GO:0050767~regulation of neurogenesis 4 0.0860
67 
75.153
85 
GOTERM_BP_
FAT 
GO:0051960~regulation of nervous system 
development 
4 0.1114
24 
83.923
59 
GOTERM_BP_
FAT 
GO:0045664~regulation of neuron 
differentiation 
3 0.1917
98 
96.292
15 
     
Score = 1.03 
GOTERM_BP_
FAT 
GO:0034754~cellular hormone metabolic 
process 
3 0.0631
61 
63.558
95 
GOTERM_BP_
FAT 
GO:0010817~regulation of hormone levels 4 0.0801
62 
72.550
87 
GOTERM_BP_
FAT 
GO:0042445~hormone metabolic process 3 0.1580
85 
93.021
96 
     
Score = 1.01 
GOTERM_MF
_FAT 
GO:0046914~transition metal ion binding 2
7 
0.0652 58.486
79 
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Table 3.3 (cont.) 		
GOTERM_MF_FAT GO:0046872~metal ion binding 37 0.066955 59.49143 
GOTERM_MF_FAT GO:0043169~cation binding 37 0.074993 63.81308 
GOTERM_MF_FAT GO:0043167~ion binding 37 0.087397 69.65401 
GOTERM_MF_FAT GO:0008270~zinc ion binding 19 0.299808 99.04121 
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Table 3.4 Genes differentially expressed (FDR-adjusted P-Value < 0.005 and log2(fold 
change) > |3|) between low and high activity genotype mice. 
Gene* Log2 (Control/Selected) 
 Foxg1 5.19633 
Kcnv1 4.88982 
Sp9 4.80959 
Dlx1 4.80199 
Gpr6 4.71176 
Drd1a 4.57751 
Zfp831 4.47846 
Cpne5 4.47141 
Kcnj4 4.42276 
Ankrd63 4.39899 
Gda 4.30171 
Lrrc10b 4.28336 
AK040671 4.26887 
Kcnf1 4.26674 
Chrm1 4.19663 
Kcng1 4.01258 
Dlx2 3.93618 
Rxrg 3.8042 
Adora2a 3.75852 
Tbr1 3.7204 
Rprml 3.60267 
Crhbp 3.56026 
Rtn4rl2 3.45839 
Vdr 3.4123 
Actn2 3.34287 
Ptprv 3.31905 
Kcnh4 3.18327 
Neurl1b 3.16774 
Sst 3.11108 
D430019H16R
ik 
3.0582 
Prss12 3.04173 
 
  
	 98	
Table 3.5 Enriched (enrichment score > 3.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes differentially expressed (P-value < 0.001) 
between low and high activity genotype mice.  
 
Category Term Co
unt 
PValu
e 
FDR 
Score = 5.36  
GOTERM_M
F_FAT 
GO:0022843~voltage-gated cation 
channel activity 
13 6.43E
-09 
8.50E-
06 
GOTERM_M
F_FAT 
GO:0022832~voltage-gated channel 
activity 
14 3.26E
-08 
4.31E-
05 
GOTERM_M
F_FAT 
GO:0005244~voltage-gated ion channel 
activity 
14 3.26E
-08 
4.31E-
05 
GOTERM_M
F_FAT 
GO:0005261~cation channel activity 15 2.21E
-07 
2.92E-
04 
GOTERM_BP
_FAT 
GO:0030001~metal ion transport 19 3.35E
-07 
5.21E-
04 
GOTERM_BP
_FAT 
GO:0006812~cation transport 20 6.92E
-07 
0.00107
7423 
GOTERM_M
F_FAT 
GO:0005249~voltage-gated potassium 
channel activity 
10 7.05E
-07 
9.32E-
04 
GOTERM_M
F_FAT 
GO:0046873~metal ion transmembrane 
transporter activity 
15 1.45E
-06 
0.00192
351 
GOTERM_M
F_FAT 
GO:0022836~gated channel activity 14 5.61E
-06 
0.00741
9277 
GOTERM_M
F_FAT 
GO:0005267~potassium channel activity 10 6.46E
-06 
0.00853
665 
GOTERM_M
F_FAT 
GO:0005216~ion channel activity 15 1.24E
-05 
0.01633
7178 
GOTERM_M
F_FAT 
GO:0022838~substrate specific channel 
activity 
15 1.75E
-05 
0.02313
3726 
GOTERM_M
F_FAT 
GO:0015267~channel activity 15 2.04E
-05 
0.02697
3665 
GOTERM_M
F_FAT 
GO:0022803~passive transmembrane 
transporter activity 
15 2.04E
-05 
0.02697
3665 
GOTERM_BP
_FAT 
GO:0006811~ion transport 21 2.13E
-05 
0.03312
5111 
GOTERM_M
F_FAT 
GO:0030955~potassium ion binding 9 2.64E
-05 
0.03489
6362 
GOTERM_BP
_FAT 
GO:0006813~potassium ion transport 10 2.89E
-05 
0.04494
1459 	
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Table 3.5 (cont.) 		
GOTERM_MF
_FAT 
GO:0031420~alkali metal ion binding 1
1 
4.72E-05 0.062340
343 
GOTERM_BP
_FAT 
GO:0015672~monovalent inorganic 
cation transport 
1
2 
2.04E-04 0.316785
555 
GOTERM_BP
_FAT 
GO:0055085~transmembrane transport 1
0 
0.038361
959 
45.59311
009 
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Table 3.6 Genes differentially expressed (FDR-adjusted P-Value < 0.005 and log2(fold 
change) > |3|) between low and high activity genotype mice. 
Gene* Log2 (Sedentary/Runner) 
Foxg1 6.58338 
Dlx1 6.3096 
Kcnv1 5.66069 
Drd1a 5.47347 
Zfp831 5.30167 
Sp9 5.23464 
Gpr6 5.23178 
Kcnj4 5.10231 
Chrm1 5.08345 
Ankrd63 5.08332 
Gda 5.03023 
Krt9 4.95871 
Lrrc10b 4.81634 
Cpne5 4.77704 
Kcnf1 4.77571 
Rxrg 4.66121 
Kcng1 4.56038 
Tbr1 4.18002 
Cntnap3 4.17254 
Adora2a 4.15213 
Crhbp 4.02149 
Rtn4rl2 3.9803 
Kcnh4 3.69834 
Ptprv 3.59163 
Lamp5 3.57371 
Neurl1b 3.50048 
Prss12 3.45094 
Rprml 3.39604 
Pak6 3.34825 
D430019H16R
ik 
3.33037 
Nts 3.26483 
Sst 3.24551 
Mchr1 3.23157 
Actn2 3.15911 
Lipg 3.08539 
Pde10a 3.05835 
Meis2 3.01728 
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Table 3.7 Enriched (enrichment score > 3.0) clusters of Gene Ontology (GO) biological 
process (BP), molecular function (MF) Functional Annotation Tool (FAT) categories, 
and KEGG pathways among the genes differentially expressed (P-value < 0.001) 
between low and high activity environment mice.   
 
Category Term Co
unt 
PValu
e 
FDR 
Score = 5.43     
Category Term Co
unt 
PValu
e 
FDR 
GOTERM_M
F_FAT 
GO:0022843~voltage-gated cation 
channel activity 
12 4.97E
-09 
6.41E-
06 
GOTERM_M
F_FAT 
GO:0005249~voltage-gated potassium 
channel activity 
11 5.33E
-09 
6.88E-
06 
GOTERM_M
F_FAT 
GO:0005267~potassium channel activity 12 5.40E
-09 
6.97E-
06 
GOTERM_BP
_FAT 
GO:0006813~potassium ion transport 12 3.03E
-08 
4.57E-
05 
GOTERM_M
F_FAT 
GO:0022832~voltage-gated channel 
activity 
12 1.62E
-07 
2.09E-
04 
GOTERM_M
F_FAT 
GO:0005244~voltage-gated ion channel 
activity 
12 1.62E
-07 
2.09E-
04 
GOTERM_M
F_FAT 
GO:0005261~cation channel activity 13 5.75E
-07 
7.43E-
04 
GOTERM_M
F_FAT 
GO:0022836~gated channel activity 13 2.14E
-06 
0.00276
8489 
GOTERM_M
F_FAT 
GO:0046873~metal ion transmembrane 
transporter activity 
13 2.97E
-06 
0.00383
9378 
GOTERM_M
F_FAT 
GO:0030955~potassium ion binding 9 4.14E
-06 
0.00534
8907 
GOTERM_BP
_FAT 
GO:0015672~monovalent inorganic 
cation transport 
12 1.66E
-05 
0.02503
0471 
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Table 3.7 (cont.) 		
GOTERM_M
F_FAT 
GO:0005216~ion channel activity 1
3 
1.94E-
05 
0.02506
0351 
GOTERM_BP
_FAT 
GO:0030001~metal ion transport 1
4 
2.57E-
05 
0.03873
3152 
GOTERM_M
F_FAT 
GO:0022838~substrate specific channel 
activity 
1
3 
2.64E-
05 
0.03404
2037 
GOTERM_BP
_FAT 
GO:0006812~cation transport 1
5 
2.94E-
05 
0.04426
4411 
GOTERM_M
F_FAT 
GO:0022803~passive transmembrane 
transporter activity 
1
3 
3.02E-
05 
0.03897
6337 
GOTERM_M
F_FAT 
GO:0015267~channel activity 1
3 
3.02E-
05 
0.03897
6337 
GOTERM_M
F_FAT 
GO:0031420~alkali metal ion binding 9 2.24E-
04 
0.28911
0001 
GOTERM_BP
_FAT 
GO:0006811~ion transport 1
5 
8.49E-
04 
1.27276
8078 
GOTERM_BP
_FAT 
GO:0055085~transmembrane transport 7 0.13199
2523 
88.1724
1872 
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Figure 3.1 Number of differentially expressed genes that overlap between HH vs LH, 
HL vs LL, and HH vs HL contrasts. 
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Figure 3.2 Number of differentially expressed genes that overlap between HH vs LH, 
HL vs LL, and HH vs HL contrasts. 
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Figure 3.3 Gene network of genes differentially expressed (FDR P-value < 0.05) in 
orthogonal contrast HL-LL. (Node Color: Red indicates under-expression, Green 
indicates over-expression, Gray indicates genes connecting differentially expressed gene 
but not differentially expressed in this study; Node Size: larger indicates a higher fold 
change, while smaller indicates a smaller fold change
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Figure 3.4 Gene network of genes differentially expressed (FDR P-value < 0.05) in 
orthogonal contrast HH-HL. (Node Color: Red indicates under-expression, Green 
indicates over-expression, Gray indicates genes connecting differentially expressed gene 
but not differentially expressed in this study; Node Size: larger indicates a higher fold 
change, while smaller indicates a smaller fold change
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Figure 3.5 Gene network of genes differentially expressed (FDR P-value < 0.05) in 
orthogonal contrast HH-LH. (Node Color: Red indicates under-expression, Green 
indicates over-expression, Gray indicates genes connecting differentially expressed gene 
but not differentially expressed in this study; Node Size: larger indicates a higher fold 
change, while smaller indicates a smaller fold change
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CHAPTER 4. UNCOVERING COMMONALITIES AMONG REWARD-DEPENDENT 
BEHAVIOR USING GENE NETWORK ANALYSIS 
 
Introduction   
 
Gene pathways have been inferred for addiction to a number of substances 
including cocaine, amphetamine, morphine, nicotine, alcohol 
(http://www.genome.jp/kegg/pathway.html).  Mouse lines exhibiting high voluntary 
activity are an established model to study addiction to exercise. A number of genes 
including dopamine receptors have been associated with high voluntary exercise and 
other addictive behaviors. Despite ample characterization of genes associated with the 
high voluntary running model, the similarities between the gene pathways underlying 
addiction to exercise and to other rewards remains poorly understood.  
While standard gene-level and functional analysis allows us to characterize gene 
expression profiles and enriched functional categories, these analyses do not give us 
information about interactions between genes. The objective of this study was to uncover 
commonalities between addiction to high voluntary activity and substances of abuse at 
the pathway level. Findings from this study could offer insights into gene targets effective 
in other addictions that could be used to manipulate preference to exercise. Conversely, 
insights from pathway comparison could aid in the identification of addictions that can be 
well studied using the high voluntary activity model.  
A previous study identified genes differentially expressed between a mouse line 
selected for high voluntary activity and a control, both on restricted and unrestricted 
activity environments. From this study, three orthogonal contrasts that provide 
complementary understanding of the changes in gene expression associated with 
genotype and environmental differences were studied. These contrasts include: 
comparison between a mouse line for high voluntary activity and control in restricted and 
unrestricted activity environments and comparison between restricted and unrestricted 
activity environment in a high voluntary activity line. 
In this chapter, genes differentially expressed in the three contrasts were mapped 
to the corresponding KEGG pathways of addiction and identified correspondences using 
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a bipartite graph-theoretic representation of genes and associated functions. The outcome 
of this bipartite network approach was a novel portrait of the functional makeup of the 
transcriptome or transcriptomic functionome applied to pathways of addiction.   
 
Materials and Methods 
 
An experiment following a randomized 2 x 2 factorial design including the 
factors of activity or exercise genetics and environment was carried out. The design 
included two mouse lines, one line selected for high voluntary physical activity (H) and 
an unselected control (L) line, and two cage environments enabling two activity levels 
blocked from wheel running or allowed to run.  The two main factors are denoted 
activity genotype and activity environment respectively. Sample size was n=4/activity 
genetic-environment combination. Six pairwise contrasts were used to profile the 
expression patterns involving four groups: high activity genotype-high activity 
environment (HH); high activity genotype-low activity environment (HL); low activity 
genotype-high activity environment (LH); and low activity genotype-low activity 
environment (LL). Among the 6 pairwise contrasts, 3 orthogonal contrasts were of 
interest: 1) HH vs. LH, 2) HL vs. LL, and 3) HH vs. HL. 
Pajek, a software package for analysis and visualization of large networks, was 
used to for network visualization and analysis on the results of our previous analyses on 
this data set (Batagelj & Mrvar, 2004). Genes present in at least one of five addiction-
related pathways in the Kyoto Encyclopedia of Genes and Genomes (KEGG, Kanehisa et 
al., 2008) were considered. Genes in the Cocaine, Amphetamine, Nicotine, Morphine, 
and Alcoholism KEGG pathways were compiled. This list was combined with the list of 
genes in each of the three contrasts and associated fold change between combination of 
activity genotype and environments. These three lists were submitted to Pajek along with 
information about the associations of the genes to the five addiction-related pathways.  
The correspondence between addiction pathways was uncovered using the genes 
differentially expressed on the three contrasts characterizing exercise addiction using 
Pajek’s bipartite graph-theoretic representation of genes and associated functions. This 
mapping was decomposed into its dual network projections using mathematical 
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properties of finite graphs (Chung et al. 1983). This approach was selected because the 
bipartite graph and its projections describe how function rearrange to unfold modern 
repertoires of differentially expressed genes. The bipartite network approach offers a 
depiction of the functional makeup of the transcriptome.   
A connection (link or undirected edge) between a function and gene (node) in the 
bipartite network represents the embedding of that function in the structural scaffold of 
the corresponding mRNA encoded gene product. Therefore, network connections 
describe how the elementary alphabet of functions associates with the structural alphabet 
of transcripts.  
 
Results 
              Tables 4.1 to 4.3 demonstrate the information used to infer similarities between 
addiction-related pathways. These tables list the genes characterized in each of the three 
orthogonal contrasts studied in the high voluntary activity experiment and present in at 
least four of the five addiction-related pathways studied. Due to space limitations, 
Tables 4.1 to 4.3 include a limited number of genes that belong to at least four pathways.  
Table 4.4 summarizes the number of genes in each addition-related pathway and 
high voluntary activity orthogonal contrast. The lower number of genes affiliated to the 
various addiction-related pathways in the HL-LL contrast relative to the other contrast is 
due to genes that could not be analyzed in that contrasts. Since the HL activity genotype-
environment combination was also present in the HH-HL contrast, the fewer genes 
analyzed in the HL-LL contrast can be traced to genes with very low abundance in the 
LL activity genotype-environment combination.  
 Table 4.5 condenses the overlap of genes between pathways and confirms the 
relationship between contrasts in the numbers of genes associated with each pathway 
observed in Table 4.4.  
                Bipartite networks are shown for the contrasts HL-LL, HH-LH, and HH-HL in 
Figures 4.1, 4.2, and 4.3, respectively. The corresponding waterfall style networks are 
shown in Figures 4.4, 4.5, and 4.6. The genes in Figures 4.1 to 4.3 are sorted by 
log2(fold change) from over-expressed (positive log2(fold change)) to under-expressed 
(negative log2(fold change)). Although the contrasts HH-LH and HH-HL involved the 
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same genes (Tables 4.4 and 4.5), the bipartite networks demonstrate different gene 
ordering between these contrasts consistent with the different differential expression 
observed for the same gene across contrasts. In the waterfall networks shown in Figures 
4.4, 4.5, and 4.6, genes are sorted top-down by increasing log2(fold change). 
Additionally, a parameter was set within Pajek to propel loosely connected genes to the 
edges and keeps genes shared by multiple pathways organized near the middle.   
 
Discussion 
 
Interpretation of bipartite networks 
Tables 4.1 to 4.3 show the number of genes associated with 4 out of 5 of the 
addiction-related pathways in HL-LL, HH-LH, and HH-HL respectively. Given their 
high connectivity within the networks, these genes appear to be core addiction-relation 
genes. Several genes appeared on all three of these lists- Grin3b, Grin2c, Adcy5, Grin2a, 
Gnas, Grin1, Grin3a, Grin2b, Grin2d, Prkaca. Of these genes, Adenylyl cyclase type 5 
(Adcy5; also known as AC5) has been clearly associated with reward processes and 
addiction to drugs of abuse. Mice lacking the AC5 gene display impaired dopamine D2 
receptor function; through increasing activation of the D1 dopamine receptor, 
administration of haloperidol and clozapine to AC5 knockout mice remarkably increased 
locomotion, demonstrating this gene’s incredible effect on the dopamine receptors and 
reward (Lee et al., (2002). In AC5 knock out mice, the behavioral effects of morphine 
including locomotor activation, analgesia, tolerance, reward, and physical 
dependence/withdrawal symptoms are weakened (Kim et al., 2006). While injection of 
DAMGO, a mu-opioid receptor selective agonist, into the striatum of normal control 
mice led to a significant increase in locomotion, so such effect was seen in AC5-knock 
out mice, which indicates that this reward process-related gene is also involved with 
activity and locomotion (Kim et al., 2006). CAMP-Dependent Protein Kinase Catalytic 
Subunit Alpha (Prkaca), a subunit of Adcy5, was found differential expressed as well. 
GNAS Complex Locus (Gnas) and the several Glutamate receptor (Grin) genes that were 
found to be significant have not been directly linked to either physical activity or 
addiction; these genes may serve as potential candidate genes for the study of addiction. 
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The weak differential expression of the genes listed in Tables 4.1 to 4.3 is not 
representative of the profile across the complete number of genes studied. These results 
suggest that genes affiliated to multiple addiction-related pathways do not exhibit major 
dysregulation on the high voluntary activity pathway. 
 Table 4.4 displays the number of genes in each contrast group which 
were found to be associated with multiple pathways. While no genes were found to be 
associated with all 5 pathways, a small number of genes in each contrast group were 
associated with 4 out of the 5. These genes are shown in Tables 4.1 to 4.3 for contrasts 
HL-LL, HH-LH, and HH-HL, respectively. The lower number of genes analyzed in the 
HL-LL contrast (Table 4.4) was associated to low gene abundance in the LL group. This 
trend could be linked to The Control genotype in an environment with restricted activity 
reward could have hinder the expression of some of these genes.  
 Table 4.5 displays the number of genes in each contrast group associated with 
each Kegg addiction-related pathway. Interestingly, in each of the 3 contrasts the 
number of genes associated with the Alcoholism pathway is significantly higher than 
those of other pathways. This result is intuitive; while years of natural evolution have 
led to the existence of genes with functions to handle alcohol, while the body has had 
less time to develop mechanisms to metabolize recently developed synthetic drugs. 
However, this result may also indicate that addiction to exercise may share molecular 
mechanisms with alcoholism, and may a suitable model for studies on alcoholism in the 
future. A noteworthy trend in Table 4.5 is that the number of genes shared across 
pathways halves with increasing number of pathways. This result highlights the 
opportunities to identify genes broadly involved in many types of addictions and genes 
unique to one or few reward-dependent behaviors. 
 The bipartite networks based on the three contrasts consistently show that the 
Cocaine and the Alcoholism pathways have genes exhibiting positive, neutral and 
negative expression patterns in the high voluntary activity experiment. Nicotine had 
genes with more intermediate expression differential in the two contrasts of activity 
genotypes (Figures 4.1 and 4.2). 
 
Interpretation of waterfall networks 
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The waterfall approach to investigate the differentially expressed genes within 
orthogonal contrast high voluntary activity genotype and environment augmented our 
understanding of the relationship between activity dependence and four substance-
dependence pathways. 
Similarities among waterfall networks of substance-dependence pathways 
between the HL-LL (Figure 4.4) and HH-LH (Figure 4.6) contrasts enabled the 
uncovering of pathway relationships common to addiction processes independent of 
activity reward environment.  The waterfall networks of pathways have similar horizontal 
structure in that the pathways in the middle (Amphetamine, Cocaine, and Nicotine) share 
most genes with the other pathways meanwhile the left- and right-most pathways has a 
number of genes not shared with the other pathways, yet shared with the high voluntary 
activity pathway. 
Dissimilarities among waterfall networks of substance-dependence pathways 
between the HL-LL (Figure 4.4) and HH-LH (Figure 4.6) contrasts enabled the 
uncovering of pathway relationships common to addiction processes dependent of 
activity reward environment. The waterfall network of pathways corresponding to the 
genes in HL-LL contrast have fewer connections among pathways than the network in 
the HH-LH contrast. This is particularly evident in the fewer connections of the Nicotine, 
Cocaine, and Amphetamine pathways in the HL-LL contrast. This finding indicates that 
the high voluntary activity pathway in an environment with reward availability 
(unrestricted running) is more similar to other substance dependence pathways than the 
same comparison on a reward restricted environment. 
Dissimilarities among waterfall networks of substance-dependence pathways 
between the HL-LL (Figure 4.4) and HH-LH (Figure 4.6) relative to the HH-HL (Figure 
4.5) contrast enabled the uncovering of pathway relationships common to addiction 
processes that could be negated by the activity reward environment. The waterfall 
networks of pathways have different horizontal structure in the Morphine pathway was 
less connected to other pathways in the activity genotype contrasts but has relatively 
more genes in common with the other pathways in the activity environment contrast. This 
result suggests that the Morphine pathway may be more similar to the pathway of genes 
differentially expressed in response to activity environment changes. 
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Similarities among waterfall networks of substance-dependence pathways 
between the HL-LL (Figure 4.4) and HH-LH (Figure 4.6) relative to the HH-HL (Figure 
4.5) contrast enabled the uncovering of pathway relationships common to addiction 
processes that could be mimicked by the activity reward environment. Alcoholism 
remains the pathway with fewer genes in common to the pathway of differentially 
expressed genes associated with activity environment differences, similar to the pathway 
of differentially expressed genes associated with activity genotype differences. 
 
Significance   
This study enabled the visualization of similarities between addiction-related 
pathways based on gene expression information on the activity addiction pathway. This 
visualization provide insights into similarities between addiction to drugs of abuse and 
addiction to activity, as well as provide a foundation for better understanding gene 
interactions behind the unique phenotype and behavioral traits that selected mice in this 
experiment display. 
With the exception of one study which used bipartite networks created in Pajek to 
interpret gene expression profiling results and study the human natural killer cell 
response to Fc receptor activation (Campbell et al., 2015) , the majority of studies using 
these kinds of networks have investigated social networks rather than genomic 
information (Jarrett et al., 2015; Lee et al., 2015; Son, Jeong, Kang, Kim, & Lee, 2015). 
A network approach to gene expression analysis offers the ability to view complex 
interactions between genes and better visualize often complex results; given the success 
and clarity of the networks created in this chapter, it is clear that this approach has merit. 
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TABLES AND FIGURES 
 
Table 4.1 Genes differentially expressed (FDR-adjusted P-value < 0.05) in the HL-LL 
orthogonal contrast that are associated with 4 out of 5 addiction-related KEGG pathways 
(Cocaine, Amphetamine, Nicotine, Morphine, and Alcoholism).  
 
Gen
e 
nam
e 
Log2(fold_c
hange) 
P-
value 
FDR-
adjus
ted P-
value 
Coca
ine 
Amphet
amine 
Nico
tine 
Morp
hine 
Alcoho
lism 
Grin
3b 
0.283349 0.520
221 
0.999
983 
X X X  X 
Adc
y5 
-1.89602 0.003
1859 
0.180
35 
X X  X X 
Grin
2a 
-0.0406627 0.938
633 
0.999
983 
X X X  X 
Gna
s 
0.023829 0.950
036 
0.999
983 
X X  X X 
Grin
3a 
-0.105548 0.847
177 
0.999
983 
X X X  X 
Grin
2d 
0.0725926 0.903
488 
0.999
983 
X X X  X 
Prka
ca 
0.0364295 0.928
957 
0.999
983 
X X  X X 
Grin
1 
0 1 1 X X X  X 
Grin
2b 
0 1 1 X X X  X 
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Table 4.2 Genes differentially expressed (FDR-adjusted P-value < 0.05) in the HH-LH 
orthogonal contrast that are associated with 4 out of 5 addiction-related KEGG pathways 
(Cocaine, Amphetamine, Nicotine, Morphine, and Alcoholism).  
 
Gene 
name 
:og2(fold_
change) 
P_val
ue 
FDR-
adjust
ed P-
value 
Coc
aine 
Amphet
amine 
Nico
tine 
Morp
hine 
Alcoh
olism 
Grin3
b 
-0.116839 0.598
43 
0.999
923 
X X X   X 
Grin2
c 
0 1 1 X X X   X 
Adcy
5 
0.175005 0.264
837 
0.999
923 
X X   X X 
Grin2
a 
0.087299 0.660
92 
0.999
923 
X X X   X 
Gnas 0.0920964 0.570
954 
0.999
923 
X X   X X 
Grin1 0 1 1 X X X   X 
Grin3
a 
0.0608015 0.767
884 
0.999
923 
X X X   X 
Grin2
b 
0.468909 0.398
417 
0.999
923 
X X X   X 
Grin2
d 
0.0409913 0.858
449 
0.999
923 
X X X   X 
Prkac
a 
0.0244129 0.864
523 
0.999
923 
X X   X X 
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Table 4.3 Genes differentially expressed (FDR-adjusted P-value < 0.05) in the HH-HL 
orthogonal contrast that are associated with 4 out of 5 addiction-related KEGG pathways 
(Cocaine, Amphetamine, Nicotine, Morphine, and Alcoholism).  
Gen
e 
nam
e 
:og2(fold_c
hange) 
P_val
ue 
FDR-
adjust
ed P-
value 
Coca
ine 
Ampheta
mine 
Nico
tine 
Morp
hine 
Alcoho
lism 
Grin
3b 
-0.0548958 0.783
101 
0.999
891 
X X X   X 
Grin
2c 
0 1 1 X X X   X 
Adc
y5 
-0.106203 0.515
129 
0.999
891 
X X   X X 
Grin
2a 
0.137666 0.528
34 
0.999
891 
X X X   X 
Gna
s 
0.0495467 0.766
664 
0.999
891 
X X   X X 
Grin
1 
0 1 1 X X X   X 
Grin
3a 
0.0174095 0.937
886 
0.999
891 
X X X   X 
Grin
2b 
-0.194388 0.701
793 
0.999
891 
X X X   X 
Grin
2d 
-0.0874407 0.723
722 
0.999
891 
X X X   X 
Prka
ca 
0.00369336 0.980
037 
0.999
891 
X X   X X 
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Table 4.4 Number of genes significantly expressed in each orthogonal contrast found in 
KEGG addiction-related pathways (Cocaine, Amphetamine, Nicotine, Morphine, and 
Alcoholism) 
Genes present in:  HL-LL HH-LH HH-HL 
Cocaine Pathway 40 47 47 
Amphetamine Pathway 51 63 63 
Nicotine Pathway 36 40 40 
Morphine Pathway 73 88 88 
Alcoholism Pathway 128 149 149 
1 Four groups: high activity genotype-high activity environment (HH); high activity 
genotype-low activity environment (HL); low activity genotype-high activity 
environment (LH); and low activity genotype-low activity environment (LL). 
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Table 4.5 The number of genes in each orthogonal contrasts shared between multiple 
KEGG addiction-related pathways (Cocaine, Amphetamine, Nicotine, Morphine, and 
Alcoholism) 
Genes present in:  HL-LL HH-LH HH-HL 
Only 1 Pathway 125 158 158 
2 Pathways 52 57 57 
3 Pathways 21 25 25 
4 Pathways 9 10 10 
5 Pathways 0 0 0 
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Figure 4.1 Gene-pathway bipartite network constructed with gene expression profiles 
from the orthogonal contrast HL-LL and addiction-related pathway information from the 
KEGG database. Nodes are sorted top-down in decreasing order of log2(fold change). 
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Figure 4.2 Gene-pathway bipartite network constructed with gene expression profiles 
from orthogonal contrast HH-HL and addiction-related pathway information from the 
KEGG database. Nodes are sorted top-down in decreasing order of log2(fold change). 
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Figure 4.3 Gene-pathway bipartite network constructed with gene expression profiles 
from orthogonal contrast HH-LH and addiction-related pathway information from the 
KEGG database. Nodes are sorted top-down in decreasing order of log2(fold change). 
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Figure 4.4 Gene-pathway waterfall network constructed with gene expression profiles 
from orthogonal contrast HL-LL and addiction-related pathway information from the 
KEGG database.  
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Figure 4.5 Gene-pathway waterfall network constructed with gene expression profiles 
from orthogonal contrast HH-HL and addiction-related pathway information from the 
KEGG database 
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Figure 4.6 Gene-pathway waterfall network constructed with gene expression profiles 
from orthogonal contrast HH-LH and addiction-related pathway information from the 
KEGG database 
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